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Mechanisms of Basal Ganglia Development 
Ori Jacob Lieberman 
 Animals must respond to external cues and changes in internal state by modifying their 
behavior. The basal ganglia are a collection of subcortical nuclei that contribute to action 
selection by integrating sensorimotor, limbic and reward information to control motor output. In 
early life, however, animals display distinct behavioral responses to risk and reward and 
enhanced vulnerability to neuropsychiatric disease. This arises from the postnatal maturation of 
brain structures such as the striatum, the main input nucleus of the basal ganglia. Here, using 
biochemical, electrophysiological and behavioral approaches in transgenic mice, I have explored 
the molecular and circuit mechanisms that control striatal maturation.  
 In Chapter 1, I begin by reviewing the structure, physiology and function of the basal 
ganglia, with an emphasis on the striatum. I then describe the existing literature on the 
development and maturation of striatal neurons and their afferents. In Chapter 2, I review the 
molecular mechanisms of macroautophagy, a lysosomal degradation pathway that has recently 
been implicated in the regulation of neurotransmission, including its contribution to neuronal 
development, neurotransmitter release, and postsynaptic function.   
 The subsequent chapters can be split into two themes. In the first, encompassing chapters 
3 and 4, I characterize the postnatal maturation of striatal physiology and define circuit 
mechanisms that control this process. In Chapter 3, I demonstrate that dopamine (DA) 
neurotransmission in the striatum initiates the maturation of striatal projection neuron (SPN) 




increased activity of the potassium channel, Kir2. Interestingly, introduction of DA beginning in 
adulthood could not rescue SPN hyperexcitability while it could during the juvenile period. In 
Chapter 4, I characterize the maturation of cholinergic interneurons (ChIs) in the striatum and 
describe the biophysical mechanisms that drive increases in spontaneous activity that occur in 
ChIs during postnatal development. Finally, I show that the functional maturation of ChIs leads 
to changes in DA release during the postnatal period.  
The second theme includes Chapters 5 and 6, in which I explore the role of 
macroautophagy in striatal function and development. In chapter 5, I used biochemical 
approaches to show that autophagic flux is suppressed postnatally in the striatum due to 
increased signaling through the kinase activity of the mammalian target of rapamycin. In Chapter 
6, I generated conditional knockouts of Atg7, a required macroautophagy gene, in different 
populations of SPNs and find that macroautophagy plays cell-type specific roles in SPN 
physiology. In one subtype of SPNs, macroautophagy regulates intrinsic excitability via 
degradation of Kir2 channels, which is the first demonstration of macroautophagic control of 
neuronal excitability.  
Finally, in Chapter 7, I conclude with a general discussion, where I highlight themes in 
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Chapter 1: Striatal Neurophysiology and Development 
Selecting appropriate actions in response to environmental cues is critical for organismal 
survival. The basal ganglia are a group of highly conserved subcortical nuclei that integrate 
sensorimotor and reward information to select appropriate actions. Although basal ganglia 
dysfunction has classically been studied in the context of neurodegenerative diseases such as 
Parkinson’s disease and Huntington’s disease, it has recently been proposed to underlie some 
symptom domains in neurodevelopmental disorders such as Autism Spectrum Disorder (ASD); 
cognitive rigidity and perseverative behaviors cause significant morbidity in children with ASD 
and can be thought of as deficits in normal basal ganglia functions (Fuccillo, 2016). Although 
neurodevelopmental disorders such as ASD continue into adulthood, they present in young 
children, suggesting that disrupted development or postnatal maturation of the basal ganglia may 
contribute to ASD symptoms. 
Here, I will review the anatomy, physiology and contribution to behavior of the basal 
ganglia with an emphasis on its main input nucleus, the striatum. I will then describe what is 
known about basal ganglia development and postnatal maturation and discuss how these may 
contribute to neurodevelopmental disorders.  
1.1 Anatomy and Function of the Basal Ganglia 
1.1.1 Compartments and Structure of the Striatum 
Although references to what we now know to be the basal ganglia can be found as early 
as the work of Galen, our knowledge of the structure and function of the basal ganglia circuitry 
has predominantly been collected over the past half century. The collection of nuclei that are 





Mehler, 1966), and represent a series of parallel loops that contribute to and modulate the 
pyramidal and extrapyramidal motor systems and the limbic system (Alexander and Crutcher, 
1990) (Figure 1.1). 
The primary input nucleus of the basal ganglia is the striatum. In primates, the striatum is 
separated into two distinct nuclei, the caudate and putamen, by the internal capsule. A third 
region, called the nucleus accumbens, is located ventrally to the striatum and is distinguished by 
the inputs it receives but will not be discussed further here.  
The spiny projection neuron (SPN) represents approximately 95% of neurons in the 
striatum (Kemp and Powell, 1971a). Originally thought to be an interneuron, elegant studies 
from Kitai, DiFiglia and others, however, conclusively demonstrated that the axons of these 
SPNs project out of the striatum (Bunney and Aghajanian, 1976; DiFiglia et al., 1976; Liles, 
1974; Preston et al., 1980). SPNs are GABAergic neurons (Kita and Kitai, 1988; Precht and 
Yoshida, 1971; Yoshida and Precht, 1971) characterized by medium-sized somata (10-20 µm) 
and radiating complex dendritic trees with a high density of dendritic spines (Kemp and Powell, 
1971a). The remaining 5% of striatal neurons are composed by numerous types of interneurons 
including the large, aspiny cholinergic interneuron and numerous types of GABAergic 





The excitatory inputs to the striatum from the cortex and thalamus were originally 
described by Ramon y Cajal. The striatum receives excitatory input from the intralaminar and 
central median nuclei of the thalamus (Buchwald et al., 1973; Cowan and Powell, 1956; Kitai et 
al., 1976; Purpura and Malliani, 1967). Cortical inputs to the striatum arise from diverse regions 
and are also excitatory (Buchwald et al., 1973; Kitai et al., 1976; McGeorge and Faull, 1989). 
The striatum also receives a dense dopaminergic projection from the substantia nigra pars 
compacta (SNc) in the ventral midbrain (Andén et al., 1966).  
 
Figure 1.1. Schematic Representation of dSPN and iSPN inputs and outputs. (A) D1-expressing dSPNs and D2-
expressing iSPNs receive inputs from cortical pyramidal neurons and the CM and Pf nuclei of the thalamus. DA inputs 
modulate dSPN and iSPN activity. dSPN axons project to the GPi/EPN and SNr and send collaterals to the GPe. iSPNs send 
projections to the GPe. (B) Cholinergic interneurons (ChAT/ChI) synapse on dSPNs and iSPNs, modulate DA release, and 
receive excitatory thalamic inputs. GABAergic (PV) interneurons receive excitatory inputs from the cortex and provide 






SPNs can be divided into two intermingled classes of neurons based on their axonal 
projections and the expression of neurochemical markers. Direct pathway SPNs (dSPNs) project 
monosynaptically to the basal ganglia output nuclei while indirect pathway SPNs (iSPNs) project 
to the external segment of the globus pallidus which is disynaptically connected to the output 
nuclei via the subthalamic nucleus. The projection pattern and downstream basal ganglia nuclei 
will be further explored below.  
Despite similar (but not identical) electrophysiological and morphological properties (see 
below), dSPNs and iSPNs express divergent molecular markers. dSPNs express the dopamine 
(DA) D1 receptor and iSPNs expressed the DA D2 receptor (Gerfen et al., 1990; Gong et al., 
2003; Surmeier et al., 1996). DA receptors are classic 7-transmembrane, G-protein coupled 
receptors and can be classified into two main classes (Kebabian and Calne, 1979): D1/5 type 
which are positively coupled to adenylyl cyclase by Gas or Gaolf (Corvol et al., 2001; Hervé et al., 
1993, 2001) and D2-type which are negatively coupled to adenylyl cyclase via Gai (Kebabian 
and Calne, 1979). The divergent DA receptor expression between dSPNs and iSPNs have led to 
a model in which acute exposure to DA stimulates dSPN activity and inhibits iSPN activity 
(Gerfen and Surmeier, 2011). These two SPN populations also differ in their expression of 
neuropeptides: dSPNs express substance P and dynorphin while iSPNs express enkephalin 
(Gerfen and Young, 1988; Gerfen et al., 1990). In addition to GABA transmission from SPN 
terminals,  neuropeptide release critically regulates basal ganglia-mediated behaviors 
(Broekkamp et al., 1979; Joyce and Iversen, 1979; Joyce et al., 1981; Kelley et al., 1985; Steiner 
and Gerfen, 1998; Stinus et al., 1978). Approximately ~200 additional genes are differentially 
expressed between dSPNs and iSPNs and may contribute to cell-type specific differences in 





In addition to the classic segregation of SPNs between the direct and indirect pathways, 
two distinct interspersed zones within the striatum, termed the striosome (or patch) and matrix, 
can be distinguished based on gene expression, afferent inputs, and projection pattern. Graybiel 
and colleagues initially observed regions of low acetylcholinesterase (AchE) expression within 
the striatum, which they called striosomes, that are small “islands” within a background of high 
AchE expression in the striatal matrix of cats (Graybiel and Ragsdale, 1978). Striosomes 
correspond with regions of high mu-opioid receptor expression in the rat (Herkenham and Pert, 
1981), and account for approximately 15% of the striatal volume. The dendrites and axons of 
SPNs within each compartment generally observe the compartment boundaries (Walker et al., 
1993). SPNs in the striosome send axon collaterals to DA neurons of the SNc in addition to their 
axonal projections to direct pathway targets (GPi/EPN and SNr) (Fujiyama et al., 2011; Gerfen, 
1984; Tokuno et al., 2002). Distinct cortical regions also project to striosomal versus matrix 
SPNs: limbic areas primarily project to striosomes while sensorimotor areas project to the matrix 
(Eblen and Graybiel, 1995; Gerfen, 1989; Jiménez-Castellanos and Graybiel, 1989; Kincaid and 
Wilson, 1996). Recent reports, however, have questioned whether there is such segregation in 
the afferents and efferents between the striosome and matrix compartments (Smith et al., 2016) 
and differences in species or technical approach may underlie the reported discrepancies. 
Nevertheless, the striosome/matrix organization of the striatum provides a mechanism for the 
integration of limbic information into the dorsal regions of the striatum that are classically 
oriented towards sensorimotor processing.   
1.1.2 Models of Motor Control by the Basal Ganglia  
The distinct projections of dSPN and iSPNs give rise to the two classic basal ganglia 





the internal segment of the globus pallidus (referred to as the entopeduncular nucleus in rodents; 
GPi/EPN) and the substantia nigra pars reticulata (SNr) (Beckstead and Cruz, 1986; Bolam and 
Smith, 1992; Chang et al., 1981; Gerfen, 1985; Kawaguchi et al., 1990). The GABAergic 
neurons of the GPi/EPN and SNr are highly active (DeLong, 1972) and provide tonic inhibition 
to the ventral thalamic nuclei via a direct projection (Deniau et al., 1978a). In addition, these 
output nuclei project to various other regions to control movement including the superior 
colliculus (Smith and Bolam, 1991; Williams and Faull, 1985), pedunculopontine and 
laterodorsal tegmentum (Tokuno et al., 1989) and reticular formation (von Krosigk et al., 1992). 
In contrast, iSPNs project indirectly to the GPi/EPN and SNr via the external segment of the 
globus pallidus (GPe) (Beckstead and Cruz, 1986; Chang et al., 1981; Flaherty and Graybiel, 
1993; Gerfen and Young, 1988; Wilson and Phelan, 1982), a GABAergic nucleus (Penney and 
Young, 1981), and the subthalamic nucleus (STN) (Smith et al., 1990), a glutamatergic nucleus 
(Deniau et al., 1978b; Hammond et al., 1978; Nakanishi et al., 1987; Smith and Parent, 1988). 
SPN projections do not exclusively go to GPi/EPN and SNr or GPe but instead each cell sends a 
large projection to one and a minor collateral to the other (Kawaguchi et al., 1990), allowing for 
crosstalk between the pathways. Finally, information that passes through the basal ganglia is also 
processed through feedback pathways, in which “downstream” nuclei, such as the STN, send 
axonal projection back to “upstream” nuclei such as the GPe; the hyperdirect pathway from 
cortex to the STN; and via complex lateral connections within the striatum, GPe and STN (Burke 
et al., 2017; Gittis et al., 2014; Nambu et al., 2002; Smith et al., 1998). 
This evidence led Ueki and Yoshida to propose the disinhibition hypothesis to explain 
how the basal ganglia control movement (Ueki and Yoshida, 1976). They proposed that the 





which facilitates thalamic activity because the thalamus is tonically inhibited by the GPi/EPN 
and SNr. This model is supported by the elegant work of Deniau (Deniau and Chevalier, 1985), 
in which (1) nigrothalamic neurons were identified via antidromic stimulation of the thalamus 
and shown to be inhibited by striatal stimulation (Deniau et al., 1976) and (2) thalamocortical 
neurons, identified by antidromic stimulation of the cortex, are inhibited by stimulation of the 
SNr (Deniau et al., 1978a). Roger Albin and Mahlon DeLong subsequently proposed that the 
indirect pathway would oppose movement by facilitating the tonic activity of the GPi/EPN and 
SNr, thereby increasing inhibition of the thalamus and decreased thalamocortical activity (Albin 




Figure 1.2. Schematic representation of direct and indirect pathways of the basal ganglia. Circuit diagram showing 
efferent projections of basal ganglia nuceli and how they regulate thalamocortical and spinal cord activity. Adapted from 






The advent of new technologies in neuroscience has led to further support for the 
Albin/DeLong/Deniau model. First, Kreitzer and Kravitz used channelrhodopsin, a light 
sensitive ion channel that can be expressed cell-type specifically (Boyden et al., 2005), to 
demonstrate that activation of dSPNs promotes locomotion while activation of iSPNs reduces 
locomotion (Kravitz et al., 2010). These findings provided additional causal support for the 
Albin and DeLong model.  
Albin and DeLong postulated that direct pathway activity would promote movements 
while indirect pathway activity would suppress alternative unwanted actions. In fact, in the same 
issue of Trends in Neurosciences that DeLong and Albin proposed their rate models, Alexander 
and Crutcher (Alexander and Crutcher, 1990) proposed the following: 
“One possibility is that both the 'direct' (GABA/substance P) and the 'indirect' 
(glutamatergic) inputs to the basal ganglia output nuclei that are activated 
selectively and concurrently in association with a particular cortically initiated 
movement may be directed to the same set of GPi/SNr neurons. With this 
arrangement, the inputs from the indirect pathway might be seen as either 
'braking' or 'smoothing' the same cortically initiated motor pattern that was being 
reinforced by the direct pathway.”  
The recent adaptation of genetically-encoded fluorescent calcium reporters (Lin and Schnitzer, 
2016) has permitted recording activity of either direct pathway or indirect pathway SPNs in 
awake behaving mice and testing the Alexander and Crutcher prediction that dSPNs and iSPNs 
would be coactivated during behavior to simultaneously promote desired movements and 
suppress unwanted movements. Costa and Lovinger, and subsequently others (Barbera et al., 
2016; Klaus et al., 2017; Parker et al., 2018; Tecuapetla et al., 2014), clearly demonstrated 
coactivation of dSPNs and iSPNs during an operant task (Cui et al., 2013), confirming the 





 Thus, the recent advances in cell-type specific tools to manipulate and record neuronal 
activity have highlighted salient aspects of classic theories of the basal ganglia, including the 
ideas that dSPNs and iSPNs coordinately process incoming sensorimotor information to select 
actions. Inappropriate activity of these pathways, or imbalance between them, could drive 
disrupted action selection seen in neurodevelopmental diseases described below.    
1.2 Cellular Physiology of Striatal Neurons and Dopamine Release 
 As its main input nucleus, the striatum represents a key node in information processing in 
the basal ganglia-cortical-thalamic loop. In this section, I will describe the key features of the 
synaptic and intrinsic properties of striatal neurons that ensure proper striatal function. 
Early work in cats and primates identified two groups of neurons in the striatum with 
distinct firing properties (Crutcher and DeLong, 1984a, 1984b; Kimura et al., 1984; Liles, 1985). 
The first group had low basal firing rates (0.5-1 Hz) but became phasically activated during 
movement.  The second had higher tonic firing rates (2-7 Hz) and, in some cases, decreased their 
firing rate in response to salient cues (Aosaki et al., 1994a).  Subsequent tracing studies 
identified the first group as SPNs (Kimura et al., 1990) and the second as cholinergic 
interneurons (ChI) (Kawaguchi, 1993). Numerous subtypes of GABAergic neurons were 
subsequently described and, although they play a significant role in the control of striatal 
activity, will be not be discussed further here as they have been reviewed in detail elsewhere 





1.2.1 Striatal Projection Neurons (SPNs) 
SPNs must filter sensorimotor and limbic information from the cortex and thalamus and 
modulatory input from the brain stem to select action plans. The mechanisms through which 
their physiology permits them to act as a filter for this information is described here.  
Intracellular recordings in anesthetized and awake rats revealed that SPNs oscillate between 
down-states, around -80 mV near the potassium reversal potential, and near-threshold up-states, 
where action potentials are fired (Wilson, 1993; Wilson and Groves, 1981; Wilson and 
Kawaguchi, 1996). Although up- and down-states are exaggerated in the anesthetized state 
because of artificial cortical oscillations elicited by anesthesia, the firing patterns of SPNs during 
this state highlight several salient features of SPN neurophysiology and are, therefore, useful to 
discuss.  
 
Figure 1.3. Intracellular recording of SPN firing in an adult rat. Intracellular recording of an SPN from an anesthetized 
rat clear shows the down-state, which is governed by Kir2 currents, the up-state, governed by other potassium currents and 







In the down-state, the primary active conductance is mediated by the inwardly-rectifying 
potassium channels (Kir) (Calabresi et al., 1987a; Nisenbaum et al., 1994; Uchimura et al., 1989; 
Wilson and Kawaguchi, 1996). SPNs express two isoforms of Kir channels: Kir2.1, encoded by 
kcnj2, and Kir2.3, encoded by kcnj4 (Cazorla et al., 2012; Karschin et al., 1996; Shen et al., 
2007). Kir2 channels are voltage-sensitive and are blocked at membrane potentials above -60 
mV (Hibino et al., 2010). Kir2 currents contribute to the short time constants and low input 
resistance of SPNs in the down-state and their rapid block in response to depolarizing inputs 
enables the sharp transition from the down-state to the up-state in SPNs (Wilson and Kawaguchi, 
1996).  
  The transition to the up-state is initiated by excitatory synaptic inputs (Kawaguchi et al., 
1989; Wilson et al., 1983) and occurs in phase with electrocorticogram signal and cortical local 
field potentials (Kasanetz et al., 2002, 2006). Once in the up-state, subthreshold fluctuations 
occur which sometimes bring the cell to the action potential threshold. In the up-state, SPN 
action potential firing is governed by additional potassium currents such as IA , IM, and ID (Shen 
et al., 2004, 2005, 2007). These contribute to a classic ramping depolarization observed in SPNs 
in response to current injection.  Thus, in both the up- and down-state, the SPN resists firing via 
several distinct potassium currents (Wilson and Kawaguchi, 1996). 
One key feature of SPN physiology is the requirement for convergent excitatory inputs to 
elicit action potential firing and select actions. Why are convergent excitatory inputs required for 
SPN firing? Kir2 currents in SPNs act as a shunt for excitatory inputs in the down-state, 
necessitating convergent excitatory inputs to the SPN to lead to voltage-dependent inactivation 
of Kir2 channels and transition to the up-state (Wilson and Kawaguchi, 1996). This property is 





being required to receive strong, convergent input to elicit an action potential allows the majority 
of cortical and thalamic “noise” to be filtered out and not passed on to downstream basal ganglia 
structures.  
The processing capacity of the SPN is further enhanced by the organization of its 
synaptic inputs. Excitatory and modulatory inputs innervate distinct regions of SPN dendrites. 
Cortical inputs primarily make asymmetric synapses onto the dendritic spine head (Kemp and 
Powell, 1971b, 1971c). Although thalamic afferents synapse asymmetrically onto both the spine 
head and dendritic shaft of SPNs, the majority form onto the dendritic shaft (Dubé et al., 1988; 
Sadikot et al., 1992; Smith et al., 1994). Dopaminergic synapses form on the spine neck and 
dendritic shaft (Bouyer et al., 1984; Freund et al., 1984), suggesting that DA release could affect 
SPN activity via modulation of afferent inputs. Importantly, individual SPNs receive inputs from 
both thalamus and cortex (Kemp and Powell, 1971d, 1971c), allowing them to synaptically 
integrate information from both brain regions. Finally, cortical regions somatotopically project 
onto areas of the striatum (Flaherty and Graybiel, 1993; Goldman-Rakic and Selemon, 1986; 
Hoffer and Alloway, 2001; Jones et al., 1977; McGeorge and Faull, 1989; Wall et al., 2013) and 
that individual cortical axons provide a few synapses onto many different SPNs (Kincaid and 
Wilson, 1996), implying that SPNs not only require strong convergent excitation to fire but also 
that this must arise from the near simultaneous activity of multiple cortical neurons.  
Interestingly, despite many similarities, cell-type specific differences in SPN morphology 
and physiology exist. The advent of transgenic mice expressing fluorescent proteins under the 
control of the promoter sequence for D1 or D2 receptors has permitted cell-type specific analysis 
of the electrophysiology and morphology of SPNs. Surmeier and colleagues have reported that 





(Gertler et al., 2008). Similar findings demonstrating electrophysiological and morphological 
differences between iSPNs and dSPNs have been reported by some groups (Warre et al., 2011), 
but not others (Cepeda et al., 2008; Suárez et al., 2014), suggesting that further research is 
required to define the exact differences between SPN subtypes. Interestingly, excitability is also 
distinct between striosome and matrix SPNs (Smith et al., 2016).  These data suggest that dSPNs 
may require more convergent excitation than iSPNs to fire action potentials with implications for 
action selection by the basal ganglia.  
1.2.2 Cholinergic Interneurons (ChIs) 
 Cholinergic interneurons (ChIs) represent approximately 1-2% of striatal neurons and 
were originally described as a population of tonically active neurons in the striatum that paused 
their firing in response to salient, or reward-associated, stimuli (Aosaki et al., 1994a; Kemp and 
Powell, 1971a, 1971d; Wilson et al., 1990). ChIs are characterized by their large somata (>50 
µm in length), dendritic fields that can extend up to 0.5-1 mm from the cell body and widespread 
and dense axonal arborizations (Chang and Kitai, 1982; DiFiglia, 1987; DiFiglia and Carey, 
1986; Kawaguchi, 1993). Their firing pattern and the fact that they innervate large volumes of 
the striatum suggest that they are positioned as key nodes in the striatal microcircuit. In this 
section, I will describe their physiology and briefly discuss their role in mediating action 
selection (Figure 1.5). The intersection between ChI activity and DA release will be discussed in 
the subsequent section.   
ChIs fire wide action potentials that are followed by deep afterhyperpolarizations at 2-7 
Hz both in vivo (Wilson et al., 1990) and in the acute brain slice (Kawaguchi, 1993). Firing 





firing. Both modes are cell-autonomous and can occur in the absence of synaptic inputs (Bennett 
and Wilson, 1999).  
 What currents contribute to ChI firing? Tonic firing is driven initially by HCN channels 
which depolarize the cell to -60 mV, where they inactivate (Jiang and North, 1991). Persistent 
sodium channels then activate and drive the cell to the action potential threshold (Bennett et al., 
2000). Cav2.1 and Cav2.2 open during the action potential which subsequently activate the BK 
and SK channels which repolarize the cell and determine the depth of the AHP (Bennett et al., 
2000; Goldberg and Wilson, 2005; Wilson and Goldberg, 2006). In response to depolarizing 
current injection (or excitatory synaptic input), ChIs increase their firing frequency with some 
spike frequency adaptation. When the depolarizing stimulus is removed, ChI firing undergoes a 
prolonged pause called the slow afterhyperpolarization (sAHP), in contrast to the AHP that 
occurs after individual action potentials that is called the mAHP. The length of the sAHP is 
determined by a barium-sensitive, rectifying potassium current (IKr) (Wilson, 2005). Following 
the sAHP, ChIs fire a rebound burst at a higher frequency than the tonic firing rate. In response 
to hyperpolarizing currents, ChIs fire bursts of action potentials as well.  
 Classic in vivo recordings of ChIs in monkeys demonstrated that, although ChIs fire 
tonically, a subset of recorded cells pause their firing for several hundred milliseconds following 
a sensory cue. If the sensory cue is not associated with a reward, approximately 15% of recorded 
ChIs will respond with a pause. Pairing the sensory cue to a reward can recruit up to 60-70% or 
recorded ChIs to pause (Aosaki et al., 1994a). What drives the pause response? The pause is 
time-locked with changes in DA neuron firing in response to rewarded cues (see below) and DA 
lesions eliminate the pause (Aosaki et al., 1994b). Furthermore, the pause depends on excitatory 





proposed model in which excitation, modulated by DA, depolarizes the ChI and activates 
 
Figure 1.4. ChI firing pattern and response to salient stimuli. (A) Whole-cell recordings of a ChI shows spontaneous 
action potential firing. (B) The action potential width in a ChI is determined by voltage gated calcium channels and BK 
channels. (C) SK channels govern the afterhyperpolarization (mAHP). Repolarization is governed by IA, HCN and persistent 
sodium currents. Adapted from(Goldberg and Wilson, 2005). (D) Single unit recordings of ChIs in an awake monkey before 
(left) and after (right) training to associate the click with a reward. ChIs pause their firing after the click after association of 
the click with reward. EMG of arm muscles shows reaching activity after click after conditioning but not before 






conductances such as IKr which drive the sAHP and a several hundred millisecond pause (Ding et 
al., 2010; Reynolds et al., 2004; Zhang et al., 2018).   
ChIs influence the striatum by their effects on muscarinic and nicotinic ACh receptors 
expressed on almost all striatal neurons (for review, see (Goldberg et al., 2012)). Postsynaptic 
muscarinic receptors on SPNs affect both intrinsic excitability, basal synaptic transmission and 
synaptic plasticity. These effects are generally considered to be slow, as muscarinic receptors are 
metabotropic. In contrast, fast effects of ACh are mediated by nicotinic receptors expressed on 
striatal GABAergic interneurons and DA axons (see below), suggesting that ChI firing not only 
affect a large proportion of striatal neurons but can act on them over distinct timescales to 
convey critical information about the salience of sensory stimuli. 
1.2.3 Dopamine (DA) release 
Ventral midbrain dopamine (DA) neurons project to the striatum to provide 
neuromodulatory input.  DA neurons can be divided anatomically into two groups called the 
ventral tegmental area (VTA; A10 group) and substantia nigra pars compacta (see above; SNc, 
A9) (Andén et al., 1966; Björklund and Dunnett, 2007). VTA DA neurons project to the nucleus 
accumbens and cortex, forming the mesocorticolimbic pathway, while SNc DA neurons project 
to the dorsal striatum, via the medial forebrain bundle (MFB) and will be the focus of further 
discussion here.  
 The activity of DA neurons conveys behaviorally relevant information and stimulates 
striatal DA release. DA neurons tonically fire at 2-8 Hz but their pacemaking is interrupted by 
short (100-200 ms) bursts of phasic firing up to 12-15 Hz (Bunney et al., 1973a, 1973b, Grace 
and Bunney, 1984b, 1984a).  DA neurons fire wide action potentials lasting up to 4 ms (Bunney 





hyperactivation-activated cation (HCN) channel-mediated IH and low- and high-threshold 
calcium channels (Galarraga and Bargas, 1995; Grace, 1991; Grace and Bunney, 1984b, 1984a, 
Kang and Kitai, 1993a, 1993b; Kita et al., 1986; Nedergaard et al., 1993; Wilson and Callaway, 
2000). The characteristic afterhyperpolarization of DA neurons is mediated by SK channels and 
inhibition of these channels is sufficient to drive bursts of action potentials (Shepard and 
Bunney, 1991; Waroux et al., 2005; Wolfart et al., 2001).   
Phasic bursts in DA neurons occur in response to salient stimuli such as sensory cues 
paired to rewards (Freeman et al., 1985; Guarraci and Kapp, 1999; Horvitz et al., 1997; Schultz, 
1998). However, with recent advances in imaging and recording techniques, phasic bursts in DA 
firing have been found to relate to other aspects of behavior including action initiation and 
aversive stimuli and excellent recent reviews have addressed advances in our understanding of 
what DA neuron firing encodes (Coddington and Dudman, 2018, 2019; Dodson et al., 2016; 
Engelhard et al., 2019; Howe and Dombeck, 2016; da Silva et al., 2018).  
 Salient stimuli associated with rewards lead to increased striatal DA release (Garris et al., 
1997, 1999; Wightman and Robinson, 2002). In addition to axonal DA release, DA can be 
released from the dendrites of DA neurons, but this will not be further explored here. 
Extracellular DA in the striatum is elevated after these stimuli due to the phasic firing of DA 
neurons (Bean and Roth, 1991; Gonon, 1988; Manley et al., 1992). Striatal DA release can also 
be regulated locally at the axon terminal at the level of DA synthesis (Haubrich and Pflueger, 
1982; Kapatos and Zigmond, 1979b, 1979a; Kehr et al., 1972; Lerner et al., 1977; Zivkovic et 
al., 1975), uptake of DA into synaptic vesicles (Edwards, 2007), and calcium entry into the 
presynaptic boutons by DA autoreceptors and heteroreceptors on the DA axon (Brimblecombe et 





that striatal DA release may not have complete fidelity with somatic activity. Furthermore, D2 
autoreceptors present on the DA axon transiently activate G-protein coupled, inwardly rectifying 
 
 
Figure 1.5. Cholinergic control of DA release. (A) Schematic of the action of ACh on DA release. When nAChR are 
activated, DA release is independent of the frequency of DA neuron activity (left). When nAChRs are not active, DA release 
scales proportionally with the frequency of DA neuron firing. (B) ChR2-mediated activation of ChIs drives DA release as 






potassium channels (GIRKs), which hyperpolarize the DA axon and reduce vesicular release 
(Cragg and Greenfield, 1997; Lacey et al., 1987; Starke et al., 1978).  
DA release is also strongly regulated by heteroreceptors for acetylcholine (ACh), opioids, 
and GABA (for review, see (Sulzer et al., 2016); Figure 1.6). I will focus here on cholinergic 
regulation of DA release. The balance between cholinergic and dopaminergic signaling is tightly 
regulated in the striatum. ACh controls DA release via nAChRs present on DA axons, primarily 
as α4α5β2 and α6β2β3 subtypes (Azam et al., 2002; Exley et al., 2008; Le Novère et al., 1996; 
Wonnacott et al., 2000; Zoli et al., 2002). The effect of nAChR activation has been studied both 
in the acute brain slice and in vivo. In the acute slice, nAChRs act as a frequency-dependent filter 
on DA release: enhancing DA release in response to single electrical stimuli but reducing DA 
release in response to phasic stimuli (Rice and Cragg, 2004; Zhang and Sulzer, 2004; Zhou et al., 
2001). This confers frequency-independence to DA release in response to striatal electrical 
stimulation in the acute brain slice. Furthermore, ACh release from ChIs can also directly elicit 
DA release via axo-axonic synapses onto DA terminals (Cachope et al., 2012; Threlfell et al., 
2012). This slice data is consistent with pharmacological experiments conducted in vivo, 
demonstrating that nicotine, at concentrations which desensitize nAChRs, enhances DA release 
in the striatum (Pontieri et al., 1996). The fact that ACh acts as a frequency-dependent filter on 
DA release may also provide additional insight into the circuit effect of ChI pauses in response to 
behavioral stimuli, which happens at the same time as phasic bursting in DA neurons (see 
above): a transient reduction in extracellular ACh amplifies DA release in response to a phasic 
burst. Thus, striatal DA release is controlled by complex regulatory mechanisms that integrates 





1.2.4 Dopaminergic Modulation of SPN Physiology. 
 Once released, DA affects SPN physiology through several mechanisms. The actions of 
DA on SPN neurophysiology is specified by both the DA receptor expressed and the resting 
membrane potential of the SPN at the time of DA action. D1 receptor signaling acts, via PKA, to 
potentiate glutamate transmission by modulating AMPAR and NMDAR (Braithwaite et al., 
2006; Lee et al., 2002; Murphy et al., 2014; Scott et al., 2006; Svenningsson et al., 2004) and 
affect intrinsic excitability via regulation of voltage-gated sodium channels (Calabresi et al., 
1987b; Carr et al., 2003; Kitai and Surmeier, 1993; Surmeier and Kitai, 1993), L/P/Q-type 
calcium channels (Gao et al., 1997; Surmeier et al., 1995), and potassium channels (Higley and 
Sabatini, 2010; Plotkin et al., 2011; Vilchis et al., 2000). Importantly, D1R signaling stabilizes 
both up- and down-states during SPN activity by reducing input resistance in the down state and 
increasing it in the up-state to promote action potential firing (Galarraga et al., 1997; Hernández-
López et al., 1997). D2 receptor signaling similarly modulates synaptic inputs to the SPN and 
intrinsic excitability by affecting surface expression and function of glutamate receptors, sodium 
channels, and calcium channels (Cepeda et al., 1993; Håkansson et al., 2006; Olson et al., 2005; 
Surmeier and Kitai, 1993). 
 In addition to the short term effects of DA on SPN excitability and synaptic inputs 
described above, DA also modulates long-term changes in synaptic strength in the striatum via 
regulation of synaptic plasticity (Centonze et al., 2001; Kreitzer and Malenka, 2008).  
The best studied form of striatal plasticity can be evoked at the corticostriatal synapse by 
high-frequency stimulation of deep-layers of the cortex or the corpus callosum paired with 
postsynaptic depolarization (HFS-LTD or HFS-LTP, see below). When NMDA receptors are 





concomitant NMDA receptor activation leading to long-term potentiation (LTP) (Calabresi et al., 
1992b, 1992a). DA release is required for the induction of HFS-LTD (Calabresi et al., 1992a) 
and HFS-LTP (Centonze et al., 1999). HFS-LTD is expressed presynaptically, as D2 receptor 
activation elicits endocannabinoid synthesis and reduced release probability (Gerdeman et al., 
2002; Ronesi et al., 2004; Yin and Lovinger, 2006). Whether this plasticity occurs in both dSPNs 
and iSPNs, or iSPNs alone remains obscure (Calabresi et al., 2007; Kreitzer and Malenka, 2007). 
Importantly, HFS-LTD is affected by motor learning suggesting that it may act as a neural 
mechanism for this process (Yin et al., 2009).  
Thus, DA, via its control of synaptic transmission and intrinsic excitability, affects the 
integrative properties of striatal neurons and action selection.    
1.3 Striatal Development and Postnatal Maturation 
The distinct physiology of SPNs, ChIs and DA neurons confer the ability on the basal 
ganglia to select actions. How these properties mature during the embryonic and postnatal period 
to achieve the adult state will be reviewed below. In this section, I will begin with a discussion of 
the embryonic development of the striatum, describe the establishment of the striatal circuitry, 
and finally the maturation of striatal neurophysiology and function during the juvenile and 
adolescent period (Figure 1.6).  
Before beginning this discussion, I will define the working definitions I use below to 
describe the different age windows during which the striatum develops and matures. These 
windows will be defined for ages in the rodent unless otherwise specified and correlations 
between rodent and human ages will explicitly not be drawn as these are difficult to make. 





birth is considered Postnatal day 0 (P0). The juvenile period begins with birth and extends until 
P28. Adolescence is generally considered to begin around P28 and continue until P45 and is 
defined not only by the onset of puberty and sexual maturity but also by typical behaviors of 
adolescence such as increased risk taking. In the studies I describe below, adult rodents are 
generally older than P60 but less than 9 months to one year old when early signs of senescence 
appear. I have adapted these guidelines from several reviews written by Linda Spear (Spear, 
2000). 
1.3.1 Cell Fate Specification and Radial Migration  
SPNs arise from the lateral ganglionic eminence (LGE) between E13 and E22 in rats 
(Bayer, 1984; Deacon et al., 1994), while striatal interneurons arise from the medial ganglionic 
eminence (Marin et al., 2000). SPNs then migrate laterally into the striatum (Halliday and 
Cepko, 1992; Hamasaki et al., 2003). Importantly, striatal neurogenesis and tangential migration 
are complete by the end of the embryonic period in the rodent. Numerous transcription factors 
have been identified that specify SPN fate such as Ctip2, Dlx1/2, FoxP1 and FoxP2 (Arlotta et 
al., 2008; Chen et al., 2016; Long et al., 2009; Precious et al., 2016). 
When do SPNs differentiate into striosome and matrix SPNs and dSPN or iSPNs?  
Interestingly, striosomal SPNs differentiate earlier (~E13-15 in rat, E10-E13 in mouse) than 
matrix SPNs (E18-20 in rat, E16.5 in mouse) and are present earlier within the striatum (van der 
Kooy and Fishell, 1987; Liao et al., 2008; Song and Harlan, 1994). Both intrinsic programs and 
extrinsic cues contribute to this early specification. Early work demonstrated that DA inputs 
from the SNc were required for the expression of neurochemical markers but not for the 
segregation of striosome and matrix compartments identified with tritiated thymidine labeling 























































signaling in the expression of these phenotypic markers (Snyder-Keller, 1991). Furthermore, 
Notch and Eph/Ephrin signaling is critical for specifying these distinct compartments (Mason et 
al., 2005; Passante et al., 2008). Similarly, dSPNs and iSPNs differentiate within the LGE and 
migrate radially following cell-fate specification. Subsequently, dSPNs and iSPNs migrate 
radially from the LGE into the striatum and intermix through a non-cell-autonomous mechanism 
to form the adult-like striatal mosaic (Tinterri et al., 2018). Distinct transcriptional programs 
specify dSPN versus iSPN fate including SP8/9, Isl1, Bcf1, and Ebf1 (Ehrman et al., 2013; Lobo 
et al., 2006, 2008; Lu et al., 2014; Rataj-Baniowska et al., 2015; Xu et al., 2018; Zhang et al., 
2016).  These data suggest that SPN subtypes and compartmental organization of the striatum are 
established during the embryonic period. 
1.3.2 Afferent Innervation of the Striatum 
Cortical afferents to the striatum initially arrive around E12-E13. These are 
predominantly fibers of passage that grow into the thalamus and pyramidal tract. Around E17-
E18, collaterals from these axons enter the striatum and arborize (Nisenbaum et al., 1998; Sheth 
et al., 1998). The majority of axonal growth is complete by P7, although some axons continue to 
mature into the second postnatal week (Butler et al., 1998; Dani et al., 1991; Sohur et al., 2014). 
Less is known about the arrival of the thalamostriatal projection but thalamic axons are present 
in the striatum by birth (Agmon et al., 1993) and thalamic stimulation is able to elicit an 
excitatory response in SPNs by postnatal day 6 (Tepper et al., 1998).  
DAergic axons from the SNc arrive in the striatum during the late embryonic period 
(Voorn et al., 1988). Varicosities are observed beginning at birth and reach adult-like densities 
around the end of the second week (Voorn et al., 1988). Interestingly, during the first postnatal 





poor striosomes in the adult (Graybiel, 1984; van der Kooy, 1984; Moon Edley and Herkenham, 
1984; Olson et al., 1972). These regions of elevated DA innervation are then masked by diffuse, 
dense arborization of DAergic axons after P7 (Graybiel, 1984; Olson et al., 1972). Mature axonal 
structure and varicosities are present by the end of the fourth postnatal week (Loizou, 1972). 
1.3.3 Maturation of SPN Activity, Synaptic Inputs and Intrinsic Properties 
Here, I will discuss the maturation of SPN physiology during the early postnatal period in 
rodents. A significant literature exists about striatal maturation in the cat. However, the feline 
striatum is more functionally mature than the rodent striatum at birth. Therefore, most of this 
work will not be considered here.  
SPNs in the adult fire action potentials in bursts, separated by epochs in a hyperpolarized 
state (see above). Tepper et al used intracellular recordings in anesthetized rats to assess the 
firing patterns and electrophysiological properties of SPNs during the postnatal period (Tepper et 
al., 1990, 1998). During the first postnatal month, two sets of changes occur in SPN activity. 
First, Before P15, few SPNs fire spontaneous action potentials in anesthetized rats. Burst firing is 
regularly observed in SPNs by P21, but up- and down-states do not emerge until the end of the 
fourth week. This suggests that the intrinsic currents that control SPN excitatbility and shape 
firing patterns mature postnatally. Second, the properties of cortical or thalamic inputs change as 
well. Cortical or thalamic stimulation elicits excitatory postsynaptic potentials (EPSPs) in SPNs 
as early as P6 (Tepper and Trent, 1993; Tepper et al., 1998). However, in adults, cortical or 
thalamic stimulation elicits an EPSP followed by a long-lasting hyperpolarization (~200-300 ms) 
and a late depolarization (Buchwald et al., 1973; Chang et al., 1981; Wilson et al., 1983). Only 
EPSPs, without the hyperpolarization or late depolarization are observed until P21. As the 





the tonic excitatory activity), this suggests that there is less tonic excitation in younger mice. 
Thus, in addition to changes in the intrinsic properties of the SPN that generate up- and down-
states, maturation of synaptic inputs occur during the postnatal period. These results suggest that 
the features of SPN physiology that confer computational power to the striatal circuit are 
acquired postnatally.  
The maturation of SPN intrinsic properties during the first four postnatal weeks. Until the 
third postnatal week, many SPNs do not exhibit inward rectification (Gertler et al., 2008; 
Misgeld et al., 1986; Peixoto et al., 2016; Tepper et al., 1998). This is accompanied by a decrease 
in the resting membrane potential and input resistance over this time period. In addition, currents 
responsible for the classic depolarized ramping response to current injection, such as ID, increase 
during this period (Surmeier et al., 1991). These intrinsic properties reach the “adult-like” state 
by the end of the fourth postnatal week, about 1 week later than the age at which adult levels of 
dendritic spines and synapses are observed (see below). Importantly, the maturation of intrinsic 
excitability matches the time course of the acquisition of mature up- and down-states, which 
does not occur until the fourth postnatal week, suggesting changes in intrinsic excitability may 
drive the maturation of overall SPN activity and firing patterns.  
Synaptic inputs onto SPNs also form during this period. Seminal electron microscopy 
studies by McGeer and Tepper have elucidated the developmental time course of striatal synapse 
formation (Hattori and McGeer, 1973; Tepper et al., 1998). Both studies demonstrated that the 
number of asymmetric synapses increases during the first four postnatal weeks. Around P14, 
SPN dendrites lack spines. During the next week, axospinous contacts are formed. In contrast to 
axospinous synapses, axodendritic synapses are present in the second postnatal week and do not 





synapse with the dendritic shafts of SPNs and subsequently form synapses on dendritic spine 
heads, as seen in the adult by Kemp and Powell (Kemp and Powell, 1971b). The period of SPN 
synaptogenesis (postnatal week 3), occurs after the dendritic arbor of SPNs has reached adult-
like levels (Lee and Sawatari, 2011). The increased density of dendritic spines during the second 
and third postnatal week corresponds with increases in the amplitude of optically evoked EPSCs 
in SPNs when channelrhodopsin is expressed in cortical neurons (Peixoto et al., 2016). 
Interestingly, the some regional differences exist in the time course of striatal 
synaptogenesis: during the second postnatal week, SPNs in the dorsolateral striatum can have up 
to two times the number of dendritic spines as those in the dorsomedial striatum (Brand and 
Rakic, 1984; Butler et al., 1997, 1998).   
There is no change in the number of symmetric synapses during this period, implying that 
lateral connections between SPNs, or synapses from local inhibitory interneurons are mature by 
the early postnatal period (<P14) (Butler et al., 1998). This is in agreement with reports 
suggesting that GABAergic interneurons of the striatum mature earlier than SPNs and exhibit 
adult-like firing patterns around P14 (Plotkin et al., 2005; Tepper et al., 1998).  
Molecularly, excitatory synaptogenesis onto SPNs is controlled by secreted factors from 
striatal afferents including brain-derived neurotrophic factor (BDNF) (Li et al., 2012), and axon 
guidance cues such as the semaphorin/plexin system (Assous et al., 2019; Ding et al., 2011a).  
What circuit mechanisms drive excitatory synaptogenesis onto SPNs? Kozorovitskiy and 
Sabatini demonstrated that SPN dendritic spine formation depends on cortical activity. 
Remarkably, as cortical activity can be controlled by the basal ganglia itself, excitatory 
synaptogenesis onto SPNs depends on GABA release from SPNs themselves in the GPe or SNr; 





iSPNs  while loss of GABA release from iSPNs leads to an increase in spine density on both 
dSPNs and iSPNs (Kozorovitskiy et al., 2012). Neuromodulation by DA signaling can further 
enhance or restrict dendritic spine formation on SPNs during this period, depending on the DA 
receptor that is activated (Kozorovitskiy et al., 2015).  
The functional properties of excitatory inputs to SPNs also mature during the first four 
postnatal weeks.  In rats, the release probability of cortical inputs onto SPNs goes down after P19 
(Choi and Lovinger, 1997). High-frequency stimulation (HFS) induced striatal plasticity changes 
polarity during the third postnatal week as well: HFS elicits potentiation of corticostriatal 
synaptic plasticity in rats before P14 but synaptic depression afterwards (Choi and Lovinger, 
1997; Partridge et al., 2000). This results from an increased synthesis in the endocannabinoid, 
anandamide, in the striatum between P13 and P16 (Ade and Lovinger, 2007). In addition to 
changes in synaptic plasticity during this period, long-lasting depolarizations are observed in 
response to cortical stimulation in SPNs before P10. These depolarizations are dependent on the 
NMDA receptor subunits NR2C/D (Dehorter et al., 2011).  
To conclude, both excitatory synapses on SPNs that initiate action potential firing and the 
intrinsic conductances that shape firing patterns frequency mature during the first four postnatal 
weeks in the rodent.  
1.3.4 Maturation of Striatal Cholinergic Neurotransmission  
 ChIs are born around E13-E15 in the rat. However, their functional maturation occurs 
over the first postnatal month (Phelps et al., 1989). In the striatum, ACh levels and the activity of 
ACh biosynthetic enzymes linearly increase between birth and P30 (Coyle and Campochiaro, 
1976; Coyle and Yamamura, 1976; Phelps et al., 1989; Sawa and Stavinoha, 1987). Functional 





behavior in the striatum matures by P21 (Burt et al., 1982; Fitzgerald and Hannigan, 1989; 
Guyenet et al., 1975). Little is known about the maturation of ChI activity, how salient cues 
affect ChI activity during the juvenile period or how the ChI control of DA neurotransmission 
matures during this period. 
1.3.5 Maturation of DA Neurotransmission 
In addition to the maturation of excitatory inputs, significant changes occur in 
modulatory inputs to the striatum during the early postnatal period. Total tissue levels of DA in 
the striatum increase dramatically postnatally, reaching adult levels around 6-8 weeks of age 
(Agrawal et al., 1966; Coyle and Campochiaro, 1976; Nomura et al., 1976). This is associated 
with an increase in the activity of the rate-limiting enzyme for DA synthesis, tyrosine 
hydroxylase (TH), from E15 to adulthood (Coyle and Axelrod, 1972).  
The increase in DA synthesis leads to changes in DA neurotransmission. The level of the 
DA metabolites, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), in 
tissue extracts increases around P9, suggesting increased DA turnover at this age as tissue levels 
of these metabolites reflect DA neurotransmission (Restani et al., 1990; Wood and Altar, 1988). 
Furthermore, evoked DA release remains immature in acute brain slices and in vivo through the 
end of the second postnatal month (Matthews et al., 2013; Stamford, 1989).  
DA neurotransmission could mature postnatally as a result of changes in the somatic 
firing properties of DA neurons in the midbrain or from changes in striatal microcircuitry that 
controls DA release at the DA axon terminal. Detailed analyses of DA neuron firing properties 
both in acute mouse brain slices and in vivo in anesthetized rats have revealed that the electrical 
activity of DA neurons matures postnatally and reaches adult-like levels around P15 (Dufour et 





early postnatal development, isolated synaptosomes pre-loaded with 3H-DA show reduced DA 
release in response to high K+ and acetylcholine, although a detailed longitudinal analysis is 
lacking (Nomura et al., 1981). Thus, both the somatic electrical properties and axonal release 
properties mature in DA neurons postnatally.    
In addition to changes in presynaptic DA release, the level and function of postsynaptic 
DA receptors mature postnatally. Linear increases in both D1 and D2 receptor levels are 
observed during the first 3 postnatal weeks in the mouse and rat (Bruinink et al., 1983; Giorgi et 
al., 1987; Murrin and Zeng, 1986; Nomura et al., 1982; Spano et al., 1976). Between P20 and 
P40, D1 and D2 receptor levels undergo further increases, followed by a reduction to levels seen 
in the mature adult (3-4 month old) (Gelbard et al., 1989; Teicher et al., 1995). The function of 
DA receptors have been analyzed using two distinct types of assays: in the first, agonist-induced 
changes in cAMP levels are measured directly, whereas in the second, downstream readouts of 
cAMP levels, such as FOS expression, are measured as a proxy of DA receptor activation. 
Interestingly, DA receptor agonists induce greater biochemical responses during the perinatal 
period (<P7) (Kim et al., 2002), followed by a period of reduced agonist sensitivity (P20-40) 
before reaching the adult state (Teicher et al., 1995). These results suggest a dynamic trajectory 
of DA receptor expression and function during the postnatal period.  
1.3.6 Role for DA in Striatal Development and Maturation. 
The early arrival of DA axons and expression of DA receptors in the striatum suggests 
that DA signaling may contribute to striatal maturation. How might DA control striatal 
development and maturation? Early work demonstrated a possible role for DA axons in the 
patterning of the striosome and matrix compartments. Although the striosome and matrix 





some neurochemical markers such as mu-opiod receptors is disrupted in striosomes (Caboche et 
al., 1991; van der Kooy and Fishell, 1992; Snyder-Keller, 1991).  
DA signaling during development also contributes to the maturation of SPN physiology; 
however, reports differ as to how DA affects striatal activity. Murer and colleagues reported a 
reduction in spontaneous SPN activity in anesthetized mice with neonatal 6-OHDA lesions 
(Galiñanes et al., 2009), whereas Tang and Lovinger demonstrated that DA is required for the 
normal ontogenetic decrease in corticostriatal release probability and reduction in miniature 
excitatory postsynaptic currents (Tang et al., 2001). Furthermore, some reports demonstrate 
reduced SPN spine density (Galiñanes et al., 2009), in agreement with a proposed role for DA in 
modulating SPN synaptogenesis (Kozorovitskiy et al., 2015).  
Importantly, loss of DA has distinct effects on SPN physiology in adulthood compared to 
early development. In addition to deficits in synaptic plasticity, which will not be described 
further here (Shen et al., 2008; Thiele et al., 2014), changes in synaptic structure and function 
and intrinsic excitability occur. Reductions in dendritic spine density are observed in iSPNs 
following 6-OHDA lesions (Day et al., 2006), although conflicting reports exist about the cell-
type specificity of changes in dendritic spine density following 6-OHDA lesion (Graves and 
Surmeier, 2019; Suárez et al., 2014; Warre et al., 2011). This is associated with atrophy of the 
dendritic tree in both iSPNs and dSPNs (Fieblinger et al., 2014).  Fieblinger and Surmeier also 
reported increased intrinsic excitability in dSPNs and reduced excitability in iSPNs following 
adult 6-OHDA lesion (Fieblinger et al., 2014). In addition, distinct adaptations in the cortico- and 
thalamostriatal circuitry occur following adult 6-OHDA lesion (Parker et al., 2016; Warre et al., 
2011). Addressing the differences in basal ganglia physiology following neonatal versus adult 






 Here, I have described the organization and physiology of the striatum, models for how 
the basal ganglia contribute to motor control and the development and postnatal maturation of 
the striatum. The existing literature on the striatum and its development suggests that many key 
features of striatal physiology and function are acquired postnatally. There are two key 
consequences of immature striatal activity during the juvenile and adolescent period: first, they 
underlie behavioral differences in reward learning and behavioral flexibility between adults and 
adolescents (Andrzejewski et al., 2011; Spear, 2000; Sturman and Moghaddam, 2012; Sturman 
et al., 2010) and, second, that genetic or environmental insults that corrupt the time course of 
striatal maturation could underlie the long-term neuropsychiatric symptoms seen in 
developmental diseases such as Autism Spectrum Disorder and Attention-deficit Hyperactivity 
disorder. Thus, defining the basic molecular and circuit mechanisms that regulate striatal 






Chapter 2: Neuronal Macroautophagy* 
2.1 Introduction 
Research over the past 40 years has defined roles for protein synthesis in neuronal 
plasticity and brain function (Davis and Squire, 1984). Recently, however, the controlled 
degradation of proteins and organelles has also been appreciated to play critical roles in 
neurotransmission (Alvarez-Castelao and Schuman, 2015). These steps occur via the degradation 
of specific cytosolic proteins through the ubiquitin / proteasome pathway and by multiple 
pathways that lead to degradation within the lysosome (Dikic, 2017).   
Christian De Duve, who with Alex Novikoff, co-discovered the lysosome, introduced the 
term autophagy to describe how “portions of a cell somehow find their way inside the cell’s own 
lysosomes and are broken down” (De Duve, 1963). De Duve also coined the terms lysosome, 
endocytosis / endosome, phagocytosis/ phagosome, / autophagosome and peroxisome (Sabatini 
and Adesnik, 2013). De Duve’s definition of autophagy encompasses the breakdown of any of a 
cell’s own components within the lysosome, but even in 1963 it was clear that proteins, lipids, 
and organelles could use multiple mechanisms of entry into the lysosomal lumen (Figure 2.1).  
In the endosomal-lysosomal degradation pathway, membrane, lumenal or formerly 
extracellular components that were endocytosed are delivered to lysosomes by fusion with 
endosomes. In this highly regulated pathway, extracellular proteins and intrinsic proteins on the 
cell surface, are internalized into small vesicles and sorted through a series of intermediate 
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vesicular structures. Some components may be recycled to other membranes, while others that 
reach a late endosome can fuse with a lysosome that is capable of proteolysis and can degrade 
proteins in both the endosomal membrane and lumen (Huotari and Helenius, 2011; Klumperman 
and Raposo, 2014).   
A relatively newly discovered autophagic pathway is known as chaperone-mediated 
autophagy (CMA) (Cuervo et al., 1994), in which cytosolic proteins are bound by the chaperone 
Hsc70 and delivered to the lysosomal membrane, where they are unfolded and transported into 
the lysosomal lumen by a membrane protein, Lamp2A (Cuervo and Dice, 1996). Proteins within 
the lumen are then exposed to lysosomal proteases and degraded. While a great deal of research 
has identified cytosolic proteins that play roles in synapses to be degraded by CMA including 
alpha-synuclein (Cuervo et al., 2004) and tau protein (Caballero et al., 2018), there has been little 
research on CMA at synapses in contrast to in cell bodies. 
In endosomal microautophagy (eMI), cytosolic proteins are similarly bound by Hsc70, 
but are internalized into small vesicles within endosomes which subsequently fuse with 
lysosomes for degradation (Sahu et al., 2011). These structures may also participate in producing 
exosomes secreted from the neurons, and so may participate in signaling and disease spread. As 
multivesicular bodies are very common in synapses and axons, these are likely to be important 
for synaptic turnover, and preliminary evidence suggests that eMI may play a role in presynaptic 
function (Mukherjee et al., 2016; Uytterhoeven et al., 2015).  
Most research on neuronal autophagy has been conducted on macroautophagy (which by 
convention will be called autophagy in this review), a process that can degrade cytosolic 
proteins, lipids and organelles. This form of autophagy has been particularly tractable because it 





with lysosomes for degradation that can be examined by microscopy and because it can be 
manipulated by modulating the activity of genes initially characterized in yeast that are 
responsible for steps in the pathway.  
Here, I will first review the molecular machinery involved in autophagy in mammalian 
cells. I will then briefly describe the history of the discovery of autophagy in neurons and 
explore how the machinery that mediates autophagy in dividing cells has been adapted to ensure 
appropriate autophagic protein degradation in post-mitotic neurons.  
Recent work has highlighted a potential role for autophagy in the regulation of synaptic 
transmission, plasticity and behavior. These studies indicate that autophagy plays some roles that 
can be revealed simply by blocking specific steps in the pathway, while others that require both 
blockade and a triggering additional factor, particularly via cellular stress responses (Hara et al., 
 
Figure 2.1. Macroautophagy, Chaperone-mediated Autophagy and Microautophagy as delivery services to the 
lysosome. Macroautophagy delivers proteins and organelles to the lysosome in double membrane vesicles. In chaperone-
mediated autophagy, substrates are imported via the concerted action of the lysosomal membrane protein, Lamp2A and the 
chaperone, Hsc70. In Microautophagy, substrates are internalized into endosomes in an Hsc70-dependent manner and then 






2006; Komatsu et al., 2006; Rowland et al., 2006; Shehata et al., 2012). Both classes of synaptic 
autophagic function may regulate pre- and postsynaptic functions during normal neuronal 
development and in disease.  
2.1 Molecular Machinery of Autophagy 
The molecular machinery that controls autophagosome formation, maturation and fusion 
with lysosomes were originally described in yeast by Yoshinori Ohsumi and colleagues 
(Ohsumi, 2014). Autophagy in mammalian cells is controlled by both proteins that are 
homologous to the yeast autophagy (atg) proteins and additional mammalian-specific 
components (Klionsky, 2007).  
 
Figure 2.2. Schematic representation of the mechanisms of autophagy. Autophagy induction is driven by mTOR and 
AMPK. These metabolic kinases stimulate PI3P synthesis which recruits the PI3P binding proteins DFCP1 and WIPI1-4 to a 
membrane source. The activity of the Atg conjugations systems and Atg9+ vesicles expand the autophagic membrane. Once 
the membrane closes, the autophagosome matures, traffics to the perinuclear area and fuses with lysosomes. Late endosomes 






In yeast and dividing mammalian cells, autophagy is strongly activated by nutrient or 
serum starvation and can be divided into distinct stages: (1) induction, (2) expansion, (3) 
maturation (Figure 2.2). 
Autophagy is induced following nutrient or serum deprivation via the activity of the 
metabolic kinases, mTOR (Blommaart et al., 1995) and AMPK (Meley et al., 2006). mTOR 
inhibits and AMPK activates the kinase ULK1, in complex with Atg13 and FIP200  (Chan et al., 
2007; Ganley et al., 2009; Hosokawa et al., 2009; Jung et al., 2009; Kim et al., 2011). ULK2, a 
ULK1 homolog in mammalian cells, may also control autophagy but it is presently unclear 
whether these kinases are redundant (Chan et al., 2007; Lee and Tournier, 2011).  ULK complex 
activation leads to the phosphorylation of Beclin-1 and activation of the class iii phosphoinositol-
3-kinase (PI3K), Vps34 (Petiot et al., 2000; Russell et al., 2013). The PI3K activity of Vps34 is 
critical both for endocytic activity (Christoforidis et al., 1999; Vieira et al., 2003) and autophagy 
(Petiot et al., 2000) and is directed to a particular pathway by its interacting proteins. For 
example, when partnered with Atg14, Vps34 activity stimulates autophagy (Matsunaga et al., 
2010), and ULK1-dependent phosphorylation of Beclin-1 specifically activates Vps34 activity 
when Vps34 is complexed with Atg14 and Ambra1 (Russell et al., 2013).  
Vps34 activity induces autophagy via local synthesis of phosphoinositol-3-phosphate 
(PI3P). The precise sites of PI3P synthesis and initial formation of the autophagic membrane 
may be at the endoplasmic reticulum (Axe et al., 2008; Hayashi-Nishino et al., 2009; Ylä-Anttila 
et al., 2009),  but contributions from plasma membrane (Ravikumar et al., 2010), mitochondria 
(Hailey et al., 2010), or recycling endosomes (Longatti et al., 2012; Orsi et al., 2012; Puri et al., 
2013, 2018) are also involved. Subsequent recruitment of PI3P binding proteins, such as DFCP1 





2004; Puri et al., 2018), initiate an enzymatic cascade that leads to the assembly of the 
autophagosomal membrane.  
Expansion of the autophagosome membrane is driven by two ubiquitin-like conjugation 
systems. In the first, Atg12 is conjugated to Atg5 by the E1-like enzyme, Atg7, and the E2-like 
enzyme, Atg10 (Mizushima et al., 1998). The Atg5-12 conjugate subsequently interacts with 
Atg16L1 (Mizushima et al., 2003). In the second pathway, Atg8 is processed by the protease, 
Atg4 (Kirisako et al., 2000), and subsequently conjugated to phophatidylethanolamine (PE) by 
Atg7 and the E2-like enzyme, Atg3 (Mizushima et al., 1998). Atg8 conjugation requires the E3-
like activity of Atg5-12 complexed with Atg16L1 (Fujita et al., 2008; Hanada et al., 2007).  
Mammals have numerous Atg8 homologs, including the LC3 and GABARAP families 
(Shpilka et al., 2011). The conjugated form of LC3 is referred to below as LC3-II and the 
unmodified protein is referred to LC3-I below. Vesicles containing Atg9, a transmembrane 
protein, then fuse with the growing autophagosome and provide an additional membrane source 
(Yamamoto et al., 2012).  
How are proteins and organelles selected for autophagic degradation (Zaffagnini and 
Martens, 2016)? Upon nutrient deprivation, bulk cytosolic proteins can be sequestered into 
autophagosomes and degraded to increase the availability of amino acids (Kopitz et al., 1990; 
Mortimore and Schworer, 1977; Takeshige et al., 1992). Alternatively, proteins and organelles 
can be selectively degraded by binding to autophagy cargo adapters such as p62 (Bjørkøy et al., 
2005; Pankiv et al., 2007), NBR1 (Kirkin et al., 2009), Tax1BP1 (Tumbarello et al., 2012), 
optineurin (Wild et al., 2011) and NDP52 (Heo et al., 2015; Lazarou et al., 2015; Mostowy et al., 
2011; Thurston et al., 2009). Proteins may contain an LC3-interacting motif that promotes 





et al., 2013; Gao et al., 2010; Zhang et al., 2011). Proteins and organelles that are targeted for 
selective degradation can also be modified by post-translational modifications such as 
ubiquitination or acetylation, which mediate interactions with autophagy cargo proteins such as 
p62 (Khaminets et al., 2016).  
 Following cargo sequestration, autophagosomes close and are trafficked retrogradely to 
the perinuclear region, where most late endosomes and lysosomes are localized (Aplin et al., 
1992; Kimura et al., 2008; Köchl et al., 2006). Retrograde trafficking of autophagosomes occurs 
on microtubules in a dynein-dependent manner (Kimura et al., 2008). Autophagosomes are 
linked to dynein via a Rab7, RILP, and OPR1L complex (Jordens et al., 2001; Wijdeven et al., 
2016) and, in the absence of these factors, mature autophagosomes accumulate. Interestingly, 
actin-dependent autophagosome transport has also been demonstrated, although this does not 
occur during starvation-induced autophagy (Lee et al., 2010). Following retrograde transport, 
autophagosome fusion with lysosomes depends on the Qa SNARE, synataxin 17; the Qbc 
SNARE, SNAP29; and the R SNARE, VAMP8 (Itakura et al., 2012). This process also depends 
on the HOPS complex (Jiang et al., 2014; Liang et al., 2008; McEwan et al., 2015) and the 
autophagosome adapter PLEKHM1 (McEwan et al., 2015). The fusion of autophagosomes with 
lysosomes leads to degradation of autophagic cargo.   
2.2 Autophagy in Neurons and Neurites 
The initial studies of autophagy by De Duve, Novikoff and others were in dividing cells. 
Neurons have long been known to possess lipofuscin, neuromelanin, and in ceroid lipofuscinosis 
disorders, ceroid pigments, that are accumulated within autophagosomes (Sulzer et al., 2008). 
Nevertheless, the initial reports in neurons of autophagosomes (also known as autophagic 





the brain of Huntington’s disease patients (Roizin et al., 1974; Tellez-Nagel et al., 1974).  The 
latter study stressed a highly increased abundance of lipofuscin in the neurons, astrocytes and 
microglia of these patients, and conjectured that this was due to insufficient autophagy, an 
impression supported by many subsequent studies in human tissue and animal models. This same 
study further noted enlarged mitochondria devoid of cristae and suggested that this could be due 
to deficient autophagy associated with Huntington’s disease, as borne out by later research by 
Marianne DiFiglia and colleagues (Kegel et al., 2000).  Cultured striatal neurons with mutant 
huntingtin gene showed were found to form prominent autophagosomes when stressed by 
dopamine-mediated oxidative stress (Petersén A et al., 2001), predicting that in synapses, some 
effects of autophagy become apparent under conditions of cellular stress. Mechanistic studies by 
Ana Maria Cuervo and collaborators indicated that in the case of huntingtin mutations that this 
could result from a lack of appropriate autophagic cargo recognition (Martinez-Vicente et al., 
2010).   
In addition to the lipofuscin pigment, work by Luigi Zecca and collaborators has shown 
that the neuromelanin pigment of substantia nigra and locus coeruleus neurons is encased with 
autophagic organelles that do apparently do not degrade these contents (Sulzer et al., 2000, 
2008), leading to an initial focus in the field on neuronal autophagy as a product of disease and 
normal aging related stress (Larsen and Sulzer, 2002). Subsequent studies by Randy Nixon, 
Anne Cataldo and colleagues revealed the presence of neuronal autophagic vacuoles in tissue 
from Alzheimer’s patients and other disorders (Boland et al., 2008; Cataldo et al., 1996; Nixon et 
al., 2005) and further work by Anne Tolkovsky, David Rubinsztein, Zhenyu Yue, Richard Youle 





associated neuronal disorders (Rubinsztein et al., 2005; Youle and Narendra, 2011; Yue et al., 
2009). 
The presence of autophagic organelles in neurites and synapses awaited identification by 
Peter Hollenbeck (Hollenbeck, 1993), who observed retrograde axonal transport and lysosomal 
delivery of fluorescent cargo by autophagic vacuoles in cultured sympathetic neurons. This study 
suggested, in contrast to the other studies of the era, that autophagy might be associated with 
synaptic activity and may occur independently from disease or aging-oriented stress.  
It took a long time for Hollenbeck’s pioneering observation to be appreciated by the field 
at large. One reason is that in dividing cells, autophagy was typically initiated by nutrient 
deprivation (Kopitz et al., 1990; Mortimore and Schworer, 1977; Takeshige et al., 1992).   While 
nutrient deprivation and starvation is a potent trigger for autophagic degradation in non-neuronal 
cells, it has little effect in most populations of central neurons (Mizushima et al., 2004). An 
exception is in the hypothalamus (Kaushik et al., 2011; Nikoletopoulou et al., 2017), a brain 
region that is critical for the maintenance of energy homeostasis (Andermann and Lowell, 2017), 
where autophagy senses energy balance to control neuronal activity (see below). Another reason 
may be that the autophagosomes, particularly in neurites, may be relatively short-lived and 
transported rapidly. 
An experimental tool that has vastly changed the study of autophagy in synaptic 
transmission is the use of fluorescently tagged LC3 to specifically label autophagosome 
membrane in living cells. A study from Erica Holzbaur and colleagues introduced an elegant 
model in which autophagosomes were primarily generated in the distal processes of neurons and 
then trafficked toward the cell body to fuse with lysosomes in proximal processes and the cell 





primary cultures of dorsal root ganglia (DRG) suggested that autophagosome formation occurs 
almost exclusively within the axon tip. This may not be surprising, as DRG neurons differ from 
most CNS axons in that they do not make en passant synapses, but instead have a single release 
site from the distal axon (Maday and Holzbaur, 2014). Similar imaging studies in synaptically 
mature primary hippocampal neurons yielded a more complex picture, with autophagosome 
formation occurring predominantly in distal processes but also in the cell body and more 
proximally in dendrites and axons (Maday and Holzbaur, 2014). Shehata et al reported the 
activity-dependent formation of autophagosomes in dendrites of primary hippocampal neurons 
(Shehata et al., 2012). Similar findings suggesting distal formation of autophagosomes have been 
reported in C. elegans (Stavoe et al., 2016). These data suggest that autophagosome formation 
occurs within pre- and post-synaptic compartments and provide a means for retrograde transport 
of autophagic cargo from distal regions of the neuron to the cell body for degradation.  
What specifies the location of autophagosome formation in neurons? Holzbaur and 
Maday proposed that PI3P synthesis occurs distally within axons, as DFCP1 puncta, which mark 
sites of PI3P synthesis and nascent autophagosome formation, were located distally in neuronal 
processes (Maday and Holzbaur, 2014). In C. elegans, Colon-Ramos and colleagues identified 
Atg9 trafficking events within the distal axon as being required for spatial organization of 
autophagosome formation (Stavoe et al., 2016). Whether additional (neuron-specific) regulators 
are involved in orchestrating autophagosome formation and maturation within these highly 
complex cells remains to be seen. 
The identification of autophagosomes, and their regulated formation and trafficking, in 
neurons without ongoing pathology suggests that autophagy may play a role in the regulation of 





used to identify changes in the behavior and neurophysiology associated with loss of autophagy. 
Unfortunately, whole-body, constitutive knockout of many autophagy genes yield perinatal 
lethality (Kuma et al., 2017). Furthermore, the consequences of autophagy loss in the CNS could 
not be disambiguated from the effect of loss of autophagy in other organs.  
Fundamental contributions to elucidating roles for autophagy in neurons were made by 
Hara, Komatsu and colleagues in the mid-2000’s who addressed this issue by generating mice 
with conditional alleles of Atg5 or Atg7 that could be knocked out in genetically-defined cell 
types following expression of Cre recombinase (Komatsu et al., 2005; Kuma et al., 2004). CNS-
specific knockout of Atg5 or Atg7 yielded similar age-dependent neurodegeneration, 
accumulation of cytoplasmic proteinaceous inclusions and motor dysfunction. Importantly, these 
phenotypes were largely overlapping, extending findings in yeast to the mammalian CNS that 
Atg5 and Atg7 occur at a similar step in autophagy. These transgenic mouse lines have become 
critical tools that have enabled the identification of cell-type specific roles for autophagy in the 
CNS (see below).   
2.3 Autophagy and Neurotransmission 
Throughout the remainder of this review, I will discuss the roles of autophagic protein 
degradation in neurotransmission.  
2.3.1 Autophagy in Synaptic Development 
Alterations in dendritic spine density have been proposed to play a role in the 
pathophysiology of ASDs. In ASD, human postmortem tissue demonstrates elevated spine 
densities in the temporal cortex (Hutsler and Zhang, 2010; Tang et al., 2014). Furthermore, in 





Fragile X syndrome, changes in spine density or morphology are observed in postmortem studies 
and in animals models (Phillips and Pozzo-Miller, 2015).  To address the underlying mechanism 
for increased spine density in human ASD cases, Tang et al. measured the spine density in 
postmortem samples of temporal cortex from cases at different ages and found significantly 
reduced spine pruning in ASD brains compared to controls. Interestingly, this was inversely 
correlated with levels of the autophagy marker LC3-II, suggesting that impaired autophagy, 
downstream of mTOR hyperactivation seen in ASD (Auerbach et al., 2011; Tang et al., 2014), 
may be responsible for the reduced synaptic pruning.  
It is worth noting here that the control of neuronal autophagy by mTOR remains 
controversial. mTOR participates in two protein complexes, mTORC1 and mTORC2, that are 
integral to cellular signaling and can be differentiated by their sensitivity to the mTOR inhibitor, 
rapamycin. Although mTORC2 is critical for nutrient sensing in the periphery (Saxton and 
Sabatini, 2017) and is involved in plasticity in multiple brain circuits (Bockaert and Marin, 2015; 
Dadalko et al., 2015), mTORC1 has been most directly linked to the regulation of autophagy 
(Dunlop and Tee, 2014).  
The role for mTOR regulation of neuronal autophagy has remained somewhat 
controversial, largely due to a variance in findings using rapamycin and its derivatives. In ventral 
midbrain dopamine neurons, mTOR activity appears to negatively regulate autophagy, as 
rapamycin induces LC3 puncta formation and conjugation of LC3-I to the lipidated LC3-II 
(Hernandez et al., 2012). Furthermore, genetic hyperactivation of mTOR following deletion of 
the mTORC1 inhibitors TSC1 and TSC2 (Tee et al., 2002, 2003; Zhang et al., 2003) in 
excitatory neurons in the cortex reduces LC3-II levels and increases p62, and decreases the 





autophagy is rescued following pharmacological inhibition of mTOR with rapamycin both in 
vivo with an 8 day treatment regimen, and in culture, in an Atg7-dependent manner (Tang et al., 
2014). Rapamycin treatment of wild-type mice in vivo and of wild-type primary cortical neurons 
was sufficient to elicit a small but significant increase in LC3-II or GFP-LC3 puncta, 
respectively (Tang et al., 2014). Autophagy activity in TSC1/2 null cells, however, may be 
complicated by a compensatory increase in AMPK signaling (Di Nardo et al., 2014), suggesting 
a more complex relationship between autophagy and this protein complex.  
Other reports have not observed a basal inhibition of autophagy by mTOR in the CNS 
(Fox et al., 2010; Maday and Holzbaur, 2016; Tsvetkov et al., 2010). Inhibition of mTOR with 
everolimus, a rapamycin-like compound, following a 6-8 week treatment paradigm failed to 
elicit an increased in LC3-II conjugation in vivo, but did engage other downstream signaling 
pathways of mTOR such as protein synthesis (Fox et al., 2010). mTOR inhibition with torin-1 
failed to elicit autophagy activation in hippocampal cultures (Maday and Holzbaur, 2016). These 
results are intriguing given that, while the effect of rapamycin-induced autophagy activation 
have been questioned, torin-1 mediated inhibition is reported to exert profound effects on 
autophagy (Thoreen et al., 2009). Differences in treatment paradigm, including the type, timing 
and concentration of mTORC1 inhibitor, and age may underlie these divergent conclusions about 
regulation of autophagy by mTORC1 in the CNS. Furthermore, differences in the regulation of 
autophagy between peripheral or dividing cells and neurons in the CNS has been clearly 
demonstrated in vivo. Starvation in the rodent induces autophagy in organs such as the kidney 
and liver but fails to do so in the brain (Mizushima et al., 2004). It is, however, possible that 
starvation-induced autophagy may not be mediated by LC3, and that measurements of GFP-LC3 





regulation of autophagy upstream kinases, such as mTOR, suggest that autophagic dysfunction 
may contribute to neurodevelopmental disorders in which these kinases are hyperactivated, such 
as ASD. 
This hypothesis was addressed in a mouse model of tuberous sclerosis complex (TSC), a 
developmental disorder characterized by intellectual disability, epilepsy, and the presence of 
cortical tubers in addition to other peripheral dysfunction (Crino et al., 2006). TSC arises from 
loss-of-function mutations in the genes TSC1 (tuberin) and TSC2 (hamartin) (European 
Chromosome 16 Tuberous Sclerosis Consortium, 1993; Kandt et al., 1992; van Slegtenhorst et 
al., 1997). TSC1 and TSC2 inhibit mTOR signaling (Tee et al., 2002; Zhang et al., 2003) via 
direct inhibition of the Ras homolog enriched in brain, Rheb (Tee et al., 2003). Multiple studies 
have attempted to identify changes in dendritic spine density in mice carrying loss of function 
alleles in TSC1 and 2 with mixed results. Sabatini and colleagues reported deficits in both 
excitatory and inhibitory synaptic transmission in TSC-null mice but did not measure differences 
in spine density in vivo (Bateup et al., 2011, 2013). They however reported increased spine 
length, decreased spine density and disruption in soma size in primary neuronal culture 
(Tavazoie et al., 2005). Examination of hippocampal granule cells identified no effect of TSC1on 
spine density (Goorden et al., 2007). Interestingly, an increased spine density was observed in 
cerebellar Purkinje cells upon loss of TSC1 in 4 week old mice, following the classical period of 
synaptic reorganization seen postnatally (Tsai et al., 2012). Future work may elucidate the 
mechanism through which spine density is elevated in these TSC mutants. For example, excess 
spines may result from multiply innervated Purkinje cells (Hashimoto et al., 2009) or spines may 





(Hashimoto and Kano, 2013). Finally, Meikle et al demonstrate a reduction in spine density on 
the apical dendrite of cortical neurons in TSC1 knockout mice (Meikle et al., 2008). 
In contrast, Tang et al showed an increased spine density in cortical neurons from an 
excitatory neuronal specific TSC1 conditional knockout and TSC2 heterozygous mice by P30. 
Interestingly, spine density was unchanged at P20, suggesting that spinogenesis was intact but 
spine pruning was specifically deficient. Furthermore, this deficit in spine pruning was 
normalized by rapamycin (Tang et al., 2014). Differences in brain region, genetic background 
and mouse age may underlie the disparate conclusions on the role for TSC1/2 and mTOR 
signaling in controlling spine density. 
What is the downstream effector for TSC1/2 that controls spine density? As described 
above, TSC1/2 loss of function leads to mTOR hyperactivation (Tee et al., 2002, 2003; Zhang et 
al., 2003). Downstream from mTOR, protein synthesis is disrupted in TSC null cells via mTOR-
dependent regulation of the S6 kinase and 4E-BP. However, mTORC1 hyperactivity also inhibits 
autophagy in TSC null neurons (Tang et al., 2014). To address whether the loss of autophagy 
was the cause of spine pruning deficits in TSC1/2 null mice, Tang et al took two strategies. First, 
they showed that conditional deletion of Atg7, a required component of the autophagosome 
biogenesis machinery, in forebrain excitatory neurons was sufficient to phenocopy the spine 
pruning deficits observed in TSC1 null mice. Furthermore, both conditional knockouts for Atg7 
and TSC1 null mice demonstrated social interaction deficits, thus providing face validity to these 
models for ASD. Tang et al then tested whether autophagy was necessary for the rescue of TSC 
spine pruning deficits by rapamycin. They generated mice harboring heterozygous TSC2 alleles 
and conditional deletion of Atg7 in forebrain excitatory neurons. Rapamycin treatment failed to 





sufficiency of neuronal autophagy for mediating spine pruning in cortical pyramidal neurons. 
Future studies will focus on the role of other genes involved in autophagy in controlling dendritic 
morphology and function.  
Intriguingly, peripheral inflammatory insults, which have been implicated in 
development of diseases such as autism (Malkova et al., 2012; Osokine and Erlebacher, 2017) 
and schizophrenia (Depino, 2017; Miller and Goldsmith, 2017), also inhibits autophagic function 
in the brain (François et al., 2014). Furthermore, neonatal exposure to drugs of abuse can lead to 
neuropsychiatric phenotypes and have previously been shown to regulate autophagy (Cubells et 
al., 1994; Larsen and Sulzer, 2002; Larsen et al., 2002; Plessinger, 1998). This suggests that 
autophagic dysfunction, due to either inflammation or genetic insults, may underlie dysfunction 
in synaptogenesis in neurodevelopmental disorders.  
 In addition to synaptic pruning, autophagy contributes to other aspects of synaptic 
refinement during development. 
In C. elegans, clustering of postsynaptic GABAA receptors in muscle depends on 
presynaptic GABA release (Gally and Bessereau, 2003). In the absence of presynaptic 
innervation by GABAergic terminals, GABAA receptors are diffusely localized on the plasma 
membrane of the muscle. Interestingly, however, the absence of both GABAergic and 
cholinergic inputs leads to endocytosis and degradation GABAA receptors via autophagy 
(Rowland et al., 2006), while deletion of autophagy in non-innervated muscles rescues deficits in 
neurotransmission. These data provide initial evidence that transmembrane postsynaptic 
receptors are degraded via autophagy, in an endocytosis-dependent manner. Notably, one family 





GABAA receptors (Kittler et al., 2001; Wang et al., 1999), suggesting that autophagy-associated 
proteins are critical regulators of biosynthesis and degradation of these receptors.  
In addition to its role in degradation of neurotransmitter receptors during development, 
autophagy is also critical for the maturation of synaptic morphology. In Drosophila, 
developmental loss of autophagy leads to a reduction in neuromuscular junction (NMJ) size, 
while increasing neuronal autophagy by overexpression of Atg1, a homolog of ULK1, leads to 
an increased number of synaptic sites (Shen and Ganetzky, 2009). In contrast, however, 
autophagy is required for dendritic spine pruning during mouse cortical development (Tang et 
al., 2014) (see above) and plays a critical role in axon pathfinding in the developing CNS (De 
Pace et al., 2018; Dragich et al., 2016; Yamaguchi et al., 2018), indicating that autophagy has 
been adapted for a range of synaptic mechanisms. 
Little is known how neuronal autophagy regulates synaptic structure. Autophagic 
degradation of neurotransmitter receptors or neurotransmitter release (see below) may contribute 
to activity-dependent synaptic development. Autophagy may also control synaptic pruning via 
selective degradation of mitochondria. In addition to the role of mitochondria in ongoing 
synaptic function and plasticity (Cameron et al., 1991; Kang et al., 2008; Levy et al., 2003; Sun 
et al., 2013; Tang and Zucker, 1997; Weeber et al., 2002), proper mitochondrial function is 
critical to the formation (Courchet et al., 2013; Kimura and Murakami, 2014; Lee and Peng, 
2008) and maintenance of synaptic contacts and strength (Li et al., 2004). In both the axon and 
the dendrite, mitochondrial localization is precisely regulated and localized to active synaptic 
contacts (Chada and Hollenbeck, 2004). Furthermore, mitochondrial function and content is 
coupled to synaptic activity (Bindokas et al., 1998; Hevner and Wong-Riley, 1993; Wong-Riley 





a synaptic contact and preclude its pruning. In support of this hypothesis, mitochondrial content 
is sensitive to neuronal activity during critical periods in synaptic development (Tieman, 1984; 
Wong-Riley and Welt, 1980), and mitochondrial motility is more dynamic during synaptic 
maturation than during adulthood (Lewis et al., 2016; Smit-Rigter et al., 2016).  
 Autophagy plays a critical role in the clearance of damaged or dysfunctional 
mitochondria through mitophagy (Youle and Narendra, 2011). Mitophagy is a process through 
which damaged mitochondria are tagged and selectively degraded. In neurons, this can occur to 
mitochondria in axons (Ashrafi et al., 2014; Berthet et al., 2014) and in the somatodendritic 
region (Cai et al., 2012; Joselin et al., 2012). As mitophagy occurs in response to the loss of 
mitochondrial membrane potential, and mitochondrial membrane potential is sensitive to 
neuronal activity, it is possible that mitophagy locally controls mitochondrial content in response 
to neuronal activity (see above). Furthermore, local mitochondrial content can contribute to 
dendritic spine pruning and synaptic maintenance, suggesting the possibility that autophagy and 
mitophagy contribute to synaptic pruning via targeted degradation of mitochondria. In support of 
this, in TSC1-deficient neurons (Ebrahimi-Fakhari et al., 2016a), which demonstrate deficient 
synaptic pruning (Tang et al., 2014), and in ASD brain (Tang et al., 2013), mitochondrial 
abnormalities are present. Future work must focus on defining the developmental stage-specific 
substrates of autophagy. 
2.3.2 Autophagy and Neurotransmitter Release 
Autophagosome formation at presynaptic terminals suggests that autophagy shapes 
neurotransmitter release. The Sulzer lab provided early evidence of a cell-autonomous role for 
autophagy in neurotransmitter release (Hernandez et al., 2012). They took advantage of the fact 





release of other neurotransmitters which depends on postsynaptic recordings of receptor 
activation, to unambiguously demonstrate that DA neurons lacking autophagy release more DA 
following electrical stimulation. This was a clear result of the role of autophagy in axons, as 
opposed to a role in cell bodies, as DA somata were not present in the brain slice preparation we 
used. Ultrastructural analysis of DA axons in the absence of autophagy revealed enlarged 
presynaptic terminals, and changes in the morphology and number of synaptic vesicles. These 
data implicated autophagy in the homeostasis of synaptic vesicles and neurotransmitter release 
machinery.  
Recent work from Ackermann, Garner and colleagues further implicates autophagy in the 
clearance of damaged synaptic vesicles. Synaptic vesicles undergo rapid cycles of release and 
reformation, and this has been hypothesized to lead to damage to synaptic vesicle associated 
proteins (Sudhof, 2004). To address whether autophagy is involved in the clearance of synaptic 
vesicle proteins, Hoffman et al fused supernova, a protein which creates reactive oxygen species 
(ROS) in response to light (Takemoto et al., 2013), to synaptotagmin, synapsin or synaptophysin 
and demonstrated that ROS-induced damage leads to autophagosome formation within the 
activated presynaptic terminal and degradation of synaptic vesicle-associated proteins 
(Hoffmann et al., 2019). Activation of autophagy was required to counteract the damage caused 
by ROS on neurotransmitter release and synaptic vesicle endocytosis. These data suggest that 
autophagy contributes to synaptic homeostasis by degrading damaged synaptic vesicles on 
demand.  
Does normal physiological activity also induce presynaptic autophagy? High-frequency 
stimulation of the Drosophila NMJ induces autophagosome formation within the presynaptic 





machinery during stimuli with elevated energy demands (Soukup et al., 2016). In combination, 
these data provide tantalizing evidence that autophagy is critical for the regulation of 
neurotransmitter release via a contribution to synaptic vesicle quality control. 
Additional insights into the dynamics of presynaptic autophagy have arisen from 
experiments aimed at defining the role of presynaptic proteins in the control of autophagy. 
Synaptojanin is a lipid phosphatase that induces synaptic vesicle endocytosis via the 
dephosphorylation of PI(4,5)P2. Recently, the SAC1 domain of synaptojanin has been implicated 
in the maturation of autophagosomes at the presynaptic terminal in Drosophila (Vanhauwaert et 
al., 2017). EndophilinA, another protein involved in synaptic vesicle endocytosis, has recently 
been found to promote presynaptic autophagy by recruiting autophagy-associated proteins to 
highly curved membranes (Soukup et al., 2016). Finally, the presynaptic proteins Bassoon and 
Piccolo suppress presynaptic autophagy by sequestering Atg5 (Okerlund et al., 2018). In the 
absence of Bassoon and Piccolo, synaptic vesicle pools are depleted and synaptic sites are lost 
via activation of autophagy. These data suggest not only that autophagy plays a clear role in 
presynaptic function, but also that presynaptic proteins contribute to autophagic function within 
the axon.  
2.3.3 Autophagy and Postsynaptic Function 
Autophagy also controls synaptic transmission via postsynaptic mechanisms. Loss of 
autophagy in cortical pyramidal neurons or using nestin-cre to knockout autophagy throughout 
the nervous system leads to elevated levels of components of the postsynaptic density such as 
PSD-95, SHANK3, and PICK1 (Nikoletopoulou et al., 2017; Tang et al., 2014). Furthermore, in 
a mouse model of Fragile X syndrome, elevations in PSD95 and the immediate early gene, Arc, 





sequestered into nascent autophagosomes formed into the dendrite or their levels are affected by 
autophagy through an alternative mechanism remains unknown. The ability of autophagy to 
degrade postsynaptic scaffolding proteins provides a possible mechanism through which 
autophagy could control synapse morphology and the efficacy of synaptic transmission.  
Autophagy also contributes to the degradation of neurotransmitter receptors. In addition 
to the degradation of GABAA receptors during the development of the Drosophila NMJ 
(Rowland et al., 2006), chemically-induced long-term depression activates autophagic 
degradation of the AMPA receptor, GluR1 (Shehata et al., 2012). The mechanism by which 
autophagy contributes to GluR1 degradation and whether this is endocytosis-dependent, remains 
unknown.  
2.3.4 Autophagy and Synaptic Plasticity 
Changes in the strength of synaptic transmission, termed synaptic plasticity, are thought 
to represent a cellular correlate of learning and memory. Disrupted synaptic plasticity has been 
reported in mouse models lacking autophagy; however, much of the mechanism through which 
autophagy regulates synaptic plasticity remains unknown.  
Long-term potentiation appears to be regulated by autophagy in some cases. Glatigny et 
al demonstrated that pharmacological inhibition of autophagy with Spautin-1 blocks theta burst 
stimulation-induced LTP in CA1 (Glatigny et al., 2019). Nikoletopoulou and colleagues suggest 
that ongoing autophagy in the hippocampus is suppressed by brain-derived neurotrophic factor 
(BDNF) to permit LTP (Nikoletopoulou et al., 2017). Autophagy may also play a role in long-
term depression (LTD), as impaired autophagy has been implicated in exaggerated hippocampal 





Autophagy may contribute to synaptic plasticity in several ways. First, autophagy may 
actively degrade AMPA receptors to reduce synaptic strength during LTD (Shehata et al., 2012). 
Second, autophagy may degrade other synapse-associated proteins required for reorganization of 
the postsynaptic membrane during plasticity (Nikoletopoulou et al., 2017; Tang et al., 2014; Yan 
et al., 2018). Autophagy may further regulate the levels of cytosolic calcium within the pre- or 
post-synaptic elements via degradation of mitochondria or endoplasmic reticulum (Mochida et 
al., 2015; Youle and Narendra, 2011). It should also be noted that several kinases that regulate 
autophagic activity, including mTOR, Akt, and AMPK, are involved in synaptic plasticity 
(Horwood et al., 2006; Jaworski and Sheng, 2006), although whether these kinases act through 
autophagy to modulate synaptic plasticity remains a key question.   
2.4 Autophagy’s Contribution to Behavior 
The contribution of autophagy to brain function has also been explored through cell-type 
specific knockouts of autophagy genes. 
2.4.1 Hypothalamus and Energy Homeostasis 
The role of autophagy in hypothalamic control of food intake and energy homeostasis has 
been extensively studied. The arcuate nucleus of the hypothalamus (ARC) controls food intake in 
response to the status of an organism’s energy store (Andermann and Lowell, 2017). Two 
neuronal populations in the ARC, Agouti-related peptide (AgRP)-expressing (ARCAgRP) and pre-
opiomelanocortin (POMC)-expressing (ARCPOMC), oppositely control feeding (Aponte et al., 
2011; Fenselau et al., 2017; Krashes et al., 2011; Zhan et al., 2013). ARCPOMC neurons release α-
MSH, a cleavage product of POMC (Dubé et al., 1978), which stimulates Melanocortin-4 
Receptors (MC4R) on neurons in the paraventricular hypothalamus (PVH) (Atasoy et al., 2012; 





AgRP, which is also released in the PVH by ARCAgRP neurons, is an antagonist of the MC4R and 
stimulates feeding (Aponte et al., 2011; Krashes et al., 2013). Circulating hormones such as 
leptin, insulin and ghrelin, and extracellular levels of glucose and lipids alter ARC neuron firing 
to elicit feeding behavior or satiety (Andermann and Lowell, 2017). These extrinsic cues activate 
intracellular biochemical cascades. In particular, mTOR and AMPK activity within ARC 
neurons control firing rates and neuropeptide release to affect feeding in response to energy 
status (Cota et al., 2006; Kohno et al., 2008, 2011; Minokoshi et al., 2004). Thus, neurons of the 
ARC represent a critical central node in energy homeostasis.  
As described above, autophagy is tightly regulated by the coordinated activity of AMPK 
and mTOR. In contrast to most of the CNS, fasting induces autophagic activity in the 
hypothalamus (Kaushik et al., 2011; Nikoletopoulou et al., 2017). To define the role of 
autophagy in ARC neurons and central control of energy homeostasis, Kaushik et al 
conditionally deleted the required autophagy protein Atg7 in ARCAgRP neurons using the Cre-
LoxP system (Kaushik et al., 2011). Mice lacking Atg7 in ARCAgRP neurons had lower body 
weight and fat mass relative to controls suggesting a deficit in ARCAgRP neuron function as these 
neurons promote feeding. One mechanism through which ARCAgRP neurons promote feeding in 
response to food deprivation is to increase the expression of AgRP mRNA. Kaushik et al 
reported that in mice lacking Atg7 in ARCAgRP neurons, fasting failed to induce an increase in 
AgRP expression. They went on to demonstrate that autophagy was required for the fasting-
induced mobilization of free fatty acids (FFA) from lipid droplets, a process known as lipophagy 
(Singh et al., 2009), within ARCAgRP neurons. Normally, fasting-induced FFA mobilization 
activates AgRP mRNA expression. These results elegantly demonstrate a cell-type specific role 





Interestingly, conditional deletion of Atg7 in ARCPOMC neurons leads to increased body 
weight. Bouret and colleagues reported that this effect correlated with decreased axonal 
arborization of ARCPOMC neurons and innervation of target regions such as the PVH (Coupé et 
al., 2012). Furthermore, both the Bouret and Lee groups demonstrated that autophagy was 
required in ARCPOMC neurons for a normal response to leptin: systemic or intracerebral 
administration of leptin did not suppress feeding in mice lacking autophagy in ARCPOMC neurons 
(Coupé et al., 2012; Quan et al., 2012). This was associated with increased circulating leptin 
levels, further suggesting a state of relative leptin resistance. The precise mechanism, however, 
through which autophagy regulates ARCPOMC axonal arborization or biochemical response to 
leptin remains obscure. Furthermore, autophagy also contributes to the cellular response to 
neuropeptide Y, another key contributor of feeding within the hypothalamus (Aveleira et al., 
2015).  
 AMPK also mediates fasting-induced synaptic plasticity within the ARC (Kong et al., 
2016). Whether changes in AMPK activity affect autophagic flux within the ARC, whether 
autophagy contributes to fasting-induced and AMPK-dependent synaptic plasticity in the ARC 
remains unknown. Although some AMPK targets, such as p21-associated kinase (PAK), are 
implicated in fasting-induced synaptic plasticity, although whether PAK modulates autophagy in 
the ARC has not been shown (Kong et al., 2016). Similarly, identification of the targets of 
autophagic degradation, such as neurotransmitter receptors or mitochondria, required for fasting-
induced plasticity requires further investigation. 
2.5.2 Hippocampus and Spatial Memory 
Recent reports highlight a role for autophagy in hippocampus-dependent behavioral 





FIP200, and Atg12 in the hippocampus reduced novel object recognition and contextual fear 
conditioning (Glatigny et al., 2019). This effect was similar when the shRNA was expressed 
under the control of a neuron-specific promoter or a general promoter suggesting that loss of 
neuronal autophagy led to these behavioral phenotypes. This group then used pharmacological 
tools to acutely manipulate autophagy and found that autophagy inhibition in the hippocampus, 
using Spautin-1, during but not after, the training phase of the contextual fear conditioning task 
reduced freezing during a probe trial while stimulation of autophagy during, but not after the 
training phase, increased freezing during the probe trial. These results suggest that hippocampal 
autophagy is required for the formation of contextual and object recognition memories. 
 A decrease in hippocampal autophagy also mediates hippocampal dysfunction in a mouse 
model of Fragile X syndrome (FXS). Suzanne Zukin and colleagues found reduced autophagy in 
hippocampal neurons lacking Fmr1, a model for FXS (Yan et al., 2018). Reduction of mTOR 
signaling in hippocampal region CA1 rescued novel object recognition in FXS mice and this was 
dependent on the required autophagy protein Atg7. Thus, at least a subset of behavioral 
phenotypes in FXS mice arise from a deficit in hippocampal autophagy. 
2.6 Conclusion 
Here, I have reviewed the accumulating evidence that autophagic protein degradation 
plays an important role in both disease-associated and non-pathogenic states within the CNS and 
contributes to synaptic transmission, plasticity and behavior. The reports that autophagy 
contributes to presynaptic homeostasis and postsynaptic function suggest that neurons have 






Chapter 3: Dopamine Triggers the Maturation of Spiny Projection 
Neuron Excitability during a Critical Period† 
3.1 Abstract 
Neural circuits are formed and refined during childhood, including via critical changes in 
neuronal excitability. Here, I investigated the ontogeny of striatal intrinsic excitability. We found 
that dopamine neurotransmission increases from the first to third postnatal week in mice and 
precedes the reduction in spiny projection neuron (SPN) intrinsic excitability during the fourth 
postnatal week. In mice developmentally deficient for striatal dopamine, direct pathway dSPNs 
failed to undergo maturation of excitability past P18 and maintained hyperexcitability into 
adulthood. I found that the absence of dSPN maturation was due to altered phosphatidylinositol 
4,5-biphosphate dynamics, and a consequent lack of normal ontogenetic increases in Kir2 
currents. Dopamine replacement corrected these deficits in SPN excitability when provided from 
birth or during a specific period of juvenile development (P18-28), but not during adulthood. 
These results identify a sensitive period of dopamine-dependent striatal maturation, with 
implications for the pathophysiology and treatment of neurodevelopmental disorders. 
 
† This chapter (except Figure 3.15 and associated discussion) was published as an Article in Neuron 
in 2018. Lieberman OJ, McGuirt AF, Mosharov EV, Pigulevskiy I, Hobson BD, Choi SJ, Frier 
MD, Santini E, Borgkvist A, Sulzer D (2018).  Dopamine triggers the maturation of striatal spiny 
projection neuron excitability during a critical period. Neuron. doi: 10.1016/j.neuron.2018.06.044. 
PMID: 30057204.  







Selecting an appropriate action in response to environmental stimuli is critical to learning 
and survival. The basal ganglia encompass subcortical circuits essential to action selection. 
Perturbations of basal ganglia development are suggested to enhance susceptibility to drug use 
and neuropsychiatric disease later in life (Spear, 2000). The elucidation of mechanisms that 
regulate basal ganglia development is thus important for unveiling the pathophysiology of 
multiple disorders. 
The main input nucleus of the basal ganglia, the striatum, undergoes significant postnatal 
development during the first through fourth postnatal weeks (Tepper et al., 1998). The principal 
neuron of the striatum is the spiny projection neuron (SPN). SPNs participate in two output 
pathways: 1) the direct pathway containing SPNs that express D1 dopamine (DA) receptors and 
project to the basal ganglia output nuclei of the substantia nigra reticulata and globus pallidus 
interna (dSPN), and 2) the indirect pathway including SPNs that express D2 DA receptors and 
project to the globus pallidus externa (iSPN) (Gerfen and Surmeier, 2011).  
In the adult, the SPN receives glutamatergic input from the cortex and thalamus that, 
together with DA inputs from the midbrain, provide a neurophysiological basis for motivational 
control of movement (Gerfen and Surmeier, 2011). Adult SPNs are characterized by low firing 
frequencies and a high threshold for action potential firing (Wilson and Groves, 1981; Wilson 
and Kawaguchi, 1996). Thus, only simultaneous activity from convergent synaptic inputs 
provides sufficient excitation to drive adult SPNs to fire and control action. Immature SPNs, 
however, are hyperexcitable and therefore do not generate mature firing patterns (Tepper et al., 
1998). Although SPN hyperexcitability and consequent inappropriate action selection has been 





schizophrenia (Cazorla et al., 2012), Parkinson’s disease (Azdad et al., 2009; Fieblinger et al., 
2014; Warre et al., 2011), Huntington’s disease (Klapstein et al., 2001), and drug abuse (Dong et 
al., 2006), little is known about the postnatal development of SPN firing patterns and how they 
acquire mature neurophysiological properties.  
SPN intrinsic excitability is shaped by a complement of potassium channels. At 
hyperpolarized potentials, inwardly rectifying potassium channels (primarily Kir2.1 and Kir2.3 
(Cazorla et al., 2012; Karschin et al., 1996; Shen et al., 2007), referred to hereafter as Kir) 
comprise the primary conductance. By driving the resting membrane potential towards the 
potassium reversal potential, these channels shape the summation of dendritic inputs and filter 
the response to excitatory glutamatergic inputs (Mermelstein et al., 1998; Nisenbaum et al., 
1994; Shen et al., 2007). Sufficient coordinated synaptic input can bring the SPN resting 
potential towards the action potential firing threshold, where Kir currents are inactive and 
additional potassium currents such as IA, ID and IM control firing patterns (Nisenbaum et al., 
1994; Shen et al., 2004, 2005; Wilson and Kawaguchi, 1996).  
SPN excitability decreases over the juvenile and adolescent period from postnatal day 
P10 to P40 in rodents (Gertler et al., 2008; Tepper et al., 1998). Postnatal day P28 marks the first 
age with “mature” up-and down-states, inward rectification, levels of excitatory input, and 
decreased input resistance during in vivo recordings of SPN (Choi and Lovinger, 1997; Tepper et 
al., 1998). Although Kir  (Gertler et al., 2008) and ID (Surmeier et al., 1991) currents have been 
shown to increase during postnatal development, the ontogenesis of adult firing patterns in the 
striatum has not been established.  
DA transmission into the striatum also changes during postnatal development. While DA 





(Ferrari et al., 2012; Voorn et al., 1988), the total levels of striatal DA increase from adolescence 
to adulthood (Matthews et al., 2013; Stamford, 1989). This period of postnatal maturation of DA 
neurotransmission occurs during a period associated with the onset of multiple neuropsychiatric 
disorders, suggesting that changes in presynaptic DA may induce developmental changes in 
dopaminoceptive regions, although this has not been previously demonstrated.  
Here, I report that DA transmission is responsible for the induction of the maturation of 
direct pathway SPN intrinsic excitability and must act during a critical window within the 
juvenile period to achieve the normal adult SPN state. 
3.3 Results 
3.3.1 SPN Excitability Decreases in Parallel in dSPNs and iSPNs During the Juvenile 
Period. 
Adult SPNs maintain a hyperpolarized resting membrane potential and high latency to 
spike. Both in vivo and ex vivo recordings have demonstrated that SPNs are hyperexcitable after 
birth and acquire their mature phenotype during the first four postnatal weeks (Gertler et al., 
2008; Peixoto et al., 2016; Tepper et al., 1998). Here, I examined the time course of these 
changes in acute brain slices from BAC-D1tomato (D1T) mice (Shuen et al., 2008). I conducted 
whole cell recordings from D1T+ and D1T- (putative iSPNs) SPNs in the dorsal striatum during 
the 2nd, 3rd and 4th postnatal weeks and adulthood (~4 months) to assess whether and how 
excitability is decreased throughout the juvenile and early adolescent period. I selected ages P12-
14, P18 and P28 for examination based on following rationales: P12-14 occurs around eye 
opening (Evans et al., 2015) and during a period of increased excitatory synaptogenesis (Peixoto 





immediately before weaning and at the end of excitatory synaptogenesis in the striatum (Peixoto 
et al., 2016); P28 marks the first age with “mature” up-and down-states during in vivo recordings 
of SPNs (Tepper et al., 1998). I also measured SPN excitability at 4 months to compare the 
juvenile and adult states. 
I found that both D1T+ and D1T- SPNs undergo reductions in excitability between P12 
and P28. Resting membrane potential (RMP) and input resistance (Rin) decreased over this 
 
Figure 3.1. dSPNs and iSPNs undergo age-dependent reductions in excitability. (A) Representative traces of whole cell 
current clamp recordings from D1T+ (black) or D1- (gray) SPNs in acute brain slices made from mice aged P18 or P28. (B) 
Resting membrane potential (RMP), (C) rheobase and (D) input resistance from D1T+ or  D1T- SPNs from mice aged P12, 
P18, P28 or P120. (E) Number of action potentials fired by SPNs in response to current injection. Data analyzed by two-way 
ANOVA followed by Bonferroni post-hoc tests. ** p<0.01, **** p<0.0001. P12: D1T+ n = 11 cells (3), D1T- n = 10 cells (3), 
P18: D1T+ n = 18 cells (3), D1T- n= 18 cells (3), P28: D1T+ n = 16 cells (3), D1T- n = 10 cells (3), P120: D1T+ n = 13 cells 






period in both dSPNs and iSPNs, while rheobase increased (Figure 3.1 A-D) (RMP: age 
p<0.0001, subtype p=0.94, interaction p=0.58. Rin: age p<0.0001, subtype p=0.03, interaction 
p=0.0618. Rheobase: age x subtype interaction p=0.045). These changes were associated with a 
difference in the number of action potentials fired in response to a range of injected current 
(current-response) (Figure 3.1E). By P28, parameters of SPN excitability were stable and not 
different from those measured at P120. Significant differences in rheobase, input resistance and 
current-response curve were also observed between dSPNs and iSPNs, similar to previous 
reports (Figure 3.1C-D) (Cepeda et al., 2008; Gertler et al., 2008). Thus, SPNs undergo a 
substantial decrease in excitability during the second and third postnatal weeks, with direct 
pathway neurons exhibiting a more profound decrease during the third and fourth weeks.  
3.3.2 Striatal Evoked DA Release Increases in the Juvenile Period. 
Why does SPN excitability change during the postnatal period? Previous work has 
demonstrated differences in DA release dynamics between the immediate postnatal, adolescent 
and adult periods (Ferrari et al., 2012; Matthews et al., 2013; Stamford, 1989), although a 
systematic characterization of evoked synaptic DA release dynamics during juvenile period has 
not been reported.  
We measured electrically-evoked DA release events in the dorsal striatum by fast-scan 
cyclic voltammetry (FSCV) in acute brain slices prepared from mice aged P8 to P110 (Figure 
3.2A) (Sulzer et al., 2016). We chose P8, an age at which DA neuron firing rates are similar to 





preceded changes in the maturation of SPN excitability. Analysis revealed a significant effect of 
age on the amplitude of peak DA release (Figure 3.2B).  
The increased evoked extracellular DA concentration measured by FSCV could be due to 
either increased presynaptic DA release or decreased DA reuptake (Schmitz et al., 2001, 2002). 
To address this, we measured the t1/2 (width at half-height) of DA peaks following electrical 
stimuli as a functional estimate of DA reuptake. We observed no effect of age on t1/2 when 
analyzed by one-way ANOVA (Figure 3.2C), suggesting that, along with increased DA release, 
DA reuptake increases during postnatal development (Jones et al., 1995; Moll et al., 2000). 
 
Figure 3.2. Electrically evoked DA release increases in the dorsal striatum over the juvenile period. (A) Representative 
traces of CV recordings in the dorsal striatum from P8 (gray) or P28 (black) mice. Applied stimuli are indicated by the 
downward pointing arrows. (B) Peak electrically evoked DA release is plotted for five age groups over the juvenile period. 
(C) Decay half-life of evoked DA transients shows no significant effect of age. (D) A significant increase in the paired pulse 
ratio (interstimulus interval: 3 seconds). Data was analyzed by one-way ANOVA **** p<0.0001. P8: n=10 (PPR: 6) (3), 
P10 n=13 (PPR: 12) (3), P18 n=13 (PPR: 6) (3), P28 n=12 (PPR: 10) (3), P110 n=11 (3). (E) Representative western blots 
against TH, DARPP32 and actin. (F) Levels of TH and DARPP32 normalized to actin expressed relative to levels in the 
adult. N=4-6 per age group. Data was analyzed by two-way ANOVA followed by post-hoc Bonferroni tests. A significant 






Consistently, nomifensine, a DAT blocker, affected peak height and t1/2 similarly at P14 and P28 
(Figure 3.3).  
To analyze why DA release increases postnatally, we examined short-term presynaptic 
plasticity by measuring the amplitude of DA release evoked by paired electrical pulses. We 
observed a significant effect of age on paired pulse ratio (2nd / 1st peak) (Figure 3.2D), suggesting 
either a larger releasable pool or faster refilling rate of release-competent synaptic vesicles. To 
examine a basis for an increased releasable pool of DA, I probed striatal tissue lysates for 
tyrosine hydroxylase (TH), the rate-limiting enzyme in DA synthesis, using DARPP-32, a 
 
Figure 3.3, DAT blockade has similar effects on DA release and reuptake at P14 and P28. (A) Traces at each P14 (pink, 
red) and P28 (gray, black) before and after perfusion (20 min) of nomifensine (10 µM). (B) Peak height showed no 
significant effect of drug but a significant effect of age (black, P28, red, P14). (C) Half-life increased at both ages with drug 






protein involved in the SPN response to DA signaling, and actin as loading controls. While no 
effect of age was observed on DARPP-32 or actin levels, TH levels increased significantly over 
the same time course as that of electrically evoked DA release measured by FSCV (Figure 3.2E-
F). Overall, these data indicate that DA synthesis and the number and/or quantal size of DA 
released during synaptic vesicle fusion increases over the P8-30 period, with the most dramatic 
increases occurring at ages less than P20. 
3.3.3 SPNs from Mice Developmentally Lacking Nigrostriatal DA Projections do not Undergo 
Ontogenetic Reduction in Excitability.  
While DA axons arrive in the striatum during the embryonic period (Voorn et al., 1988), 
our results indicate that DA release dynamics continue to mature throughout the first four weeks 
postnatally (Figure 3.2). These ontogenetic increases in DA release immediately precede major 
postnatal reductions in SPN excitability, suggesting that DA could induce these changes (Figures 
3.1-2). To address this hypothesis, I utilized the Pitx3KO mouse, which harbors a loss-of-
function mutation upstream of the Pitx3 gene, leading to developmental loss of DA neurons in 
the substantia nigra pars compacta by P0-P1 (Nunes et al., 2003). Thus, dorsal striatal SPNs in 





I first confirmed that nigrostriatal projections are not present in Pitx3 mice. Consistent 
 
Figure 3.4. SPNs from Pitx3KO mice fail to undergo age-dependent reductions in excitability. (A) Representative 
images (scale bar 100 µm) of TH immunofluorescence in the dorsal striatum of Pitx3WT and Pitx3KO mice. n=3 WT, 4 
KO. (B) Representative traces of evoked DA measured with FSCV in the dorsal striatum of Pitx3WT (n=6) and Pitx3KO 
(n=4) mice. (C) Traces from whole cell current clamp recordings of SPNs from the dorsal striatum of P28 Pitx3WT or 
Pitx3KO mice. (D) RMP, (E) rheobase, (F) input resistance of SPNs from Pitx3WT or Pitx3KO mice aged P14, P18, P28 
and P110. (G) Height of delayed ramp during square current injection 10-20 pA below the rheobase from P28 Pitx3WT and 
Pitx3KO mice. (H) Latency to fire the first action potential in response to a current injection at the rheobase from P28 
Pitx3WT and Pitx3KO mice. (I and J) Current-response curves for SPNs from (I) P18 and (J) P28 Pitx3WT and Pitx3KO 
mice. Data were analyzed by two-way ANOVA followed by Bonferroni post-hoc test. * p<0.05, ** p<0.01, *** p<0.001. 
WT mice: P14 n = 7 cells (2), P18 n = 8 cells (2), P28 n = 24 cells (3), P110 n = 15 cells (3); KO mice: P14 n = 12 cells (3), 
P18 n = 8 cells (2), P28 n = 25 cells (3), P110 n = 14 cells (3). (K) Representative traces of spontaneous excitatory 
postsynaptic events (sEPSC) from P28 Pitx3WT and Pitx3KO SPNs. (M) sEPSC Frequency and (N) amplitude show no 






with the literature, we found that P28 Pitx3KO mice do not express TH labeled DA axons in the 
dorsal striatum (Figure 3.4A) and electric stimulation of the dorsal striatum did not elicit DA 
release (Figure 3.4B). I then conducted whole cell recordings from SPNs in acute brain slices 
from P14, P18 and P28 Pitx3WT and Pitx3KO mice. I chose P14 as the earliest age to examine 
in this experiment as this is the beginning of a period of excitatory synaptogenesis (Tepper et al., 
1998) and the end of a robust period of dopaminergic axon retraction (Oo and Burke, 1997). 
SPNs become significantly less excitable from P14 to P18, as demonstrated by a reduced RMP, 
an increased rheobase, and reduced input resistance in both genotypes (Figure 3.4C-F) (RMP: 
age x genotype interaction p=0.04. Rin: age x subtype interaction p=0.001. Rheobase: age x 
subtype interaction p=0.0002). Pitx3WT SPNs then underwent further reductions in excitability 
from P18 to P28, as demonstrated by reduced RMP and input resistance and increased rheobase 
(Figure 3.4B-D). In striking contrast, however, P28 Pitx3KO mice showed no further decrease in 
excitability after P18 and displayed significantly elevated RMP, input resistance and decreased 
rheobase compared to P28 WT SPNs (Figure 3.4B-D). Adult SPNs also demonstrate a long delay 
to first spike in response to square current pulses and, at subthreshold current levels, display a 
voltage ramp response (see Figure 3.9 for example). I measured the magnitude of the voltage 
ramp in response to current injections 10-20 pA below the rheobase in SPNs from Pitx3WT and 
Pitx3KO mice at age P28 and found no difference (Figure 3.4G, p=0.9795). Similarly, no effect 
of genotype was observed on the latency to fire the first action potential in response to a square 
current injection at the rheobase (Figure 3.4H, p=0.9941). Finally, a higher number of action 
potentials are triggered in response to injected current in Pitx3KO than Pitx3WT at P28 but not 
at P18 (Figure 3.4I-J) (P18: Current p<0.0001, Genotype p=0.5323, current x genotype 





I then recorded from SPNs of 4-month old Pitx3WT and Pitx3KO mice to address 
whether the hyperexcitable SPN phenotype of the Pitx3KO mouse persisted into adulthood. A 
significant effect of genotype was observed for rheobase, RMP, and input resistance (Figure 
3.4C-F). These data indicate that SPN excitability matures in DA-independent (P14-P18) and 
DA-dependent (>P18) stages, and the absence of striatal DA causes hyperexcitability of SPNs in 
adulthood.  
To address whether these changes in intrinsic excitability were homeostatic in response to 
reduced glutamatergic synaptic inputs, we measured spontaneous excitatory postsynaptic current 
(sEPSC) frequency and amplitude at P28 and observed no difference between genotypes (Figure 
3.4K-M). These findings suggest that in the absence of developmental DA signaling, excitatory 
inputs onto SPNs function normally, but SPN intrinsic excitability is increased.  
3.3.4 Kir Currents do not Undergo Ontogenetic Increases in SPNs from Pitx3KO Mice. 
To identify which ion channels may be responsible for the hyperexcitability of SPNs 
from Pitx3KO mice, we measured currents elicited following voltage steps from a holding 
potential of -60 mV (Figure 3.5A). I observed a difference between SPNs from Pitx3WT and 
Pitx3KO mice following hyperpolarizing voltage steps in a range where currents are 
predominantly mediated by Kir2 channels, while there was no difference between genotype 
following depolarizing voltage steps (Figure 3.5A). These results are consistent with our current 
clamp recordings indicating a difference in RMP and input resistance, which are mediated by 
Kir2 channel in SPNs, but not in spike latency or subthreshold ramping, which are mediated by 
other K+ currents (Figure 3.4). I then measured the current elicited by hyperpolarizing voltage 
steps in Pitx3WT and Pitx3KO SPNs at P14, P18, P28 and adulthood (~P110) to see whether 





hyperpolarizing voltage step from -60 mV to -150 mV was not different between genotype at 
ages P14 and P18, but was significantly greater in Pitx3WT SPNs at P28 and P110 (Figure 3.5B) 
(age x genotype p=0.0005), mirroring the age-dependent changes in current clamp parameters we 
observed in Pitx3KO mice (Figure 3.4). Additionally, we found no significant difference in 
membrane capacitance between WT and Pitx3KO SPNs (Figure 3.5C), but a significant 
difference between genotypes was observed for the Kir2 current density at P28 (Figure 3.5D).  
 
 
Figure 3.5 Kir current increases with age in Pitx3WT SPNs but not SPNs from the Pitx3KO mouse. (A) IV curve of 
currents elicited from Pitx3WT (black) and Pitx3KO (red) SPNs following 10 mV voltage steps from -60 mV. (B) Current 
elicited with a voltage step from -60 mV to -150 mV plotted against age. Data were analyzed with two-way ANOVA 
followed by Bonferroni post-hoc tests. (C) Capacitance was unchanged but (D) inward current density was significantly 
lower in P28 Pitx3KO SPNs. Data in (C) and (D) were analyzed by two-tailed t tests. WT mice: P14 n=7 cells (2), P18 n=8 
cells (2), P28 n=24 cells (3), P110 n=13 cells (3); Pitx3KO mice: P14 n=12 cells (3), P18 n=8 cells (3), P28 n=25 cells (3), 
P110 n=12 cells (3). (E) Representative voltage clamp recordings before and following addition of 1 mM CsCl2 and 
subtracted traces from SPNs recorded in slices from P28 Pitx3WT and Pitx3KO mice. (F and G) IV curves from (F) 
Pitx3WT and (G) Pitx3KO mice before and following addition of CsCl2 and (H) CsCl2 subtracted currents. Pitx3WT: n=8 






To directly address whether these differences in the IV curve were mediated by 
differences in Kir2 currents, we measured current elicited in the presence of tetrodotoxin (TTX; 
to block sodium channels) with and without cesium chloride (CsCl2), which blocks Kir2 
channels (Cazorla et al., 2012; Mermelstein et al., 1998). The Kir2 currents were extracted by 
subtracting the currents in the presence of CsCl2 from those in the absence of CsCl2. CsCl2 
significantly decreased currents elicited by hyperpolarizing voltage steps from -60 mV in both 
Pitx3WT and Pitx3KO SPNs at P28 (Figure 3.5E-G) (WT: current x CsCl2 p<0.0001. KO: 
current x cesium p<0.0001). CsCl2-sensitive currents, however, were reduced in Pitx3KO SPNs 
compared to Pitx3WT, indicating a role for Kir2 channels in mediating the hyperexcitability of 
Pitx3KO SPNs (Figure 3.5H) (current x genotype p<0.0001). The reversal potential and voltage 
dependence of Kir2 currents were not different in SPNs from Pitx3WT and Pitx3KO mice 
(Figure 3.5H). In summary, Kir2 channel activity failed to increase in SPNs from Pitx3KO mice 
after P18, suggesting a possible mechanism for SPN hyperexcitability due to an absence of DA 
during development. 
3.3.5 Increased Extracellular DA Before P18 Does Not Accelerate Maturation of SPN 
Excitability. 
To test if DA-independent maturation prior to P18 might be limited due to low levels of 
DA, we examined mice deficient for the DA uptake transporter (DAT KO) mice, which 
demonstrate elevated extracellular DA (Gainetdinov et al., 1999; Giros et al., 1996). I recorded 
from SPNs at P18 in DAT WT or DAT KO mice and measured SPN excitability. I found no 
difference in RMP, rheobase, input resistance, or maximal Kir current between genotypes 
(Figure 3.6). Further, no difference was observed in the current-response curve, consistent with 





2007).  These data indicate that the insensitivity to DA before P18 is not due a low level of 
extracellular DA, but is rather prior to a developmental change in postsynaptic response to DA.  
 
 
Figure 3.6. Increasing striatal DA before P18 does not accelerate maturation of SPN excitability. (A and B) 
Representative traces of P18 SPNs from DAT WT and DAT KO mice. (C) RMP, (D) Rin, (E) Rheobase, (F) Kir current and 
(G) current-response curves were not different between P18 DAT KO and DAT WT SPNS. DAT WT: N=20 cells from 3 
mice. DAT KO: N= 19 cells from 3 mice. C-F compared with unpaired, two-tailed t test; p>0.05. G compared with two-way 






3.3.6 The Maturation of Intrinsic Excitability of dSPNs, but not iSPNs, is Disrupted in 
Pitx3KO Mice. 
DA induces distinct biochemical signaling cascades in dSPNs and iSPNs. In dSPNs, DA 
activates the D1 receptor to stimulate cAMP production while, in iSPNs, DA activates the D2 
receptor to inhibit cAMP production (Beaulieu and Gainetdinov, 2011). To determine if DA 
leads to the selective maturation of SPN excitability in one or both subtypes, I crossed Pitx3KO 
mice with mice carrying the BAC-D1-tomato allele (Shuen et al., 2008). I confirmed D1-Tomato 
expression in Pitx3KO mice (Fig 3.7A).  
I prepared acute brain slices from P28 Pitx3WT;D1T or Pitx3KO;D1T mice and 
measured SPN excitability. D1T+ SPNs from Pitx3KO;D1T mice displayed a significantly 
depolarized RMP (genotype x subtype interaction p=0.22; genotype p=0.035; subtype 
p=0.9966), elevated input resistance (genotype x subtype interaction p=0.0025) and decreased 
rheobase (genotype x subtype interaction p=0.0002) compared to D1T+  SPNs from 
Pitx3WT;D1T mice (Figure 3.7B-D). D1T- SPNs, in contrast, showed no difference between the 
genotypes (Figure 3.7B-D). We observed a significant difference in the current-response curve 
between D1T+ SPNs (genotype x current interaction p<0.0001) from Pitx3WT and Pitx3KO 
mice, but not between D1T- SPNs (genotype x current interaction p = 0.9776; genotype 
p=0.5993; subtype p<0.0001) (Figure 3.7F-G). These results demonstrate that DA is 
preferentially required for dSPN maturation in the juvenile period, while iSPNs mature normally 







Figure 3.7. dSPNs but not iSPNS are hyperexcitable in P28 Pitx3KO mice. (A) Immunohistochemistry for TH and D1-
Tomato demonstrates the absence of TH immunoreactivity in the dorsal striatum of P28 Pitx3KO mice but similar numbers 
of D1-tomato positive cells. Scale bar 50 µm. (B) RMP, (C) input resistance, (D) rheobase in D1T+ and D1T- SPNs from 
P28 Pitx3 WT and Pitx3 KO mice. Data were analyzed by two-way ANOVA followed by Bonferroni post-hoc tests. (E) 
Sample Traces from D1T+ and D1T- SPNs from P28 Pitx3WT and Pitx3KO mice. (F and G) current-response curves from 
(F) D1T+ and (G) D1T- SPNs from Pitx3WT and Pitx3KO mice. D1T+ WT, n = 52 cells (10): D1T-, WT, n = 9 cells (3): 
D1T+ , KO n = 50 cells (7): D1T- KO, n = 17 cells (4). (H) Representative dendritic skeletons of D1T+ SPNs from Pitx3WT 
(black) and Pitx3KO (red) mice. (I) No effect of genotype was observed in cumulative dendritic length, p=0.5686. (J) Sholl 
analysis revealed no effect of genotype on dendritic arborization. Pitx3WT: N = 14 cells (4). Pitx3KO: N = 17 cells (3). (K-
N) sEPSC frequency, amplitude and kinetics measured in whole cell recordings of D1-SPNs (Vhold = -70 mV) showed no 






I then sought to further examine the role of excitatory synaptic inputs and dendritic 
arborization on intrinsic excitability in Pitx3KO SPNs. The size and complexity of the dendritic 
arbor has previously been linked to the intrinsic excitability of SPNs (Cazorla et al., 2012; 
Gertler et al., 2008). To address whether the hyperexcitability in Pitx3KO D1T+ SPNs arises 
from altered dendritic morphology, I reconstructed neurobiotin-filled cells by confocal 
microscopy (Figure 3.7H-J). I measured dendrites at P28, the first age at which Pitx3KO D1T+ 
SPNs were found to be hyperexcitable (Figures 3.5 and 3.7). I found no effect of genotype on the 
cumulative dendritic length or on the complexity of the dendritic tree as measured by Sholl 
analysis (Figure 3.7H-J; genotype x distance interaction: p > 0.9999; distance: p<0.0001; 
genotype: p = 0.7748). These data indicate that hyperexcitability of D1T+ SPNs is independent of 
altered dendritic complexity in Pitx3KO mice. 
The D1T reporter further provided a means for a direct assessment of excitatory inputs in 
D1T+ SPNs. We found no effect of genotype on sEPSC frequency, amplitude, rise or decay time 
(Figure 3.7K-N), further confirming an absence of excitatory synaptic deficits at P28. 
I then assessed which SPNs exhibit decreased Kir currents. We found a significant effect 
of genotype on Kir currents only in D1T+ SPNs (Figure 3.8A-C), whereas no difference was 
found in D1T- SPNs between Pitx3WT and Pitx3KO mice (compared on one panel for clarity, 
D1: genotype x current p<0.0001. D2: genotype x current p>0.9999, genotype p=0.9689, current 
p<0.0001). I conclude that Kir currents are specifically reduced in D1T+ SPNs from Pitx3KO 






Changes in additional potassium channels may contribute to the hyperexcitability of 
D1T+ SPNs from Pitx3KO mice. The Kv1.2 and Kv4.2 channels mediate ID and IA potassium 
currents, respectively, and control the timing and number of action potentials (Nisenbaum et al., 
 
Figure 3.8. Altered PIP2 dynamics mediate lower Kir2 current in D1T+ SPNs from Pitx3KO mice. Sample voltage 
clamp recordings from (A) D1T+ and (B) D1T- SPNs from P28 Pitx3WT and Pitx3KO mice following a protocol to elicit 
inward currents. (C) IV curves for inward current from D1T+ and D1T- SPNs from both genotypes. Data were analyzed by 
two-way repeated measure ANOVA followed by Bonferroni post-hoc tests. Preplanned post-hoc tests comparing genotypes 
for each subtype showed significant genotype effects between D1T+ SPNs but not D1T- SPNs. * p<0.05, *** p<0.001, **** 
p<0.0001. D1T+ WT, n = 11 cells (3): D1T-, WT, n = 9 cells (3): D1T+ , KO n = 22 cells (4): D1T- KO, n = 17 cells (4). (D) 
Sample voltage clamp traces from Pitx3WT and Pitx3KO D1T+ SPNs immediately at membrane rupture (t=0s) and after 
dialysis of 1 mM neomycin (neo; t=180s). (E) Percent change in inward currents after dialysis with neo or with neo and 50 
µM diC8-PIP2 (PIP2) compared to no drug control.  Experiments including or compared to PIP2 were analyzed after 12 
minutes. Data were analyzed with one-way ANOVA followed by Bonferroni post-hoc test. ** p < 0.01. WT neo (3 min): N 
= 7 cells. KO neo: N = 9 cells. WT neo (12 min): 7 cells. WT neo + PIP2: N = 7 cells. (F) Sample traces from Pitx3WT and 
Pitx3KO D1T+ SPNs immediately at membrane rupture (t=0min) and after dialysis of 50 µM PIP2 (t=12 min). (G) PIP2 
significantly increases inward currents in Pitx3KO but not Pitx3WT mice. Data analyzed with a two-tailed unpaired t test. 






1994; Shen et al., 2004, 2005; Wilson and Kawaguchi, 1996). I measured two parameters, which 
are controlled by these channels: the latency to fire the first action potential and voltage ramping 
 
Figure 3.9. No difference between D-type currents in D1T+ SPNs from P28 Pitx3WT and KO mice. (A) Sample current 
clamp traces showing first spike for Pitx3Wt (WT) or Pitx3KO (KO) SPN. (B) Latency to first spike during a square current 
pulse, p=0.9941. (C) Sample current clamp trace showing subthreshold voltage ramp of typical SPNs. (D) Ramp height in 
response to square current pulse, p=0.9795. WT N=48 from 8 mice, KO N=46 from 6 mice. (E) Sample voltage clamp 
traces from D1T+ SPNs. (F) No significant effect of genotype was observed on D-type current density (genotype x current 
interaction: F(7,288) = 0.01638 p > 0.9999; current: F(7,288) = 61.77 p<0.0001; genotype: F(1,288) = 2.264, p = 0.1335). 
WT: N = 20 cells from 4 mice. KO: N = 18 cells from 3 mice.   (G) A significant effect of genotype on Kir current density. 
(genotype x current interaction: F(9,315) = 7.984 p<0.0001). (H) Maximal ID current density relative to maximal Kir current 
density within each cell, p= 0.0037). WT: N = 20 cells from 4 mice. KO: N = 18 cells from 3 mice. (I) Representative 






in response to subthreshold current injections. I found no significant effect of genotype on these 
two parameters in D1T+ SPNs from P28 mice (Figure 3.9A-D, see also Figure 3.4G-H). I further 
investigated the ID current with voltage clamp recordings, as this current increases during the 
postnatal development of SPNs (Surmeier et al., 1991). I found no difference in ID current 
density between D1T+ SPNs from P28 Pitx3WT and Pitx3KO mice (Figure 3.9E-F). In the same 
subset of cells, however, Pitx3KO SPNs had a significantly reduced Kir2 current density (Figure 
3.9G). The ratio of maximal ID to maximal Kir2 current for each cell was significantly greater in 
Pitx3KO mice than in Pitx3WT mice (Figure 3.9H). The protein level of Kv1.2, the main channel 
underlying ID in SPNs (Shen et al., 2004), did not differ in striatal lysates between Pitx3WT and 
KO mice at P28 (Figure 3.9I-J). These data suggest that Kir2 currents, but not the other K+ 
currents measured, fail to undergo postnatal maturation in dSPNs from Pitx3KO mice.  
3.3.7 Increasing PIP2 levels, but not cAMP production, rescues decreased Kir currents 
in D1T+ SPNs from Pitx3KO mice. 
Kir currents are dynamically regulated in SPNs via changes in protein expression 
(Cazorla et al., 2012), phosphorylation status (Zhao et al., 2016) and lipid interactions (Shen et 
al., 2007). One possible explanation for the reduced Kir current in Pitx3KO SPNs is a reduction 
in total Kir2 protein level or a change in the relative levels of the two Kir2 subunits expressed in 
SPNs, Kir2.1 and Kir2.3 (Cazorla et al., 2012; Karschin et al., 1996; Shen et al., 2007). We 
found no difference in protein levels of Kir2.1 and Kir2.3 in striatal lysates from Pitx3WT and 
Pitx3KO mice by immunoblot (Figure 3.10).  Alternatively, relatively more Kir2.3, which has a 
smaller single channel conductance than Kir2.1, could explain diminished whole cell Kir2 
currents (Hibino et al., 2010). The relative contribution of each subunit to whole cell Kir2 





2010; Liu et al., 2001; Schram et al., 2003). I did not observe a difference in the IC50 of barium 
for whole cell Kir2 currents between D1T+ SPNs from Pitx3WT and Pitx3KO mice (Figure 
3.10). I note, however, that the absolute difference in Kir2 currents between genotypes is also 
present in this cohort and the remaining current, comprised primarily of Kleak, after perfusion of 1 
mM BaCl2, did not differ. These data suggest that the reduced Kir2 currents in D1T+ SPNs from 
Pitx3KO mice do not arise from reduced Kir2 protein or differences in Kir2 subunit composition. 
Alternatively, modulation of Kir2 current by PKA/cAMP signaling could be disrupted in 
Pitx3KO mice. However, we found no difference in PKA activity and forskolin did not rescue 
Kir currents in Pitx3KO mice (Figure 3.11). 
 
Figure 3.10. Striatal Kir2 levels and subunit composition is unchanged in D1T+ SPNs from P28 Pitx3KO mice. (A) 
Representative images of immunoblots against Kir2.1, Kir2.3, and actin in striatal lysates from P28 Pitx3WT (WT) and 
Pitx3KO (KO) mice. (B and C) Quantification of (B) Kir2.1 and (C) Kir2.3 levels normalized to actin relative to WT 
control. No difference was observed between genotype (2.1: p=0.8722. 2.3: p=0.6097). WT: N = 5. KO N = 5 (2.1) and 4 
(2.3). (D-F) Effect of a range of concentrations of BaCl2 on Kir2 currents in D1T+ SPNs from P28 Pitx3WT and Pitx3KO 
mice. (D) Absolute current levels demonstrate a significant interaction between genotype and [BaCl2] (F(5,75)=5.12 
p=0.0004). (E) Current normalized to current elicited in the absence of BaCl2. (F) No effect of genotype was found on the 






I next addressed whether alterations in Kir2 interactions with its partner, 
phosphatidylinositol 4,5-biphosphate (PIP2), could explain reduced whole cell Kir2 currents in 
Pitx3KO D1T+ SPNs. PIP2 is required for proper Kir2 channel function, as it promotes channel 
opening (Hibino et al., 2010). PIP2 interacts with Kir2 electrostatically and this interaction can be 
disrupted by addition of neomycin to the intracellular pipette solution (Xie et al., 2008). We 
found that neomycin significantly reduced Kir2 currents in D1T+ SPNs from P28 Pitx3WT mice 
but not P28 Pitx3KO mice (Figure 3.8D-E). Further addition of a water-soluble short-chain 
analog of PIP2, diC8-PIP2, blocked the inhibitory effect of neomycin on WT neurons, confirming 
the specificity of neomycin’s action on Kir2 channels via PIP2 (Figure 3.8E, right). To further 
analyze this mechanism, we included diC8-PIP2 alone in the intracellular pipette solution and 
measured Kir2 currents. Remarkably, I found that diC8-PIP2 significantly increased Kir2 
currents in D1T+ SPNs from Pitx3KO mice but had no effect in D1T+ SPNs from Pitx3WT mice  
 
Figure 3.11. PKA activity is not affected and does not regulate differences in Kir2 currents between Pitx3WT and 
Pitx3KO mice. (A) Representative immunoblot from P28 Pitx3WT and Pitx3KO mice against phosphorylated PKA 
substrates. (B) No difference was observed between genotypes (p = 0.6282; WT: N=6, KO: N=6). (C) Representative 
voltage clamp traces before and after addition of 20 µM forskolin. (D) A significant effect of genotype but not of forskolin 







Figure 3.12. Dopamine replacement from birth, but not in the adult, rescues mature SPN excitability in Pitx3KO 
mice. (A) Schematic depicting chow treatment from birth to P28 (Group 1; red), from P18 to P28 (Group 2; gray) and from 
P90 to P110 (group 3; pink). (B) Sample current clamp traces from SPNs treated in Groups 1-3 from the specified genotype. 
B or L after the group number indicates the type of chow provided (B indicates benserazide and L indicates benserazide+ L-
DOPA). (C-E) (C) RMP, (D) input resistance, and (E) rheobase from specified groups. The effect of L-DOPA in the chow 
within each age was evaluated by one-way ANOVA of Pitx3KO 1B, 1L, and 2L following by Bonferroni post-hoc test 
(RMP: p>0.4423, Rin: F=8.33, p<0.0001, rheobase: F=11.11 p<0.0001) or two tailed unpaired t test for 3B and 3L (RMP: 
p=0.3, Rin: p=0.7295, rheobase: p=0.4071).  Gray bar denotes the WT 1B mean and error (sem; see also Figure S9). (F and 
G) current-response curves for groups (F) 1B, 1L and 2L or (G) 3B and 3L. Repeated measures (RM) two-way ANOVA 
with Bonferroni post-hoc tests between (F) WT 1B and KO 1B, 1L and 2L shows significant differences between WT 1B 
and KO 1B but not 1L and 2L at specified currents. (G) Repeated measures two-way ANOVA shows no significant 
interaction between current and treatment group. (H) Sample voltage clamp traces from all groups. (I and J) IV curve for 
inward currents for (I) groups at P28 and (J) in adulthood. (I) Significant differences were observed between inward 
currents evoked in SPNs from KO 1B compared to other groups as specified. (J) No significant interaction was observed 
between current and treatment group. Repeated measures two-way ANOVA followed by Bonferroni post-hoc tests were 
used. * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001. KO: N= 1B: 21 cells (2), 1L: 28 cells (4), 2L: 19 from 4 mice, 3B: 







(Figure 3.8F-G). These results are consistent with reduced PIP2-Kir2 interactions leading to 
diminished whole cell Kir2 currents in D1T+ SPNs from Pitx3KO mice.  
3.3.8 L-DOPA Supplementation During the Juvenile Period, but not During Adulthood, 
Induces Normal SPN Maturation in Pitx3KO Mice.  
To confirm if DA plays an important role in establishing mature SPN excitability during 
early postnatal development, I gave breeding pairs of Pitx3KO and Pitx3WT mice, or adult 
Pitx3KO mice, access to food pellets supplemented with the DA precursor, L-DOPA, which is 
converted to DA and released from serotonergic terminals in the DA-denervated striatum 
(Lindgren et al., 2010; Mosharov et al., 2015), together with  benserazide (bsrz) to block the 
peripheral conversion of L-DOPA to DA. I split these mice into three treatment groups 
depending on the age at treatment initiation to address whether DA was required to act during a 
specific age window. Mice in Group 1 received either bsrz (referred to as B in Figure 3.12) or 
bsrz/L-DOPA (referred to as L in Figure 3.12) from birth to P28. Mice in Group 2 received bsrz 
or bsrz/L-DOPA from weaning at P18 to P28 and mice in Group 3 received bsrz or bsrz/L-
DOPA starting at P90 to P120 (Figure 3.12A). Importantly, with this paradigm, I found that 
serum L-DOPA levels are relatively constant throughout the day (Table 3.2), providing an 
advantage over pulsatile treatment with DA receptor agonists.   
To expose mice in the postnatal and juvenile period (Group 1), breeding pairs of Pitx3KO 
or Pitx3WT mice were placed together and chow was switched to either bsrz alone or bsrz/L-
DOPA. Breeding pairs and pups were maintained on the specified diet until weaning at P18. 
Pups were then weaned onto the diet on which they were raised and sacrificed at P28-30 for 





I first compared striatal monoamine content across genotype and treatment. In Pitx3WT 
mice, we found no significant effect of L-DOPA treatment on striatal tissue levels of DA or its 
metabolites, homovanillic acid (HVA) or DOPAC (Figure 3.13). In Pitx3KO mice, as expected 
in assays of striatal tissue content (Wood and Altar, 1988), I found no effect of L-DOPA 
treatment on DA levels but observed a significant increase in the levels of HVA and DOPAC 
(Figure S6). Increases in these metabolites are due to increased extracellular DA (Wood and 
Altar, 1988), and demonstrate that L-DOPA elevated striatal DA turnover in Pitx3KO mice.  
 
Figure 3.13. L-DOPA chow increases DA metabolites, HVA and DOPAC, in Pitx3KO but not Pitx3WT mice. Striatal 
catecholamine concentration from (A) Pitx3WT group 1 (Benserazide only (Bsrz): N=11, Benserazide and L-DOPA (B+L): 
N=4), (B) Pitx3KO group 1 (B n=11, B+L n=9), (C) Pitx3KO group 2 (B n=4, B+L n=4), (D) Pitx3KO Group 3 (B n=5, 







I then determined whether L-DOPA treatment affected SPN excitability in Pitx3WT mice 
compared to bsrz alone. I found no significant differences between bsrz and bsrz/L-DOPA 
treated Pitx3WT mice at P28 in resting membrane potential, input resistance, rheobase, and peak 
inward current (Figure 3.13). 
To examine the role of DA in the developmental maturation of SPN excitability, we 
examined SPN excitability after treatment from birth to P28 (KO Group 1B vs. KO Group 1L; 
Figure 3.12C-E). In contrast to Group 1L-treated Pitx3WT SPNs, Group 1L-treated Pitx3KO 
SPNs exhibited a trend of decreased resting membrane potential and a significantly increased 
rheobase and decreased input resistance compared to Pitx3KO SPNs in group 1B (Figure 3.12C-
E). Furthermore, current-response curves for Pitx3KO SPNs from Group 1L were significantly 
shifted towards the right compared to Group 1B (Figure 3.12F). We note that Pitx3WT SPNs in 
Group 1B (reproduced from Figure 3.13) are shown throughout Figure 3.12 for comparison. 
The intrinsic excitability of SPNs from Pitx3KO mice was indistinguishable from 
Pitx3WT mice until P18 but diverged by P28 (Figure 3.4) and increasing DA levels before P18 
failed to accelerate the maturation of SPN excitability (Figure 3.6). I therefore tested whether 
treatment from P18 to P28 with L-DOPA was sufficient to rescue SPN excitability in Pitx3KO 
mice (Group 2L; Figure 3.12C-F). First, I confirmed that a 10-day treatment with bsrz/L-DOPA 
increased striatal DA turnover by HPLC, compared to P28 Pitx3KO mice maintained on bsrz 
from birth (Figure 3.13). Remarkably, L-DOPA treatment from P18 to P28 had the same effect 
as treatment from birth (Figure 3.12C-F). Thus, the presence of DA during a specific 10-day 
window is sufficient to induce normal maturation of SPN intrinsic excitability, but DA is not 





I then addressed whether DA could lead to SPN maturation if introduced in adulthood. I 
placed naïve adult Pitx3KO mice on bsrz or bsrz/L-DOPA chow from P90 to P110 (Group 3). L-
DOPA treatment had no effect on resting membrane potential, rheobase, or input resistance 
(Figure 3.12C-E). Furthermore, L-DOPA treatment how no effect on the current-response curve 
in SPNs from Group 3L compared to 3B (Figure 3.12G). Together, these results demonstrate that 
DA must act during a critical window in the juvenile period to provide normal maturation of 
SPN excitability.  
Using voltage clamp, I then tested whether diminished Kir currents in Pitx3KO SPNs 
were rescued by L-DOPA. Pitx3KO SPNs from Group 1L and 2L had significantly increased Kir 
currents compared to Pitx3KO SPNs from Group 1B (Figure 3.12H-I). L-DOPA treatment in 
Group 3 did not increase Kir currents (Figure 3.12H and J). Thus, L-DOPA during the juvenile 
period rescued underlying deficits in Kir2 currents, but not during adulthood.  
3.3.9 L-DOPA Treatment from P18 to P28 Rescues Pitx3KO D1T+ SPN Excitability and 
Kir2 Current via Control of PIP2 Dynamics without Affecting D1T- SPN Excitability or 
Kir Currents. 
I have shown that L-DOPA treatment during a critical period in SPN development 
rescues deficits in intrinsic excitability and Kir currents in Pitx3KO mice (Figure 3.12). To 
confirm whether L-DOPA treatment selectively rescued D1T+ SPN hyperexcitability in Pitx3KO 
mice or also affected D1T- SPN excitability, I treated Pitx3KO;D1-tomato mice with bsrz (Group 
2B) or L-DOPA and bsrz (Group 2L) from P18 to P28 and recorded SPN excitability at P28 
(Figure 3.14B). L-DOPA treatment specifically rescued D1T+ SPN excitability (RMP, rheobase, 







Figure 3.14. L-DOPA treatment from P18 to P28 only affects Pitx3KO D1T+ SPN excitability, via control of PIP2-Kir 
dynamics. (A) Sample traces from P28 Pitx3KO D1T+ and D1T- SPNs treated from P18 with either benserazide (Group 2B) 
or L-DOPA and benserazide (Group 2L) (B) Schematic of groups administered chow (reproduced from Figure 7). (C) RMP, 
(D) rheobase and (E) input resistance are changed in D1T+ SPNs in in Group 2L, but no effect was observed on D1T- SPNs. 
(F) Sample voltage clamp traces and (G and H) quantification of Kir current from (G) D1T+ and (H) D1T- SPNs in Group 
2B and Group 2L shows a selective rescue of L-DOPA on Kir current from D1T+ SPNs. D1T+: 2B n = 14 cells from 2 mice, 
2L n = 13 cells from 4 mice. D1T-: 2B n = 8 cells from 2 mice, 2L n = 9 cells from 4 mice. (I) Representative voltage clamp 
traces at membrane rupture (0s) and 180s after rupture and diffusion of neomycin into the cell for D1T+ SPNs in Group 2B 
and 2L. (J) Quantification of percent change in Kir current following dialysis with neomycin from Pitx3KO P28 D1T+ SPNs 






Finally, I asked whether L-DOPA treatment from P18 to P28 would rescue Pitx3KO D1T+ SPN 
Kir currents via PIP2 dynamics. We recorded Kir currents from Pitx3KO D1T+ SPNs in Group 
2B and 2L with neomycin in the internal solution to disrupt PIP2-Kir2 interactions (Figure 3.14I-
J). Neomycin had no effect on Kir currents in Group 2B SPNs, similar to what we observed in 
untreated Pitx3KO D1T+SPNs (Figure 3.8). However, neomycin significantly inhibited Kir2 
currents in cells from Group 2L (Figure 3.14J), demonstrating that L-DOPA treatment during the 
appropriate developmental period rescued PIP2-Kir2 dynamics in D1T+ SPNs of Pitx3KO mice. 
 
Figure 3.15. Distinct electrophysiological phenotype following loss of DA in adulthood. (A) 6-OHDA-lesioned WT 
D1tomato mice show significantly less tyrosine hydroxylase immunofluorescence relative to sham-lesioned mice. N= 3 
sham and 3 6-OHDA lesioned mice. (B-D) No significant difference in (B) RMP, but a significant increase in (C) input 
resistance and decrease in (D) rheobase in D1T+ SPNs from 6-OHDA lesioned mice compared to sham-lesioned mice. (E) 
Significantly reduced Kir2 current, but not (F) Kir2 current density in D1T+ SPNs from 6-OHDA lesioned mice compared 
sham-lesioned. (G) D1T+ SPNs from 6-OHDA lesioned mice have significantly reduced total dendritic length. (H) Addition 
of diC8PIP2 to the pipette solution increases Kir2 currents in D1T+ SPNs from adult Pitx3KO mice but not 6-OHDA 
lesioned mice. (A-G) Sham: N=8 cells from 3 mice. Lesioned: N= 9 cells from 3 mice. Data were analyzed with unpaired, 
two-tailed t tests. (H) Sham/Pitx3WT: N=13 cells from 3 mice, Adult Pitx3KO: N=12 cells from 3 mice, 6-OHDA lesioned: 
N=9 cells from 3 mice. Data were analyzed with a one-way ANOVA followed by Bonferroni post-hoc test. * p<0.05, ** 






3.3.10 Distinct electrophysiological phenotype following adult loss of DA. 
D1T+ SPNs from Pitx3KO mice demonstrate intrinsic hyperexcitability because of 
decreased Kir2 currents without a change in their dendritic arborization. Following loss of DA in 
the adult, dSPNs have been reported to also demonstrate intrinsic hyperexcitability but this arises 
from decreased dendritic complexity (Fieblinger et al., 2014), suggesting that the loss of DA in 
adulthood leads to a distinct set of electrophysiological changes in D1T+ SPNs compared to the 
absence of DA during postnatal development. However, no data has been reported about Kir2 
currents in this model.  
To address this, I injected 6-hydroxydopamine (6-OHDA; (Ungerstedt, 1968)) or vehicle 
unilaterally into the median forebrain bundle to lesion the DA system in adult D1tomato mice. 6-
OHDA-lesioned mice had reduced tyrosine hydroxylase immunoreactivity ipsilateral to the 
lesion compared to sham-lesioned mice (Figure 3.15A). I then recorded from D1T+ SPNs four 
weeks after the 6-OHDA lesion (Fieblinger et al., 2014).  As previously reported, the resting 
membrane potential was not changed in D1T+ SPNs from 6-OHDA lesioned mice compared to 
sham-lesioned mice (Figure 3.15B). However, input resistance was decreased and rheobase was 
increased in 6-OHDA lesioned mice compared to sham-lesioned mice (Figure 3.15C-D). 
Interestingly, whole cell Kir2 currents were decreased in D1T+ SPNs from 6-OHDA lesioned 
mice (Figure 3.15E). Normalization for cell capacitance to measure the current density, however, 
clearly showed that whole cell Kir2 currents were decreased because of a change in cellular 
capacitance (Figure 3.15F). I reconstructed the dendritic tree of recorded cells and found a 
reduction in the length of the dendritic tree in D1T+ SPNs from 6-OHDA lesioned mice 
compared to controls, supporting a reduced capacitance that normalizes Kir2 current density 





that arises from changes in the cable properties of the D1T+ SPNs as previously reported 
(Fieblinger et al., 2014) and not a change in Kir2 currents as I found in cells from Pitx3KO mice 
(Figure 3.3).  
A second open question is why DA replacement does not rescue D1T+ SPN intrinsic 
hyperexcitability in adult Pitx3KO mice. This could arise from a change in the coupling between 
D1R and PIP2 or changes in cellular Kir2 levels such that D1R stimulation increases PIP2 
concentration but cannot increase Kir2 currents. To address this, I measured the change in Kir2 
current following rupture of the cell membrane with diC8PIP2 in the internal solution in D1T+ 
SPNs from adult Pitx3KO mice compared to adult Pitx3WT mice. Addition of PIP2 to the 
internal solution significantly increased Kir2 current in Pitx3KO mice compared to Pitx3WT 
mice, suggesting that D1R coupling to PIP2 levels is disrupted in adult Pitx3KO mice (Figure 
3.15H).   
In addition, I addressed whether PIP2 could rescue Kir2 currents in 6-OHDA lesioned 
mice but found that it did not significantly affect Kir2 currents compared to Pitx3WT D1T+ 
SPNs (Figure 3.15H). These data further support the conclusion that distinct electrophysiological   
changes occur following adult loss of DA compared to loss of DA during the early postnatal 
period.  
3.4 Discussion 
DA neurotransmission has long been suspected to regulate the maturation of basal 
ganglia circuitry (Galiñanes et al., 2009; Kozorovitskiy et al., 2015). I found that evoked DA 
release in the striatum increases dramatically over the juvenile period. In the Pitx3KO mouse, 





until P18, but then displayed persistent hyperexcitability into adulthood. DA replacement to 
juveniles but not to adults corrected SPN excitability in Pitx3KO mice, identifying a mechanism 
through which DA regulates basal ganglia development.   
3.4.1 Developmental Changes in Striatal DA Release. 
Nigrostriatal DA fibers arrive by E14 in the mouse, and while there is a morphological 
absence of axonal boutons on DAergic axons until P14 (Voorn et al., 1988), DA axons are 
capable of Ca2+-dependent DA release in the striatum as early as P7 (Ferrari et al., 2012). 
Support for increased DA release comes from reports that the total striatal tissue content of DA 
(Coyle and Campochiaro, 1976), TH activity, and TH protein (Coyle and Campochiaro, 1976; 
Matthews et al., 2013) each increase during the juvenile period. DA reuptake is also thought to 
increase during this developmental period, as there is increased striatal DAT expression and 
tritiated DA uptake (Cao et al., 2007; Coulter et al., 1996; Tarazi et al., 1998). 
To examine changes in evoked DA neurotransmission in striatal tissue, we performed 
cyclic voltammetry recordings in the dorsal striatum. I found that the total evoked DA signal 
increased dramatically through the juvenile period, with an increased amplitude and unchanged 
half-life of evoked DA transients. As detailed previously (Schmitz et al., 2001; Venton et al., 
2003), peak height in these measurements mostly reflects the amount of evoked release, with 
some further increase if DAT is blocked, whereas the t1/2 is mostly controlled by DAT activity. 
An increase in peak height with a similar t1/2 as seen here is consistent with both increased 
release and increased DAT activity: in contrast, if DA release increased but DAT activity did not 





3.4.2 Diminished Kir2-PIP2 Interactions Underlie dSPN Hyperexcitability in Pitx3KO 
Mice. 
DA release increases during the first four postnatal weeks leading to reductions in dSPN 
intrinsic excitability. In Pitx3KO mice, which lack DA in the dorsal striatum from birth, the 
ontogenetic increase in Kir2 currents during postnatal development of SPNs fails to occur 
beyond P18 in D1+ SPNs. I propose that this deficit is responsible for the intrinsic 
hyperexcitability observed beginning at P28 in dSPNs from Pitx3KO mice.  
Kir2 currents in SPNs play a critical role in setting the RMP and the response to inputs 
that drive the cell away from this potential (Mermelstein et al., 1998; Nisenbaum et al., 1994; 
Wilson and Kawaguchi, 1996). Decreased Kir2 currents lead to a more depolarized RMP, 
increased input resistance and decreased rheobase, all of which are observed in D1T+ SPNs in 
Pitx3KO mice.  
Interestingly, the latency to fire the first action potential and subthreshold voltage 
ramping, key characteristics of SPN firing patterns, were unchanged in SPNs from Pitx3KO 
mice. Consistently, the D-type potassium current, which also increases postnatally in SPNs 
(Surmeier et al., 1991) and contributes to delayed spiking (Shen et al., 2004), was not different in 
Pitx3KO and Pitx3WT SPNs at P28. I thus conclude that the intrinsic hyperexcitability and 
increased action potential firing in response to current injections arises predominantly from 
decreased Kir currents and the consequent elevated RMP and input resistance. Together, these 
results indicate that striatal DA tone during postnatal development is critical for the maturation 





Why are Kir2 currents reduced in Pitx3KO SPNs? No difference was observed in the 
expression of Kir2.1 or Kir2.3, the predominant Kir2 subunits in SPNs (Cazorla et al., 2012; 
Karschin et al., 1996; Mermelstein et al., 1998; Shen et al., 2007), suggesting that post-
translational regulation of Kir2 channels is critical to this phenotype. I note, however, that small 
changes in Kir2 protein levels may not be apparent in total striatal lysates, as diminished Kir2 
currents are only observed in a subset of Pitx3KO SPNs.  
PIP2 is a membrane phospholipid that modulates numerous ion channels and membrane 
receptors (Suh and Hille, 2008). PIP2 is a required cofactor for Kir2.1 and Kir2.3 activity, as 
blocking PIP2/Kir2 interactions pharmacologically or genetically greatly decreases Kir2 currents 
(Hibino et al., 2010). To address whether diminished PIP2/Kir2 interactions were responsible for 
reduced Kir2 currents in D1T+ SPNs from Pitx3KO mice, I acutely screened PIP2 by addition of 
neomycin or included a short chain, water-soluble PIP2 (diC8-PIP2) in the patch pipette (Figure 
6). I found that neomycin reduced Kir2 currents in WT D1T+ SPNs by ~30%, but had no effect in 
Pitx3KO SPNs. Furthermore, diC8-PIP2 increased Kir2 currents in Pitx3KO SPNs, but had no 
effect in Pitx3WT SPNs. These findings suggest that Kir2/PIP2 interactions are nearly saturated 
in D1T+ SPNs from Pitx3WT mice, but decreased at baseline in Pitx3KO SPNs, underlying the 
diminished whole cell currents observed in Pitx3KO SPNs after P18.  
I found that DA controls Kir currents in dSPNs during the striatal critical period 
identified here via regulation of PIP2 dynamics. PIP2 synthesis undergoes developmental 
increases in brain regions including the hippocampus via upregulation of its main biosynthetic 
enzyme, PIP5K (Unoki et al., 2012). Ontogenetic increases in PIP5K expression may be 
dependent on dopaminergic tone in the striatum. Alternatively, posttranslational regulation of 





calcium entry through NMDA receptors (Nakano-Kobayashi et al., 2007; Unoki et al., 2012), 
both of which are strongly influenced by DA signaling in SPNs. Finally, PIP5K activity is 
closely regulated by Rho small GTPases  (Weernink et al., 2004). Intriguingly, DA D1 receptor 
stimulation acts through RhoA GTPases to control dendritic morphogenesis in the prefrontal 
cortex, which may in turn modulate PIP2 (Li et al., 2015). 
PIP2 degradation via phospholipase C (PLC) is stimulated by Gq-coupled receptors. In 
dSPNs, the predominant Gq coupled receptor is the muscarinic M1 receptor. Intriguingly, Ding et 
al.  demonstrate that striatal cholinergic interneurons are hyperactive in adult Pitx3KO mice, 
suggesting the possibility of a hypercholinergic tone that may lead to increased PLC activity and 
PIP2 degradation (Ding et al., 2011b). However, pharmacologic M1R activation failed to inhibit 
Kir2 channels in DSPNs, suggesting that this may not play a prominent role in the regulation of 
Kir2 channels in DSPNs in Pitx3KO mice (Shen et al., 2007).  
Remarkably, I found that IKir but not ID is disrupted in D1T+ SPNs from Pitx3KO mice. 
Kv1.2 channels, which are the predominant source of ID in SPNs (Shen et al., 2004), are also 
modulated by PIP2 (Kruse and Hille, 2013; Rodriguez-Menchaca et al., 2012). The effect of PIP2 
on Kv1.2 differs from its effect on Kir2, however, by modulating voltage sensing and kinetics 
rather than current amplitude (Kruse and Hille, 2013). Thus, subtle changes in Kv1.2 channel 
activation may be present in Pitx3KO SPNs that were not detected here. Alternatively, the effect 
of disrupted PIP2/Kir2 interactions on Kir2 currents may be indirect and mediated by Kir2 
localization to cholesterol-rich membrane microdomains (Romanenko et al., 2004). The lipid raft 
localization of Kir2 is dependent on PIP2 (Rosenhouse-Dantsker et al., 2014) and Kv1.2 channels 
are not strongly modulated by cholesterol, although it remains possible that cholesterol controls 





3.4.3 DA Induces Maturation of SPN Excitability in Development and Maintains SPN 
Firing Patterns in Adulthood. 
My results demonstrate a role for DA in regulating the maturation of DSPN intrinsic 
excitability. In the adult striatum, DA depletion leads to SPN hyperexcitability, which is thought 
to reflect a homeostatic compensation in response to a loss of excitatory inputs onto SPNs 
(Azdad et al., 2009; Fieblinger et al., 2014; Warre et al., 2011). My results suggest that the SPN 
hyperexcitability following DA depletion during development may not represent a homeostatic 
mechanism to ensure proper striatal activity, but rather the absence of DA-mediated 
developmental increase in Kir channel function that controls SPN excitability. In support of this 
hypothesis, I did not observe changes in dendritic arborization or in functional measurements of 
synaptic inputs at P28 in D1T+ SPNs from Pitx3KO mice. How might this be congruent with a 
causal link between SPN hyperexcitability and dendritic morphology reported previously 
(Cazorla et al., 2012)? In that study, Cazorla et al. demonstrate that reduced Kir currents in DA 
D2 receptor overexpressing (D2-OE) mice leads to dendritic shrinkage in SPNs. These models 
differ, however, as SPN hyperexcitability in D2-OE mice occurs in cells not expressing the D2 
transgene, although to a lesser degree, and was mediated by a downregulation of Kir2.1 and 2.3 
protein expression (Cazorla et al., 2012). In contrast, the changes in intrinsic excitability in 
Pitx3KO SPNs were not present in all subtypes and were independent of changes in Kir2 
expression. The changes in SPN excitability observed in the Pitx3KO mouse indicate a 
fundamental role for DA in the ontogeny of corticostriatal neurotransmission. 
3.4.4 DA as a Critical Period Signal in the Striatum. 
Treatment of juvenile, but not adult, Pitx3KO mice with L-DOPA rescued SPN 





DA and its metabolites in striatal lysates by HPLC. I found that L-DOPA increased the levels of 
the dopamine metabolites, DOPAC and HVA, which primarily represent released DA (Lindgren 
et al., 2010; Mosharov et al., 2015; Wood and Altar, 1988), to a similar extent in juvenile and 
adult Pitx3KO mice. I conclude that L-DOPA treatment increases DA turnover in the striatum of 
both juvenile and adult Pitx3KO mice. 
Difference in postsynaptic DA sensitivity may explain the specific response of juvenile 
Pitx3KO mice to L-DOPA that are absent in adult animals. Both DA receptor levels and DA 
receptor-coupled signaling change dramatically during the juvenile period (Andersen, 2002; 
Teicher et al., 1995). It is possible that DA receptor dynamics, and downstream signaling 
cascades such as PIP2 levels, require a minimum threshold of DA to undergo ontogenetic 
changes during the juvenile period to change SPN excitability. I note, however, that this 
threshold may be low, as the increases in DOPAC and HVA required to rescue SPN 
hyperexcitability in Pitx3KO mice remain lower than those observed in Pitx3WT mice. 
Nevertheless, without this exposure to DA, SPNs from Pitx3KO mice fail to respond to increased 
DA from L-DOPA supplementation during adulthood. 
Why is DA unable to reduce SPN intrinsic excitability in adult Pitx3KO mice? A recent 
report has demonstrated dendritic atrophy in adult Pitx3KO mice (Suarez et al., 2018). It is 
possible that prolonged reductions in striatal DA initially lead to SPN hyperexcitability at P28 
and subsequently to dendritic shrinkage in adulthood (Suarez et al., 2018). Reduced glutamate 
signaling from synapse loss in the adult Pitx3KO mouse may prevent increased DA signaling 
with L-DOPA treatment from rescuing Kir2 function. In support of this hypothesis, the activity 
of several GTPases in SPNs are under the dual control of glutamate and DA (Girault et al., 





activate Kir2 channels and reduce intrinsic excitability (Weernink et al., 2004). DA replacement 
increased Kir2 currents and decreased SPN excitability in Pitx3KO mice prior to P28, when 
glutamate signaling is not different than Pitx3WT SPNs , as indicated by the absence of 
difference in synaptic inputs or dendritic arborization. Thus, prolonged DA depletion may lead to 
homeostatic changes in glutamatergic signaling, prohibiting DA supplementation from rescuing 
SPN hyperexcitability in adulthood.  
3.4.5 Implications for Developmental Diseases of the Striatum. 
I have established a timeline of ontogenesis of SPN intrinsic excitability and striatal DA 
neurotransmission, and identified a role for striatal DA in the regulation of a postnatal decrease 
of DSPN excitability during a specific critical period. The study of normal brain development 
may elucidate pathogenic mechanisms (Spear, 2000), and the present findings may indicate new 
therapeutic directions if decreased DA signaling is identified in neurodevelopmental disorders.  
3.5 Materials and Methods 
Experimental Model and Subject Details 
Animals 
All mouse lines, including Pitx3ak mice (referred to as Pitx3KO) (Nunes et al., 2003), 
DATKO (Giros et al., 1996) and Drd1a-tdTomato line 6 (Shuen et al., 2008), were obtained from 
Jackson Laboratories (Bar Harbor, Maine). All mice were maintained on a C57/BL6J 
background. Mice were housed in same sex groups of 2-4 on a 12-hour light/dark cycle with 
water and food available ad libitum. Breeding pairs were checked daily for pregnancy and new 
litters. Mice were used for experiments on the specified postnatal day (± 1) in all experiments 





Animal Care and Use Committee and followed NIH guidelines. No differences were observed 
between male and female mice, so all data were combined. 
Method Details 
Subjects were randomly allocated to chow treatment group. All experiments were 
replicated in mice from separate litters. All electrophysiology data was obtained from 3-8 mice 
per group. N in the figure legend or text indicated the number of cells and the number in 
parentheses represents the number of mice. For immunohistochemistry and western blotting, N is 
the number of mice and for FSCV n is the number of slices. For FSCV, slices from at least 3 
mice were analyzed for each age. Sample-sizes were estimated based on past studies from our 
groups. No formal power analyses were conducted. Exclusion criteria for whole-cell patch clamp 
recordings are as follows: series resistance and the pipette capacitance transients were monitored 
online and recordings were discarded when series resistance or pipette capacitance transient was 
unstable, series resistance greater than 20 MΩ or a change in pipette capacitance transient of 
>20%. For CV, slices were excluded if electrically evoked DA release varied by more than 30% 
over a 10 minute period. In some experiments, data sets were formally tested for outliers by the 
Grubbs’ test. 
Electrophysiology 
Acute striatal slices were prepared from animals at the specified ages as previously 
described (Borgkvist et al., 2015). Briefly, mice underwent cervical dislocation. The brain was 
removed and placed in ice-cold sucrose cutting solution (in mM): 10 NaCl, 2.5 KCl, 25 
NaHCO3, 0.5 CaCl2, 7 MgCl2, 1.25 NaH2PO4, 180 sucrose, 10 glucose bubbled with 95% O2/5% 
CO2 to pH 7.4. Coronal slices (250 µm) that included the striatum were collected and allowed to 





25 NaHCO3, 1.5 CaCl2, 1 MgCl2, 1.25 NaH2PO4 and 10 glucose bubbled with 95% O2/5% CO2 
to pH 7.4. Slices were then bubbled in ACSF until recordings.  
For recordings, slices were placed in a bath at 26°C with constant perfusion with 
oxygenated ACSF (1.5-2 mL/min). SPNs were identified in the slice using IR/DIC optics by 
their small cell bodies (approximately 10-15 µm diameter) and characteristic 
electrophysiological properties including resting membrane potential less than -65 mV, delayed 
spike in response to a square depolarizing pulse and lack of spontaneous action potential firing. 
Cells were also examined for fluorescence from the D1-Tomato allele where specified. Whole 
cell recordings were then established with glass pipettes (3-6 MΩ) with an internal solution of 
(in mM): 115 potassium gluconate, 20 KCl, 20 HEPES, 1 MgCl2, 2 MgATP, 0.2 NaGTP 
adjusted to pH 7.25 with KOH, osmolarity 285 mOsm. Liquid junction potential was not 
corrected. Data were digitized at 10 kHz and filtered at 5 kHz. All recordings were made within 
5 hours of slice preparation.  
Membrane properties were extracted from current clamp recordings in which a series of 
hyper- and depolarizing current steps (20 pA) were injected into the cell. Input resistance was 
determined by taking the voltage difference between steps in which+60 and -60 pA were 
injected. Rheobase was determined following a ramp depolarization at 200 pA/s. Capacitance 
was calculated from tau extracted from a fit of a -5 mV current injection and the input resistance 
determined as described above. Current-response curves were determined from the number of 
action potentials fired over the 500 ms square current pulse (Cazorla et al., 2012). 
Inward and Kir2 currents were measured in voltage clamp with a Vhold of -60 mV and a 
series of 10 mV voltage steps. Voltage steps lasted one second and the current measurement used 





inactivating (Cazorla et al., 2012; Mermelstein et al., 1998). In Figure 3.5, Kir2 currents were 
measured by using the voltage clamp protocol described above in the presence of tetrodotoxin 
(TTX; 1μM) and in the presence of both TTX and CsCl2 (1mM). The CsCl2 sensitive current is 
the Kir2 current (Cazorla et al., 2012). As no difference was observed in the CsCl2 resistant 
current (See Figure 3.5D-E) but only in the current elicited with TTX alone, in Figures 3.7, 3.8 
and 3.12, the inward current evoked with the voltage clamp protocol described above was used 
as a proxy for Kir2 currents without CsCl2 subtraction (Gertler et al., 2008). 
D-type currents were evoked from a Vhold of -90 mV followed by a series of steps to+30 
mV (15 mV increments) and return to a Vhold of -60 mV in the presence of TTX (1 μM) 
(Surmeier et al., 1991). Steady-state current at the end of the 1 s voltage steps was measured.  
The effect of neomycin was measured by the addition of 1 mM neomycin (Gabev et al., 1989) to 
the internal pipette solution. Giga-Ohm seals were established and the cell membrane was 
ruptured. Immediately, a voltage clamp protocol was begun with cells being held at a voltage of -
60 mV and stepped to -130 mV for 500 ms every 10- 30 seconds for 3 minutes (the time required 
for the maximal effect of neomycin on Kir2 currents (Rosenhouse-Dantsker et al., 2014)). Series 
resistance was monitored online with a -10 mV voltage step. Percent change of Kir2 current was 
calculated by subtracting the relative change of Kir2 current from time 0 (membrane rupture) to 
t=3 min (maximal effect of neomycin) and normalizing it to the relative change in cells patched 
without neomycin in the internal solution. 
The effect of diC8-PIP2 (50 μM; Echelon Biosciences) was measured as described for 
neomycin except that Kir2 current was measured every 30 seconds for 12 min (maximal effect of 
diC8-PIP2 (Rosenhouse-Dantsker et al., 2014)). Percent change of Kir2 currents combining 





The effect of forskolin on Kir2 currents was measured by first adding synaptic blockers 
(picrotoxin, CNQX and AP5) to the bath. Kir2 currents (Vhold -60 mV step to -130 mV) were 
measured every 30 seconds. Baseline was measured for 5-10 minutes followed by addition of 
forskolin (20 μM) to the perfusate. Kir2 currents were then measured for 12 minutes.  
Cyclic voltammetry  
Electrochemical recordings of endogenous dopamine release were collected as detailed 
previously (Pereira et al., 2016). Striatal slices were prepared as for electrophysiological 
experiments except for an increased CaCl2 concentration (2 mM). During recordings, slices were 
kept under constant superfusion of oxygenated ACSF (2 mL/min, 34 °C). Carbon fiber 
electrodes (5 μm diameter, cut to ~150 μm length) were placed in the dorsolateral striatum 50-70 
μm into the slice. A triangular voltage wave (−450 to+800 mV at 294 mV/ms vs Ag/AgCl) was 
applied to the electrode every 100 ms and the resulting current was detected with an Axopatch 
200B amplifier (Axon Instruments) using a 5 kHz low-pass Bessel Filter setting and 25 kHz 
sampling rate. Signals were digitized using an ITC-18 board (Instrutech) and recorded with 
IGOR Pro 6.37 software (WaveMetrics), using custom in-house acquisition procedures (Pereira 
et al., 2016). Slices were stimulated with a bipolar stainless steel electrode placed ~150 μm from 
the recording electrode using an Iso-Flex stimulus isolator triggered by a Master-9 pulse 
generator (AMPI). Single pulses (100 μs × 200 μA) were applied every 2 min and once stable 
release was achieved, four consecutive peaks were analyzed. To test DAT blockade, the 
perfusion solution was switched to ACSF containing 10 μM nomifensine after stable baseline 
was achieved and slices were stimulated every 5 min (Jones et al., 1995). Data were analyzed 
using an in-house written procedure in IGOR Pro. Electrodes were calibrated by characterizing 






Custom chow was ordered from TestDiet (St. Louis, Missouri). PicoLab rodent diet 
205053 was supplemented with either 0.2% w/w levodopa (Sigma-Aldrich, St. Louis, Missouri) 
and 0.0125% w/w Benserazide HCl (Sigma-Aldrich, St. Louis, Missouri). No effect of genotype 
or treatment was found on litter size (data not shown).  
High-pressure liquid chromatography (HPLC) 
Brains were removed and striata were dissected rapidly on an ice-cold surface. Tissue 
DA, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) levels were 
determined by HPLC with electrochemical detection as previously described (Feigin et al., 2001; 
Mosharov et al., 2006).   
Immunohistochemistry 
Mice were anesthetized and perfused transcardially with ice-cold 0.9% saline (~10 mL) 
and then with 4% paraformaldehyde (PFA) in 0.1M phosphate buffer pH 7.4 (~40 mL). Brains 
were removed and post-fixed overnight in 4% PFA at 4°C. Brains were then sectioned on a 
vibratome (50 µm) and stored at -20°C in cryoprotectant until analysis. For 
immunohistochemistry, sections were permeabilized and blocked in 0.1% triton-X, 2% normal 
donkey serum (Jackson) in 1X TBS and then stained overnight in blocking solution at 4°C 
containing the following primary antibodies: rabbit anti-RFP (1:500; Rockland) and/or mouse 
anti-tyrosine hydroxylase (1:1000; Millipore).  Secondary antibodies (1:500) were obtained from 
Invitrogen conjugated to Alexafluor dyes.  
Western Blotting 
Mice underwent rapid cervical dislocation and brains were removed onto an ice-cold 





then placed in RIPA buffer (25 mM Tris HCl pH7.6, 150 mM NaCl, 1% NP-40, 1% sodium 
deoxycholate, 0.1% SDS) and homogenized with a hand sonicator. Protein concentration was 
determined using the BCA protein determination assay (Thermo). Equivalent amounts of total 
protein (10-25µg) were then loaded onto 10% SDS-PAGE gels. Proteins were then transferred 
onto PVDF membranes (Immobilon FL, LI-COR). Membranes were blocked with LI-COR 
blocking buffer (TBS) and incubated with primary antibody overnight. Membranes were then 
incubated with secondary antibody (LI-COR) and imaged in the Odyssey blot image (LI-COR. 
For blots of Kv1.2, Kir2.1 and Kir2.3, membranes were incubated with secondaries conjugated to 
horseradish peroxidase (Jackson ImmunoResearch). Membranes were then reacted with 
immobilon western chemiluminescent HRP substrate (Millipore) and imaged using a film 
developer.  
Quantification and Statistical Analysis 
All data analysis was conducted blinded to genotype and treatment. Electrophysiology 
data were analyzed offline using Clampfit software (Molecular Devices, Sunnyvale, California). 
Statistical analysis was conducted in GraphPad Prism 7 (La Jolla, CA). All bar graphs show the 
mean+/- standard error of the mean. Data comparing two variables was analyzed with a two-way 
ANOVA. Post-hoc Bonferroni tests were conducted when significant differences were found 
with the two-Way ANOVA. Data comparing one variable amongst >2 groups was analyzed with 
one-Way ANOVA and Bonferroni post-tests and among 2 groups a two-tailed t test. Data were 







Table 3.1 Index of ages examined throughout Chapter 3. 
Figure  Age of mice Genotype 
3.1 P12, P18, P28, P120 D1tomato 
3.2 P10, P14, P18, P28, P110 C57/BL6 
3.4 P14, P18, P28, P110 Pitx3WT or Pitx3KO 
3.5 4B-P14, P18, P28, P110 
Remainder of figure: P28 
Pitx3WT or Pitx3KO 
3.7 P28 Pitx3WT;D1T or 
Pitx3KO;D1T 
3.8 P28 Pitx3WT;D1T or 
Pitx3KO;D1T 
3.12 P28 or P120 Pitx3WT or Pitx3KO 
3.3 P14 or P28 C57/BL6 
3.6 P18 DAT WT or DAT KO 
3.9 P28 S3A-H: Pitx3WT;D1T or 
Pitx3KO;D1T 
S3I-J: Pitx3WT or Pitx3KO 
3.10 P28 S4A-C: Pitx3WT or 
Pitx3KO 
S4D-F: Pitx3WT;D1T or 
Pitx3KO;D1T 
3.11 P28 Pitx3WT;D1T or 
Pitx3KO;D1T 
3.13 A-C: P28 
D: P110 
E: P28 
Pitx3WT or Pitx3KO 






Table 3.2. Bsrz + L-DOPA treatment increases blood L-DOPA levels throughout the day. 
Blood L-DOPA levels were measured from tail vein samples of mice before being provided with 
chow and four days after presentation of chow. Samples were collected either immediately 
following the lights turning on (Lights On) or immediately after the lights were turned off 
(Lights Off) and samples were processed with HPLC. Repeated measure two-way ANOVA 
revealed a significant effect of chow, but no significant effect of time of day.  
 L-DOPA +/- sem (n) before 
treatment 
L-DOPA +/- sem (n) after 
treatment 
Lights on 13.33 +/- 8.511 nM (3) 864.3 +/- 111.3 nM (3) 





Chapter 4: Postnatal Maturation of Striatal Cholinergic 
Interneuron Physiology‡. 
4.1 Abstract 
 Dynamic changes in motor abilities and motivated behaviors occur during the juvenile 
and adolescent periods. In the adult, the striatum represents a critical subcortical nucleus for 
action selection, motor learning and reward processing. The tonically active cholinergic 
interneuron (ChI) is a critical node in striatal information processing. Thalamic and 
dopaminergic inputs initiate pauses in ChI firing following salient sensory cues that are extended 
for several hundred milliseconds by intrinsic regenerative currents. Here, I characterize the 
electrophysiological and morphological features of ChIs during mouse postnatal development. I 
demonstrate that ChI spontaneous activity increases linearly and the length of the pause in firing 
induced by depolarizing inputs decreases during postnatal development. Maturation of ChI 
activity is driven by two distinct changes in their physiology: decreased amplitude of the 
afterhypolarization between P14 and P18 and increased Ih between the late postnatal period and 
adulthood. Interestingly, the dendritic arborization of ChIs reaches adult levels before P10. 
Finally, using fast scan cyclic voltammetry (FSCV), the effect of immature ChI physiology on 
DA release properties in the striatum was analyzed. These data provide the first characterization 
of the physiological maturation of ChI activity and suggest that changes in ChI activity 
postnatally may contribute to an increasingly complex behavioral repertoire during this period.   
 






The early postnatal period encompasses a time of increased sensory stimulation and 
development of a complex repertoire of motor skills (Altman and Sudarshan, 1975; Shaywitz et 
al., 1979; Westerga and Gramsbergen, 1990). In rodents, locomotor activity increases 
dramatically during the second postnatal week(Altman and Sudarshan, 1975; Shaywitz et al., 
1979; Westerga and Gramsbergen, 1990). This is associated not only with increased exploration 
but also a shift towards motivated behaviors that incorporate both internal and external states 
(Hall et al., 1977).  
 The striatum is the main input nucleus of the basal ganglia and contributes to action 
selection, motor learning and motivated behaviors in the adult(Gerfen and Surmeier, 2011). 
Although comprising around 1-5% of striatal neurons(Kemp and Powell, 1971a, 1971d), the 
cholinergic interneuron (ChI) represents a critical node in striatal computation because of its 
widespread axonal arborization and synaptic connections with other striatal neurons (DiFiglia, 
1987; DiFiglia et al., 1976; Goldberg and Reynolds, 2011; Goldberg et al., 2012; Kawaguchi, 
1993). Furthermore, ChIs form axo-axonic synapses with dopaminergic axons and regulate 
dopamine (DA) release during motivated behaviors (Azam et al., 2002; Exley and Cragg, 2008; 
Le Novère et al., 1996; Mohebi et al., 2019; Sulzer et al., 2016; Zoli et al., 2002). ChIs are 
tonically active neurons with spontaneous firing frequencies between 2-10 Hz (Bennett and 
Wilson, 1999; Wilson et al., 1990). In vivo, ChIs respond to salient stimuli (either rewarding or 
aversive) with pauses in their firing that can last for several hundred milliseconds (Aosaki et al., 
1994a). Whether the firing properties of ChIs and the mechanisms that drive pauses in ChI firing 





 In the adult, spontaneous ChI activity is driven by intrinsic conductances and occurs in 
the absence of synaptic activity (Bennett et al., 2000). Ih, mediated by HCN channels, 
depolarizes ChIs to -60 mV where HCN channels inactivated. A persistent sodium current then 
drives the cell to its action potential threshold where CaV2 calcium channels open (Bennett et al., 
2000). The calcium-activated potassium channels, SK and BK, then repolarize the cell and are 
responsible for the depth of the afterhyperpolarization (mAHP) during spontaneous tonic firing 
(Goldberg and Wilson, 2005). The pause in ChI activity following salient cues is initiated by 
excitatory thalamic inputs(Matsumoto et al., 2001) and depends on DA signaling (Aosaki et al., 
1994b; Reynolds et al., 2004; Zhang et al., 2018). However, the reduction in firing persists 
beyond the initial excitatory input and is driven by a combination of Ih and a barium-sensitive 
potassium current that may be mediated by delayed-rectifier, KV7, channels (Wilson, 2005; 
Zhang et al., 2018). The intrinsic component of this pause is called the slow 
afterhyperpolarization (sAHP) and can be experimentally evoked by injecting depolarizing 
current into ChIs.  
To address the postnatal maturation of ChI activity, I completed cell-attached and whole-
cell recordings of ChIs in the dorsal striatum in acute brain slices from mice at different ages. I 
found that the spontaneous activity of ChIs undergoes a linear increase beginning at P10 into 
adulthood. Two distinct transitions in ChI physiology drive overall changes in firing rate: the 
mAHP decreases dramatically between P14 and P18 followed by an increase in the putative 
HCN current between P28 and adulthood. In addition to the maturation of spontaneous activity, 
the sAHP decreases in length from P10 to adulthood. Finally, using fast-scan cyclic voltammetry 





provide a foundation for further studies of the role of ChIs in the postnatal acquisition of 
complex motor tasks and motivated behaviors.  
4.3 Results 
4.3.1 The Firing Frequency and Pattern of ChIs Matures Postnatally. 
To address how the activity of ChIs matures postnatally, I performed cell attached 
recordings of visually identified ChIs at different ages across postnatal development. Cell-
attached recordings were utilized to assess spontaneous activity in order to minimally disturb the 
intracellular milieu and preserve spontaneous activity. ChIs were visually identified by their 
large cell bodies under DIC optics and cellular identity was confirmed following conversion to 
the whole cell configuration (see below). I recorded from a total of 100 ChIs at P10, P14, P18, 
P28 and in adults (P110-P120). Two cells recorded from a mouse at P10 were not spontaneously 
Figure 4.1. Postnatal maturation 
of spontaneous ChI activity. (A) 
Sample cell-attached recordings 
from ChIs at P10, P14, P18, P28 and 
adults (P110-120). (B) A significant 
increase in ChI spontaneous firing 
frequency from P10 to adulthood. 
P10 n=18 cells (4 mice), P14 
n=16(2), P18 n= 23(4), P28 n=15(3), 
Adult n=28(6). N is the same in (C-
D).  (C) Age significantly affects the 
coefficient of variation of ChI 
spontaneous activity. (D) Plot of 
coefficient of variation and 
spontaneous firing frequency for 
each recorded cell. Cells are colored 
by age. **** p<0.0001. Data 
analyzed in (B) and (C) with one-






firing in the cell-attached configuration but showed classic ChI charecteristics in the whole-cell 
configuration (discussed below) and were included in subsequent analysis. All spontanerously 
active cells were considered to fire with a tonic or rhythmic firing patterns except for two cells 
(one recorded at P14 and one at P18) which were considered to be “Bursty” (Bennett and 
Wilson, 1999). Spontaneous firing frequencies significantly increased across postnatal 
development (Figure 4.1A-B). ChIs can have variation in the regularity of their firing and ChIs 
classically have an inverse correlation in spontaneous firing frequency and the coefficient of 
variation of their firing in the acute brain slice (Bennett and Wilson, 1999).  Correspondingly, the 
coefficient of variation of ChIs was decreased during postnatal development (Figure 4.1C). 
When the firing frequency and coefficient of variation is plotted for each individual recorded 
cell, a clear inverse correlation is observed between these parameters (Figure 4.1D). Thus, the 
spontaneous activity of ChIs matures postnatally. 
4.3.2 ChI Dendritic Arborization is Mature by P10. 
 Neuronal firing patterns can be influenced by the complexity of their dendritic arbor 
(Mainen and Sejnowski, 1996). Following cell-attached recordings, a whole-cell configuration 
was established and internal solution containing neurobiotin (1 mg/mL) was allowed to diffuse 
into the cell. Sections were post-fixed, stained with fluorescently-labelled streptavidin and filled 
cells were reconstructed using confocal microscopy. A subset of 61 cells from the 100 recorded 
and described above were successfully reconstructed. Cumulative dendritic length was not 
significantly different between the ages examined (Figure 4.2A). Interestingly, however, Sholl 
analysis revealed a significantly more complex dendritic arbor in ChIs at P14 than at P10 and 





of ChIs is largely mature by P10 and reveals a previously unreported stage of dendritic 
overgrowth and regression at P14.  
 
4.3.4 Maturation of the mAHP but not Resting Potential or Action Potential Threshold 
during the Juvenile Period. 
 As the dendritic arborization of ChIs does not mature in parallel with spontaneous firing 
frequency, I examined additional properties of ChI physiology that could contribute to the 
increasing firing frequency observed during postnatal development.  
Figure 4.2. Postnatal maturation of ChI dendritic morphology. (A) There was no effect of age on the cumulative 
dendritic length of ChIs. P10: n=6(3), P14: n=13 (2), P18:15 (4), P28: n=14(3), Adult: n=13(5). (B) Sholl analysis reveals a 
significantly increased number of dendritic crossings in ChIs from P14 mice 50-90 µm from the soma compared to all other 
ages. Data analyzed with a two-way repeated measures ANOVA followed by post-hoc Bonferroni test. Age x Distance: 







 First, I confirmed the age-dependent increase in ChI spontaneous firing frequency also 
occurred in the whole-cell configuration (Data Not Shown). I then confirmed that recorded cells 
displayed classic features of ChIs such as a sag in response to hyperpolarizing current injection 
and pause in firing following depolarizing current injection (Figure 4.3A) (Bennett and Wilson, 
1999; Kawaguchi, 1993). Cells without a sag or pause were excluded from the dataset. I 
analyzed properties of ChI action potentials that could underlie changes in firing frequency. 
Sample pairs of action potentials are shown in Figure 4.1A. In these examples the action 
potential threshold is set to the dashed line as this did not significantly differ with age (see 
below). To emphasize the salient features of these traces the action potential amplitude is 
Figure 4.3. The afterhyperpolarization decreases between P14 and P18. (A) Sample current clamp trace of ChI activity 
in response to depolarizing and hyperpolarizing current injections. (B) Sample expanded traces of pairs of action potentials 
from ChIs recorded at the specified ages. (C) No significant effect of age on RMP (age: p = 0.2919) or AP threshold (age: p 
= 0.4404). (D) A significant effect of age on the of the afterhyperopolarization (p = 0.0102). For (C-D), P10 n=18 cells (4 
mice), P14 n=16(2), P18 n= 23(4), P28 n=15(3), Adult n=28(6). (E) Correlation between afterhyperpolarization and firing 






truncated. These changes are valid because neither action potential width nor amplitude was 
significantly affected by age (data not shown).  
One possibility to explain why spontaneous firing frequency of ChIs increases during 
postnatal development is that the action potential threshold could become more hyperpolarized, 
allowing threshold to be reached more rapidly. Alternatively, the resting membrane potential 
(midpoint between two action potentials) could become more depolarized. Age did not 
significantly affect either parameter (Figure 4.3A-B). In contrast, the afterhyperpolarization 
(mAHP) significantly decreased between P10 and adulthood (Figure 4.3C), suggesting that this 
may contribute to increased firing frequency during postnatal development. In support of this, a 
clear negative correlation is observed between mAHP and firing rate in ChIs (Figure 4.3D). 
Interestingly, mAHP appears to reach the adult level at P18, which suggest that additional 
changes in ChI physiology may drive increases in firing frequency that occur beyond this age. 
These data suggest that changes in mAHP amplitude may contribute to increasing firing 







4.3.4 Maturation of Inward Currents. 
 Depolarization of ChIs from the hyperpolarized potential of the mAHP, is driven by Ih 
(Bennett et al., 2000; Robinson and Siegelbaum, 2003). The magnitude of Ih can be measured in 
voltage clamp experiments by holding the cell at -60 mV, where HCN channels are closed, and 
stepping the cell to hyperpolarized potentials (Bennett et al., 2000). Importantly, Ih inactivates 
following a hyperpolarizing voltage step and the current remaining at steady-state is mediated by 
leak channels (Figure 4.4A). Thus, the magnitude of the inactivated current is a proxy for Ih 
(Robinson and Siegelbaum, 2003). The inactivated inward current did not increase between P10 
and P28 but was significantly increased compared to all previous ages in adulthood (Figure 
4.4B). These data suggest that increased Ih may contribute to elevated spontaneous firing 
frequencies in adulthood compared to earlier ages.  
Figure 4.4. Postnatal maturation of putative Ih currents. (A) Sample voltage clamp recording demonstrating the 
inactivating Ih current. (B) Aggregate Ih current density shows a significant increase between P28 and adulthood but no 
difference at younger ages.  P10 n=18 cells (4 mice), P14 n=16(2), P18 n= 23(4), P28 n=15(3), Adult n=28(6). Data 








4.3.5 The sAHP is Extended During the Early Juvenile Period. 
Another critical feature of ChI physiology is a pause in firing frequency in response to 
salient sensory stimuli (Aosaki et al., 1994a). Although the pause can be initiated by excitatory 
thalamic inputs (Matsumoto et al., 2001) or D2 receptor stimulation (Aosaki et al., 1994b; Ding 
et al., 2010; Reynolds et al., 2004; Straub et al., 2014), intrinsic potassium and non-specific 
cation (Ih) conductances define the length of the pause (Wilson, 2005; Wilson and Goldberg, 
2006; Zhang et al., 2018). These conductances can also be triggered by injection of depolarizing 
currents, which mimic excitation by synaptic inputs or DA (Wilson, 2005; Wilson and Goldberg, 
2006; Zhang et al., 2018), and drive a pause in firing which is called the slow 
afterhyperpolarization (sAHP). A depolarizing current step was delivered to ChIs at different 
ages and the length of the pause in firing after the end of the current injection was measured 
(Figure 4.5A). The length of the sAHP was extended at P10 and P14 relative to adulthood 
Figure 4.5. Postnatal decreases in the sAHP. (A) Sample current clamp recording showing the response to injection of 
depolarizing current. The length of the pause in firing following the end of the current step is quantified in (B). (B) 
Aggregate sAHP length shows a significant effect of age. P10 n=18 cells (4 mice), P14 n=16(2), P18 n= 23(4), P28 






(Figure 4.5A-B). These data suggest that the conductances which drive the sAHP are 
exaggerated during the early juvenile period. 
4.3.6 Frequency-dependence of DA Release in the Juvenile and Adult Striatum. 
 The pause in ChI firing following salient sensory cues is proposed to affect local DA 
release in the striatum. The interaction between DA and ACh can be probed in the acute brain 
slice as nAChR activation on DA axons acts as a frequency-dependent filter on DA release (Rice 
and Cragg, 2004; Zhang and Sulzer, 2004; Zhou et al., 2001): ACh amplifies DA release in 
response to low-frequency stimuli and reduces DA release following high-frequency stimuli. 
Therefore, I hypothesized that the reduced ChI activity in the juvenile striatum (~P10) may lead 
to differences in DA release properties. This hypothesis is supported by reduced DA release in 
response to single electrical pulses in the juvenile striatum (See Figure 3.2) (Lieberman et al., 
2018a).  
To address this, DA release was measured using fast-scan cyclic voltammetry (FSCV) in 
acute brain slices from mice at P10, P28, and in adulthood, following intrastriatal electrical 
stimulation. DA release following a single pulse increased significantly with age (Figure 4.6A-
B). However, stimulation with 5 pulses at 100 Hz significantly increased evoked DA release at 





following 100 Hz stimulation or 1 pulse (Figure 4.6C) and this ratio is significantly lower at P28 
and in adulthood compared to P10. These results demonstrate that DA release properties mature 
Figure 4.6. Reduced cholinergic activity at P10 leads to immature DA release properties. (A) Sample FSCV traces of 
evoked DA release with a single pulse (sp) or 5 pulses at 100 Hz at P10 or in adults. Scale bar: 200 nM and 200 ms. (B) 
Absolute concentrations of evoked DA release following a single pulse (1p) or five pulses at 100 Hz. (C) Ratio of DA evoked 
with 5 pulses at 100 Hz or a single pulse in slices from mice aged P10, P28 or Adult. Note that this is a transformation of data 
from (B).  P10 n=14 slices (4 mice), P28 n=12 slices from 3 mice, Adult n=14 slices from (3). Data analyzed with one-way 
ANOVA followed by Bonferroni post-hoc test. (D) DHbE (1 µM) significantly increases the 100 Hz/1p ratio at P28 and adult 
but not at P10. Data analyzed with two-way repeated measures ANOVA followed by Bonferroni post-hoc test. Age x Drug: 





between P10 and P28. Interestingly, the fact that similar levels of DA are evoked following 100 
Hz stimulation at P10 and P28 (Figure 4.6C) suggests that the lower evoked DA at P10 
following a single pulse (Figure 3.2 and Figure 4.6) does not arise from differences in DA stores 
but instead from changes in DA release properties.  
In the adult, the frequency-independence of DA release arise from nAChR activation on 
DA axons (Sulzer et al., 2016). Given the frequency-dependence of DA release in the juvenile 
striatum, I hypothesized that the effect of a nAChR antagonist, Dihydro-β-erythroidine 
hydrobromide (DHbE), on this property of DA release would be occluded at P10. FSCV was 
conducted on acute brain slices. Evoked DA release was measured in response to a single pulse 
and a train of five pulses at 100 Hz in vehicle and then DHbE was superfused onto the slice and 
evoked DA was measured in response to the same stimulation paradigms. DHbE significantly 
increased the 100Hz/1p ratio at P28 and in the adult but had no effect at P10. These data suggest 
that the difference in DA release properties between P10 and P28 or adults arises from reduced 
cholinergic activity in striatum during this period. 
4.4 Discussion 
Here, I investigated the ontogeny of ChI firing during the postnatal development of the 
striatum. Using patch-clamp electrophysiology and FSCV, I demonstrate the functional 
immaturity of ChI physiology and cholinergic modulation of DA release. Notably, significant 
transitions in ChI physiology occur around ages (P14) where significantly more complex motor 
patterns are expressed (Altman and Sudarshan, 1975), complementing previous studies that have 
shown neurochemical maturation of cholinergic signaling during this window (Coyle and 





possible link between ChI physiology in the juvenile striatum with maturation of an animal’s 
behavioral repertoire.  
4.4.1 The Development and Maturation of the Striatal Cholinergic System.  
  The striatum contains the highest concentration of ACh in the brain (Fibiger, 1982). In 
contrast to most other brain regions, however, the striatal cholinergic innervation arises from a 
population of interneurons as opposed to afferent innervation from, for example, the basal 
forebrain system (Henderson, 1981; Kimura et al., 1980).  
Cholinergic interneurons (ChIs) are generated earlier, between E13 and E15 (Phelps et 
al., 1989), than striatal projection neurons or non-cholinergic striatal interneurons (E15-P2) (van 
der Kooy and Fishell, 1987; Liao et al., 2008; Song and Harlan, 1994). Although a major 
biosynthetic enzyme for ACh, choline acetyltransferase (ChAT), is present in ChIs at birth, 
ChAT expression levels increase linearly during the first four postnatal weeks and reach adult 
levels around P28 in both the rat and the mouse (Aznavour et al., 2003; Coyle and Yamamura, 
1976; Guyenet et al., 1975; Phelps et al., 1989). Striatal ACh levels follow a similar 
developmental trajectory (Coyle and Campochiaro, 1976; Coyle and Yamamura, 1976; Phelps et 
al., 1989). This protracted postnatal development of ACh neurochemistry manifests as a delayed 
interaction between cholinergic and dopaminergic pharmacology in the development rodent, 
reaching functional maturity around P20 (Burt et al., 1982; Fitzgerald and Hannigan, 1989). 
Interestingly, although striatal ChIs are born in tandem with cholinergic neurons in the basal 
forebrain system, their functional development lags behind the basal forebrain system (Phelps et 
al., 1989), suggesting that cues specifically present in the striatum may contribute to the 





Here, I have extended previous characterizations of the ontogeny of the striatal 
cholinergic system and examined the electrophysiological phenotypes of ChIs across postnatal 
development of the mouse. Remarkably, the maturation of ChI firing frequencies mirrors the 
time course of tissue ACh levels and expression of ChAT. This suggests the possibility that ACh 
itself may act as a feedback mechanism to drive maturation of ChI physiology during postnatal 
development. Furthermore, the time course of the maturation of ChI activity is similar to that of 
DA release, suggesting a possible connection between DA signaling and ChI maturation.  
4.4.2 Biophysical Mechanisms of the Maturation of ChI Firing. 
 The frequency of tonic ChI firing is determined by the coordinated activity of its intrinsic 
conductances (Bennett et al., 2000; Goldberg and Reynolds, 2011; Goldberg and Wilson, 2005; 
Wilson et al., 1990). What drives the maturation of ChI spontaneous firing described here? At 
P10 and P14, the amplitude of the mAHP is significantly increased relative to ages above P18 
(Figure 4.3). In the adult, the mAHP is determined by the activity of SK and BK channels 
(Goldberg and Wilson, 2005). Future efforts will determine whether the activity of these 
channels changes during this postnatal window and is responsible for the maturation of ChI 
activity. SK and BK currents can mature not only through differences in channel levels or 
function but also in response to changes in calcium entry during action potential firing that 
initiates SK and BK channel opening. Calcium imaging experiments could distinguish between 
these possibilities.  
 Interestingly, a second mechanism must drive further increases in spontaneous ChI firing 
beyond P18 as the mAHP amplitude reaches adult levels at this age (Figure 4.1 and 4.3). One 
possible mechanism for this could be increases in Ih as Ih currents depolarize ChIs from the 





measured inactivating inward currents in voltage clamp recordings and found that magnitude of 
these currents increased from P28 to adulthood (Figure 4.4). Future experiments will focus on 
pharmacologically isolating Ih currents using antagonists of HCN channels such as ZD7288. 
Furthermore, the effect of submaximal concentrations of ZD7288 on spontaneous AP firing 
could be measured at different ages. I hypothesize that submaximal ZD7288 would have a 
smaller effect on spontaneous firing frequency at P28 or earlier than in adulthood. 
 Finally, the sAHP also matures during postnatal development (Figure 4.5). Although the 
ChI pause is driven by initiated by synaptic inputs from the thalamus and requires DA signaling, 
regenerative intrinsic properties determine the length of the ChI pause (Aosaki et al., 1994b; 
Matsumoto et al., 2001; Reynolds et al., 2004; Wilson, 2005; Zhang et al., 2018). As the length 
and amplitude of the pause contributes striatal-based learning by altering DA neurotransmission 
and synaptic plasticity onto SPNs (Goldberg et al., 2012), differences in ChI pause dynamics 
could represent a neural mechanism for changes in learning strategy and reward sensitivity 
during the juvenile and adolescent period (Doremus-Fitzwater et al., 2012; Spear, 2013; Sturman 
and Moghaddam, 2012; Sturman et al., 2010). I have limited my analysis of the ChI pause to its 
intrinsic components. Future work must address whether thalamic and DA inputs to ChIs mature 
in parallel with intrinsic mechanisms, if the ChI pause is truly distinct during the juvenile period 
in vivo and if differential ChI activity during this period is causally related to behavior.  
 A final limitation of this study is that I did not directly correlate changes in ChI firing 
patterns with ACh release. For example, it is possible that the mechanisms that couple somatic 
action potential firing with ACh release may differ early in postnatal development and 
compensate for reduced spontaneous firing frequencies. Interestingly, both tissue ACh levels, 





with a time course that mirrors the maturation of spontaneous ChI firing (Butcher and Hodge, 
1976; Coyle and Yamamura, 1976; Guyenet et al., 1975; Murrin and Ferrer, 1984). This suggests 
that ACh vesicular release and the dynamics of ACh release events, which is governed by AChE 
activity, change during the juvenile period and may interact with the maturation of ChI 
physiology to contribute to differences in striatal function. Recent advances in fluorescent 
sensors have permitted the direct measurement of extracellular ACh levels both in vivo and in 
vitro (Jing et al., 2018) and will be the focus of future work.  
4.4.3 Maturation of DA Release Properties Depends on ChIs. 
 To address the functional implications of immature ChI activity during the juvenile 
period, DA release properties, which are regulated by nAChR activity in adulthood (Rice and 
Cragg, 2004; Sulzer et al., 2016; Zhang and Sulzer, 2004; Zhou et al., 2001), were measured 
using FSCV. I have previously reported that evoked DA release increases during postnatal 
development in the striatum (Figure 3.2). In the adult striatum, electrical stimulation elicits DA 
release through two mechanisms: cell-autonomous depolarization of DA axons and via evoked 
ACh activating nAChRs on DA axons (Rice and Cragg, 2004; Sulzer et al., 2016; Zhang and 
Sulzer, 2004; Zhou et al., 2001). In fact, nAChR antagonists block the vast majority of evoked 
DA after a single electrical stimulation in the striatum. Reduced cholinergic tone in the striatum 
would, thus, contribute to decreased evoked DA following a single pulse during the early 
juvenile period.  
 Here, these findings were extended by assessing the frequency-dependence of evoked DA 
release at P10, P28 and in adulthood. In addition to the potentiation of evoked release in response 
to a single electrical stimulation, nAChR activity reduces DA release in response to a high-





adult striatum (Rice and Cragg, 2004; Sulzer et al., 2016; Zhang and Sulzer, 2004; Zhou et al., 
2001). In contrast to the adult, we found that DA release is highly frequency-dependent at P10 
but not at P28. Furthermore, addition of a nAChR antagonist did not further enhance the 
frequency-dependence of DA release at P10 but increased it at P28 and in adults. Future efforts 
will focus on a more detailed characterization of the age at which DA release properties mature.  
Importantly, these data do not directly connect changes in ChI activity with immature DA 
release properties in the juvenile striatum but instead could be explained by increased expression 
of nAChRs on DA axons. Recent work, however, has shown that nAChR mRNA expression in 
DA neurons reaches adult levels around birth (Hobson, Lieberman, Sims and Sulzer, 
unpublished data). Nevertheless, the data I present here demonstrate a functional effect of 
immature ChI activity in the juvenile striatum.   
4.4.4 Conclusion 
Here, I have used patch-clamp electrophysiology to characterize the maturation of striatal 
ChIs. In the adult, ChIs play a central role in the striatal control of action and learning new motor 
tasks. I show here that key features of ChI electrophysiology, such as spontaneous firing 
frequency and pauses in their activity, mature during the first four postnatal weeks, a period of 
acquisition of complex motor skills and enhanced sensitivity to reward. Future work will focus 
on identifying factors that drive the maturation of ChI activity, such as DA or other trophic 
factors.     






C57Bl6J breeder pairs were obtained from Jackson Laboratories (Bar Harbor, ME). Animals 
were housed and bred as described in Chapter 3. Experimental animals were within +/- 1 day of 
the specified age and of mixed sex.  
Electrophysiology 
Slices were generated as described in Chapter 3, 5, and 6. Notably, all recordings were 
conducted with 2 mM CaCl2 in the ACSF and at 34°C in contrast to patch clamp recordings in 
Chapters 3 and 6. The internal solution was potassium gluconate based as in Chapter 3.  
Cyclic voltammetry 
Procedures were the same as in Chapter 3. 
Dendritic reconstructions 






Chapter 5: mTOR Suppresses Macroautophagy during pPostnatal 
Development of the Striatum.§ 
5.1 Abstract 
Macroautophagy (hereafter referred to as autophagy) plays a critical role in neuronal 
function related to development and degeneration. Here, I investigated whether autophagy is 
developmentally regulated in the striatum, a brain region implicated in neurodevelopmental 
disease. I demonstrate that autophagic flux is suppressed during striatal postnatal development, 
reaching adult levels around postnatal day 28 (P28). I also find that mTOR signaling, a key 
regulator of autophagy, increases during the same developmental period. I further show that 
mTOR signaling is responsible for suppressing autophagy, via regulation of Beclin-1 and VPS34 
activity. These results demonstrate that neurons coopt metabolic signaling cascades to 
developmentally regulate autophagy and establish mTOR as a central node in the regulation of 
neuronal autophagy.   
5.2 Introduction 
Macroautophagy (hereafter referred to as autophagy) is a degradative process for long-
lived proteins and damaged organelles (Ohsumi, 2014). In neurons, autophagy is considered to 
play both protective and pathogenic roles, as it contributes not only to proteostasis and cell 
survival (Hara et al., 2006; Komatsu et al., 2006; Yamamoto and Simonsen, 2011; Yamamoto et 
al., 2006), but also to autophagic cell death in neurodegenerative diseases (Chakrabarti et al., 
2009; González-Polo et al., 2005; Wang et al., 2006; Yamamoto and Yue, 2014; Yang et al., 
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2011). Recently, autophagy has been recognized as an important cellular process during neuronal 
development (Dragich et al., 2016; Ebrahimi-Fakhari et al., 2016b; Kim et al., 2017; Lieberman 
et al., 2018b; Tang et al., 2014). Autophagic dysfunction is observed in neurodevelopmental 
disorders (Byrne et al., 2016; Hor and Tang, 2018; Lee et al., 2013; Poultney et al., 2013), and 
mouse models with reduced autophagy display phenotypes implicated in autism spectrum 
disorders (ASD) (Kim et al., 2017; Tang et al., 2014; Yan et al., 2018). Yet, little is known about 
the developmental regulation of neuronal autophagy.  
The striatum is the main input nucleus of the basal ganglia, a brain circuit controlling 
action selection and reward processing, and is implicated in the pathophysiology of multiple 
neurodevelopmental diseases (Fuccillo, 2016; Gerfen and Surmeier, 2011). Although the 
principal neurons of the striatum, the spiny projection neurons (SPNs), migrate to the striatum 
during the embryonic period (Song and Harlan, 1994), significant further maturation occurs 
during the first four postnatal weeks. SPNs receive excitatory inputs from the cortex and 
thalamus during the second and third postnatal weeks (Tepper et al., 1998). Dopaminergic axons 
innervate the striatum at birth but their ability to release neurotransmitter increases during the 
first two weeks (Lieberman et al., 2018a; Voorn et al., 1988). Finally, the intrinsic excitability of 
SPNs matures from weeks two through four (Tepper et al., 1998). Autophagy has been proposed 
to contribute to synaptic maturation and plasticity and dopamine release (Hernandez et al., 2012; 
Nikoletopoulou et al., 2017; Tang et al., 2014). Thus, establishing whether autophagy is 
differentially regulated during postnatal development of the striatum would provide an insight 
into its role in neurodevelopment.  
Autophagy is a tightly regulated multi-step process (Bento et al., 2016) that, in dividing 





mammalian target of rapamycin (mTOR). mTOR regulates autophagy via several mechanisms 
(He and Klionsky, 2009), including by phosphorylating and negatively regulating Unc-51-like 
autophagy-activating kinase 1 (ULK1) at Ser757 (Jung et al., 2009; Kim et al., 2011). This step 
prevents ULK1-mediated phosphorylation of Beclin-1 at Ser14, and the subsequent increase of 
PI3K activity of Vps34 (Russell et al., 2013). These molecular events initiate the formation of 
preautophagic structures that are subsequently expanded by a molecular cascade resulting in the 
modification of LC3, one of the mammalian homologs of the yeast Atg8 (Shpilka et al., 2011). 
Processing of LC3, leads to phagophore expansion and sealing and is used as a biochemical 
readout of autophagosome formation (Kabeya et al., 2000; Klionsky et al., 2016). The enclosed, 
mature autophagosome then traffics to the lysosome where the autophagic cargo and cargo 
adaptors, such as p62, are degraded (Tanida et al., 2005).   
Whether similar signaling regulates autophagy in neurons remains controversial. It has 
been proposed that autophagy may act as a constitutive process for cellular homeostasis, thus 
circumventing the control of metabolic kinases such as mTOR (Yamamoto and Yue, 2014). The 
links between nutrient status and autophagy in neurons moreover remain elusive, with reports 
suggesting a regional and age-specific autophagic response to nutrient deprivation in neurons 
(Kaushik et al., 2011; Nikoletopoulou et al., 2017) and studies indicating the contrary 
(Mizushima et al., 2004). Moreover, direct regulation of autophagy by mTOR, independent of 
nutrient status, has been reported by some (Hernandez et al., 2012; Tang et al., 2014) but not 
others not (Maday and Holzbaur, 2016; Tsvetkov et al., 2010). These contrasting results raise the 
important question of whether autophagic activity is dynamically controlled in brain regions 
implicated in neurodevelopmental disease, and if so, whether autophagy in neurons is regulated 





Using biochemical, pharmacological and histological approaches, we demonstrate that 
autophagy is dynamically downregulated during postnatal development, following the 
upregulation of mTOR activity. Our results suggest that autophagy may play temporally-specific 
roles in brain development.  
5.3 Results 
5.3.1 Markers of Autophagic Activity Decrease during Postnatal Development. 
To identify changes in autophagic activity during postnatal striatal development, I 
collected striata from mice at postnatal days 8, 14, 18, 28 and in adults (postnatal day 120). 
These postnatal ages represent critical timepoints for striatal development (Lieberman et al., 
2018b; Peixoto et al., 2016; Tepper et al., 1998). Briefly, synaptic dopamine release has begun 
 
Figure 5.1. Autophagy decreases during striatal development. (A) Representative Western blot images for LC3B, p62, 
DARPP32, and actin. (B-D) Quantification of (B) LC3B-ii relative to actin, (C) LC3B-ii relative to LC3B-i, (D) p62 relative 
to actin normalized to P120 values. Data analyzed with one-way ANOVA; (B) Age: F (4,21) = 6.526, p=0.0014; (C)  Age: 
F(4,22)=3.797, p=0.0171; (D) Age: F(4,15)=3.762, p=0.0260.  * P<0.05, ** p< 0.01, **** p<0.0001, n=4-6 mice/ age. (E-F) 
Representative images of DARPP32 stained striatal neurons and RFP fluorescence from mice aged P10 and P28. Dashed 
lines indicate cell body outlines. (G) Quantification of number of LC3 puncta/cell. Unpaired, two-tailed t test, t4 = 4.392, 





and interneurons are active in the striatum at postnatal day 8 (Ferrari et al., 2012; Lieberman et 
al., 2018b; Plotkin et al., 2005). By postnatal day 14, excitatory inputs from the cortex and 
thalamus arrive and eye opening has occurred (Tepper et al., 1998), providing higher levels of 
sensory input. P18 represents the end of synaptogenesis and an age immediately before weaning. 
At age P28, the period of postnatal refinement has ended (Tepper et al., 1998). I compared tissue 
from these ages to mice in early adulthood at postnatal day 120.  
I first measured the levels of DARPP32, a classic SPN marker, and actin as a loading 
control across postnatal development and found no differences (Figure 5.1A; (Klionsky et al., 
2016; Tanida et al., 2005). I then measured the level of total and processed form of the Atg8 
family member, LC3B. I found a significant effect of age on the levels of processed LC3B 
(LC3B-ii) relative to actin and unprocessed LC3B (LC3B-i) (Figure 5.1A-C). The level of the 
autophagic adapter protein, p62, whose steady-state levels are determined by its own autophagic 
degradation, increased over the postnatal period (Figure 5.1D). These data suggest that overall 





5.3.2 LC3+ Puncta Decrease in Striatal Spiny Projection Neurons during Postnatal 
Development. 
Western blot analysis of total striatal lysates includes proteins from all cell types present 
in the striatum, including neurons, glia, and vascular cells. To define the cell type in which the 
developmental changes in autophagy occur, I utilized a transgenic mouse ubiquitously 
expressing LC3 fused to both green (GFP) and red fluorescent proteins (RFP) (Figure 5.2A; 
 
Figure 5.2. Live 2-photon imaging of tfLC3 in striatal slice. (A) Schematic representation of tfLC3 reporter. LC3B fused 
to RFP and GFP allows detection of cytosolic and membrane bound LC3 by fluorescence microscopy. GFP fluorescence is 
quenched in acidic environments, permitting analysis of autophagosome and autolysosome numbers. (B) Schematic of 
imaging setup. (C) Representative images of tfLC3 mice shows diffuse GFP imaging and punctate RFP patterns at both 





tandem fluorescent-tagged LC3 or tfLC3) (Li et al., 2014). After processing, LC3 transitions 
from the cytosol to become membrane-bound on the autophagosome (LC3B-ii). Visualizing the 
distribution of fluorophore-tagged LC3 (LC3 puncta) provides a well-established assay for 
monitoring autophagic activity within a cell (Klionsky et al., 2016).  
Furthermore, as the fluorescence of the GFP component is quenched by the low pH of the 
lysosome, tfLC3 permits analysis of the total number of autophagosomes and autolysosomes 
(RFP+ puncta) and non-acidified autophagosomes (GFP+RFP+ puncta). We first used 2-photon 
microscopy to simultaneously image GFP and RFP signals in acute brain slices tfLC3 mice at 
age P10 and P28 (Figure 5.2B-C). At both ages, GFP fluorescence was diffuse in the cytosol and 
processes of striatal cells and RFP+ puncta were present in the soma. The density of the striatal 
neuropil prevented analysis of tfLC3+ puncta in axons or dendrites (Figure 5.2B-C). Because the 
level of GFP fluorescence was too strong in the soma to discern individual puncta, we used the 
number of RFP puncta as a proxy for autophagosomes, with the caveat that we were unable to 
determine whether these puncta were also fused with lysosomes.  
To identify the number of RFP+ puncta in specific cell types, I perfused mice at age P10 
and P28 and co-labelled with cell-type specific markers of striatal neurons.  Spiny projection 
neurons can be identified by immunostaining with antibodies against DARPP-32. I observed a 
significant decrease in RFP+ puncta in DARPP32+ cells between P10 and P28 (Figure 5.1E-G), 
indicating that the reduction in autophagic activity I measured using biochemical assays of bulk 
striatal lysates occurs specifically in SPNs. 






Changes in the level of LC3B-ii, or the number of LC3 puncta, can arise from increases 
in autophagosome biosynthesis or decreases in the efficiency of autophagosome maturation and 
lysosomal degradation. To dissect the changes in autophagy during the postnatal period, we 
developed an ex vivo system to test the effects of drugs that do not cross the blood-brain barrier 
(Figure 5.3A). I generated acute brain slices from P10 or P28 mice and removed non-striatal 
tissue. I found that neither the slice procedure nor the incubation affected the age-dependent 
reduction in autophagy markers observed in vivo (Figure 5.3A-B compared to Figure 5.1). This 
 
Figure 5.3. Striatal autophagic flux decreases from P10-P28. (A) Schematic of coronal brain section showing dissection 
boundaries for ex vivo experiments. (B) Quantification of LC3B-ii relative to actin for every vehicle-only slice showed in 
Figures 2, 4, and 5. Unpaired, two-tailed t test, t52 = 5.824, ****p<0.0001. (C) Representative Western blot images of actin, 
DARPP32 and LC3B in slices obtained from P10 or P28 mice, incubated with BafA1 (100 nM, 3 hours) or vehicle (Veh; 
DMSO, 0.1%). (D) LC3B-ii relative to actin, normalized to vehicle condition at each age. P10: Unpaired, two-tailed t test, 
t25 = 5.113, ****p<0.0001; P28: Unpaired, two-tailed t test, t10 = 0.6228, p=0.5473. P10: Veh: n= 16 slices, BafA1 n = 11 





confirms that the mechanisms underlying changes in autophagic markers during postnatal 
development can be defined using this ex vivo system. 
I incubated slices from mice at age P10 and P28 with bafilomycin A1 (BafA1, 100 nM), a 
specific inhibitor of the vacuolar proton pump, or vehicle (DMSO, 0.1%) for three hours, an 
incubation time and drug concentration similar to that used in cultured cells (Klionsky et al., 
2016; Maday and Holzbaur, 2016; Yamamoto et al., 1998), to prevent lysosomal acidification 
and block autophagosome-lysosome fusion. As treatment with BafA1 prevents LC3B-ii 
degradation, changes in LC3B-ii levels following BafA1 treatment are interpreted as the rate of 
autophagic flux. BafA1 treatment increased LC3B-ii in slices from P10 mice, but had no 
significant effect in slices from P28 mice (Figure 5.3C-D). BafA1 treatment had no effect on 
DARPP32 levels at either age (Figure 5.3C). Slices from either age treated with BafA1 for one 
hour showed no change in LC3B-ii levels (data not shown). This suggests that the higher 
baseline level of LC3B-ii at P10 arises from increased autophagosome biosynthesis.  
5.3.4 mTOR Signaling is Upregulated During the Postnatal Development. 
mTOR signaling is a key negative regulator of autophagic activity. We therefore 
hypothesized that mTOR activity in the striatum increases during postnatal development and 
suppresses autophagy. 
mTOR kinase activity can be monitored by measuring the state of phosphorylation of its 
downstream targets. The level of phosphorylation at serine 757 of ULK1, which is phosphorylated 
by mTOR and inhibits ULK1 kinase activity (Kim et al., 2011), increased during the postnatal 
period in the striatum (Figure 5.4A-C). I then confirmed that ULK1 kinase activity is inhibited by 
monitoring the phosphorylation state of Beclin-1, a ULK1 target.  Phosphorylation of Beclin-1 at 





the phosphorylation of the ribosomal protein S6 (rpS6) on serine 240 and serine 244 (Magnuson 
et al., 2012). I observed a sharp increase in rpS6 Ser240/244 at P18 before decreasing into 
adulthood (Figure 5.4B and 5.4D). Overall these data indicate an increase in mTOR activity during 
striatal postnatal development. Interestingly, we did not observe a significant effect of age on 
phosphorylation of ERK1/2 (Figure 5.4B and 5.4D) suggesting that increased mTOR activity 
during the postnatal period is not associated with a global change in molecular signaling.  
5.3.5 Inhibition of Vps34 Reduces LC3B-ii Levels During Early Postnatal Development. 
mTOR negatively regulates autophagosome biosynthesis by inhibiting ULK1 activity 
(Jung et al., 2009; Kim et al., 2011). When ULK1 is active, it promotes  
 
Figure 5.4. mTOR signaling increases during striatal development. (A) Schematic representation of mTOR targets. 
mTOR inhibits ULK1 activity by phosphorylating Ser757. P-ULK1 activates Vps34 activity (not shown) by 
phosphorylating Beclin-1 on Ser14. mTOR promotes protein synthesis by phosphorylating rpS6 on Ser240/244. (B) 
Representative Western blot images quantified in C-D. (C) Quantification of pULK1 S757 relative to actin (grey squares) 
and p-Beclin S14 relative to total Beclin-1 (black dots). Data analyzed with one-way ANOVA; p-ULK1 S757/ actin: Age: 
F(4,13) = 6.093, p=0.0055; p-Beclin-1S14/ total Beclin-1: Age: F(4,14) = 4.945, p=0.0107. (D) Quantification of p-rpS6 
S240/244 and p-Erk1/2 relative to total rpS6 and total Erk1/2, respectively. Data analyzed with one-way ANOVA; p-rpS6 
240/244: Age: F(4,20) = 12.69, p<0.0001. p-Erk1: Age: F(4,17) = 2.625, p=0.0712. p-Erk2: Age: F(4,17) = 0.3561, 





autophagosome formation by phosphorylating Beclin-1, which increases the PI3K activity of its 
partner, Vps34 (Russell et al., 2013). To address whether elevated autophagy at P10 was a result 
of enhanced Vps34 activity, I incubated acute striatal slices with the Vps34 inhibitor, SAR405 (1 
µM) or vehicle (DMSO, 0.1%) for three hours (Ronan et al., 2014). SAR405 significantly 
reduced the level of LC3B-ii in slices from mice at age P10 but had no effect on slices from P28 
mice (Figure 5.5A-C). This demonstrates that elevated autophagic activity in the striatum of 
early postnatal mice is Vps34-dependent. The lack of effect of SAR405 on autophagic activity at 
P28 indicates that reduced Vps34 activity, possibly via increased mTOR signaling (Figure 5.4), 
is responsible for the lower levels of autophagosome biosynthesis at P28.  
 
Figure 5.5. Vps34 activity is required for maintaining LC3B-ii levels at P10 and mTOR inhibition increases p-Beclin-
1 and LC3B-ii levels at P28. (A) Representative Western blot images for actin, DARPP32 and LC3B-i and -ii in striatal 
slices obtained from P10 or P28 mice, treated with SAR405 (1 µM) or vehicle (Veh; DMSO, 0.1%). (B-C) Quantification of 
LC3B-ii relative to actin, normalized to vehicle condition at each age. (B) P10: unpaired, two-tailed t test, t11 = 2.985, 
p=0.0124; P28: Unpaired, two-tailed t test, t24 = 1.807, p=0.0922. P10: Veh: n=6 slices, SAR405 n=7 slices from 3-4 mice/ 
age. (C) P28: Veh: n=9 slices, Baf n=7 slices from 3-4 mice/ age. * p<0.05. (D) Representative Western blot images for 
actin, DARPP32, p-Beclin-1 Ser14 and LC3B-i and -ii in striatal slices from P28 mice, treated with Torin-1 (5 µM) or 
vehicle (Veh; DMSO, 0.1%). (E-F) Quantification of (E) LC3B-ii and (F) p-Beclin S14 relative to actin, normalized to 
vehicle. Data analyzed with unpaired, two-tailed t test; (E) LC3B-ii/ actin, t24 = 2.853, p=0.0088. Veh: n=19 slices, Baf n=7 
slices from 5-7 mice. * p<0.05. (F) p-Beclin S14/ actin, t22 = 3.337, p=0.0030. ** P<0.01, Veh: n=18 slices, Torin-1 n=6 





5.3.6 mTOR Inhibition Increases LC3B Processing During the Late Postnatal Period. 
Having shown that Vps34 drives elevated autophagy at P10, I explored whether enhanced 
mTOR activity inhibits autophagy at P28. mTOR activity can be pharmacologically inhibited by 
direct active site inhibitors, such as Torin-1 (Thoreen et al., 2009). I incubated striatal slices from 
mice at P28 with Torin-1 (5 µM) or vehicle (DMSO, 0.1%) for three hours and measured LC3B-
ii levels. Torin-1 treatment increased LC3B-ii levels and the phosphorylation of Beclin-1 at the 
ULK1 site (Ser14), suggesting that mTOR inhibition activates autophagy in a ULK1/Beclin-1 
dependent manner (Figure 5.5D-F).  
5.4 Discussion 
Neuronal autophagy has been proposed to play a key role in neurodevelopment and 
autophagic dysfunction may lead to neurodevelopmental disorders (Dragich et al., 2016; Kim et 
al., 2017; Lieberman et al., 2018b; Tang et al., 2014; Yan et al., 2018). In this study, I address 
whether autophagic activity is developmentally controlled in the principal neurons of the 
striatum, a brain region implicated in neurodevelopmental disorders (Fuccillo, 2016). I found 
that autophagy is dynamically regulated in SPNs during postnatal development, reaching adult 
levels around P28. These findings provide mechanistic insight into the regulation of autophagy 
during striatal postnatal development and establish the basis for a further evaluation of its role in 
physiological and pathological conditions.  
By analyzing key endogenous biochemical markers (such as LC3B-ii, p62, p-Ser757-
ULK1 and p-Ser14-Beclin-1), we discovered that autophagy decreases progressively during the 
postnatal development of SPNs. The autophagy markers were measured in bulk lysates 
containing neurons, glia and endothelial cells (among others). To identify the cell types that 





the challenges in assaying endogenous autophagic proteins using immunofluorescence, tfLC3 
mice provide a unique resource, as overexpressed LC3 is fused to fluorescent proteins that 
permit morphological characterization of autophagic structure. While the high levels of 
expression prevented the identification of individual autophagic puncta in both live imaging and 
fixed tissue, the level of autophagolysosomes represented by RFP-LC3+ puncta was higher in 
SPN somata at P10 than at P28, in agreement with our biochemical analysis.  
Autophagic flux is determined by the kinetics of autophagosome biosynthesis, 
autophagosome maturation and autophagic cargo degradation by lysosomal proteases. Steady-state 
measurement of LC3B-ii levels provide a useful proxy for the measurement of autophagic activity. 
An elevated level of LC3B-ii could indicate either increased or decreased autophagic flux, as both 
increased autophagosome biosynthesis and decreased lysosomal degradation of autophagic 
proteins can increase LC3B-ii (Kabeya et al., 2000; Klionsky et al., 2016). To functionally measure 
autophagic flux in striatal tissue, we developed an ex vivo acute brain slice system and found that 
steady state increases in LC3B-ii levels at P10 were further elevated by acute blockade of 
lysosomal degradation with BafA1 compared to LC3B-ii levels at P28. This suggests that 
increased autophagix flux is responsible for the higher steady-state LC3B-ii levels, as inhibition 
of lysosomal degradation would not have an effect on LC3B-ii levels if lysosomal degradation 
were already compromised. These results indicate that the postnatal suppression of autophagy 
results from changes in autophagosome biosynthesis or maturation.  
In line with changes in autophagosome biosynthesis/maturation during striatal 
development, we found that mTOR-dependent signaling increases over the course of postnatal 
development, thereby suppressing autophagosome synthesis via inhibition of ULK1 and Beclin-1 





autophagy, such as ULK1. mTOR specifically phosphorylates ULK1 at Ser757 and inhibits its 
kinase activity (Kim et al., 2011). Consistently, we also observed a decrease in the level of 
phosphorylation on the ULK1 site in Beclin-1, a key component of the class III-PI3K complex 
required for autophagosome biosynthesis (Itakura et al., 2008; Russell et al., 2013). These results 
provide a functional readout for increased mTOR activity on autophagy-specific downstream 
targets and demonstrate a direct link between mTOR signaling and a regulation of autophagy 
activity observed during the postnatal development. Inhibition of mTOR activity at P28, when 
mTOR activity is elevated, induces autophagy and increases the phosphorylation of Beclin-1 at 
Ser14 and LC3B-ii levels. Further work will also focus on whether additional kinases which 
integrate metabolic status in the periphery, such as AMPK (He and Klionsky, 2009), control 
developmental changes in neuronal autophagy. 
These findings may help to resolve conflicting results present in the literature. Several 
groups have found that mTOR inhibition fails to increase autophagic activity in primary neuronal 
culture (Maday and Holzbaur, 2016; Tsvetkov et al., 2010) or in vivo (Fox et al., 2010). In contrast, 
others report that pharmacological (Hernandez et al., 2012; Tang et al., 2014) or genetic inhibition 
of mTOR drives autophagy (Yan et al., 2018) as well as hyperactivation of mTOR signaling 
inhibits autophagy in the CNS (Ebrahimi-Fakhari et al., 2016a; McMahon et al., 2012; Tang et al., 
2014). This discrepancy may arise from model system used (i.e., cell culture vs in vivo), 
developmental stage, or treatment paradigm. Further complicating the link between mTOR and 
autophagy is that standard activators of autophagy such as starvation in vivo and nutrient or serum 
deprivation ex vivo may not have effects in the brain (Maday and Holzbaur, 2016; Mizushima et 
al., 2004; Nikoletopoulou et al., 2017; Young et al., 2009). My findings suggest that mTOR 





neurons in a manner unrelated to nutrient status. mTOR signaling is under the control of several 
neural-specific signals such as patterned neuronal activity and specific neurotransmitters or 
neuromodulators (Auerbach et al., 2011; Bockaert and Marin, 2015; Santini et al., 2009; Sutton 
and Caron, 2015; Yin et al., 2006), suggesting possible mechanisms through which mTOR activity 
is regulated within developing neural circuits. There are a broad range of significant changes in 
neurotransmitter content, neuronal firing patterns and synaptic plasticity that occurs during this 
period, providing a plethora of candidates that could dynamically regulate mTOR signaling and 
autophagy during the course of postnatal development. Autophagy is also known to regulate 
surface levels of neurotransmitter receptors, axon pathfinding, synaptic maturation and plasticity, 
suggesting that autophagy acts dynamically during early postnatal developmental to entrain adult-
like neuronal activity that subsequently suppresses autophagy by activating mTOR signaling 
(Dragich et al., 2016; Hernandez et al., 2012; Nikoletopoulou et al., 2017; Rowland et al., 2006; 
Shehata et al., 2012; Tang et al., 2014). Such a feedback process may provide a temporal and 
mechanistic framework for future studies that address the role of autophagy, and its regulation by 
mTOR, in neuronal development. 
In summary, I find that the postnatal development of SPNs is correlated with a change in 
autophagy and this is determined by mTOR signaling status. Intriguingly, this signaling cascade 
is also critical for nutrient-deprivation induced autophagy in dividing cells (He and Klionsky, 
2009), suggesting that the same signaling cascade may be triggered by different cues depending 
on the tissue type. There is a broad range of significant changes in neurotransmitter content, 
neuronal firing patterns and synaptic plasticity that occurs during this period, providing a 
plethora of candidates that could dynamically regulate mTOR signaling and autophagy during 





neurotransmitter receptors, axon pathfinding, synaptic maturation and plasticity, suggesting that 
autophagy acts dynamically during early postnatal developmental to entrain adult-like neuronal 
activity that subsequently suppresses autophagy by activating mTOR signaling (Dragich et al., 
2016; Hernandez et al., 2012; Nikoletopoulou et al., 2017; Rowland et al., 2006; Shehata et al., 
2012; Tang et al., 2014). Such a feedback process may provide a temporal and mechanistic 
framework for future studies that address the role of autophagy, and its regulation by mTOR, in 
neuronal development. 
5.5 Materials and Methods 
Animals 
Breeder pairs of C57/BL6J were obtained from Jackson Laboratories (Bar Harbor, ME). 
Mice were checked every day or every other day for pregnancy and new litters. TfLC3 mice 
were obtained from Jackson Laboratories (C57BL/6-Tg(CAG-RFP/EGFP/Map1lc3b)1Hill/J; 
Strain No. 027139). Breeder pairs were housed on a 12-hour light/dark cycle with water and food 
available ad libitum. Offspring were weaned between postnatal day 18 and 20 and split into same 
sex groups of 2-5. All experimental procedures were approved by the Columbia University 
Institutional Animal Care and Use Committee. Mice of both sexes were utilized for experiments 
and data were combined as no effect of gender was observed.  
In vivo sample preparation 
Striatal sample preparation was performed as previously described (Santini et al., 2007). 
Mice at specified ages were rapidly decapitated and their head was briefly placed in liquid 
nitrogen. The brain was subsequently removed and a single striatum was dissected and flash 





Samples were then homogenized in 1% SDS by a brief sonication. Protein content was 
determined by the BCA assay (Thermo Fisher). No significant effect of age was found on total 
protein (data not shown). Samples were then boiled in sample buffer and frozen until western 
blot analysis.  
Acute brain slice 
Acute brain slices were prepared essentially as described (Lieberman et al., 2018a). 
Briefly, mice underwent cervical dislocation and the brain was removed and placed in ice-cold 
high sucrose cutting solution (in mM): 10 NaCl, 2.5 KCl, 25 NaHCO3, 0.5 CaCl2, 7 MgCl2, 1.25 
NaH2PO4, 180 sucrose, 10 glucose bubbled with 95% O2/5% CO2 to pH 7.4. Brains were 
mounted on a VT1200 vibratome (Leica Biosystems) and coronal sections (250 µm) including 
the striatum were collected. Slices were then transferred to a basin contained ice-cold cutting 
solution and the striatum was manually dissected. Slices were moved to scintillation vials 
containing 7 mL of ACSF (in mM): 125 NaCl, 2.5 KCl, 25 NaHCO3, 2 CaCl2, 1 MgCl2, 1.25 
NaH2PO4, and 10 glucose bubbled with 95% O2/5% CO2 to pH 7.4 at 34 ºC. Slices from two 
mice at the same age were combined in individual experiments and split into 4 conditions. Slices 
were allowed to rest for one hour followed by addition of vehicle or drug. Following incubation 
with drug at 34 ºC for the specified time, slices were removed and flash frozen in liquid nitrogen. 
After slices were collected from a complete experiment (i.e. slices from 4-6 mice per age, at P10 
and P28), slices were homogenized by sonication in 1% SDS and prepared as described above 






Equivalent amount of protein per sample (5-25 µg/well) were loaded into 10% or 12% 
polyacrylamide gels as described (Santini et al., 2007). Protein was transferred from the gel to an 
Immobilon FL PVDF membrane (pore size 0.2 µm). Blots were blocked in TBS with 0.1% 
Tween-20 (TBST) and 5% bovine serum albumin (BSA) for one hour at room temperature. Blots 
were then incubated with primary antibody (see Table 1 for detailed information regarding 
antibodies) diluted in TBST with 5% BSA as specified (see table 1 for dilution and antibody 
sources) overnight at 4 ºC. Blots were then washed with TBST and incubated in secondary 
antibody for one hour at room temperature. Blots were developed using either the Odyssey 
imaging system (LICOR) or an enhanced chemiluminescence (ECL) system (Amersham) and 
imaged using an Azure Biosystems C600 system. Western blots developed using the Odyssey 
system were analyzed in Image Studio Lite (LICOR). Western blots developed with the ECL 
system were analyzed using standard routines in ImageJ. All samples were probed for beta-actin 
and DARPP32 as loading and dissection controls, respectively.  
Drugs and chemicals 
BafA1 (0.1 µM) and Torin-1 (5 µM) were purchased from Tocris. SAR 405 (1 µM) was 
purchased from Cayman Chemicals. All drugs were dissolved in DMSO and slices were 
incubated in ACSF containing the drugs or equivalent volume of vehicles for three hours at 
34ºC. DMSO did not exceed a final concentration of 0.1%. All other chemicals were purchased 
from Fisher Scientific. 
2p-microscopy 
Two-photon images were acquired on a Prairie Ultima microscope system (Middleton, 





perfused with oxygenated ACSF at room temperature.  Samples were excited with a Coherent 
(Santa Clara, CA) Chameleon Ultra two-photon laser at 980 nm, and images were 
simultaneously collected through two photomultiplier tube channels with corresponding 585-630 
nm and 490-560 nm emission windows.  The objective used was a 60X, 0.9 NA water immersion 
lens, and images were 1024x1024 pixels in size.   
Immunohistochemistry 
Mice were deeply anesthestized and transcardially perfused with 0.9% Nacl followed by 
4% paraformaldehyde (PFA) in 0.1M phosphate buffer (PB). Brains were removed and post-
fixed overnight in 4% PFA in 0.1M PB. Brains were then washed three times in 1X phosphate 
buffered saline and cut into 40 µm sections using a VT1200 vibratome (Leica Biosystems) and 
stored in cryoprotectant (0.1M PB, 30% glycerol, 30% ethylene glycol) at -20 ºC. For 
immunofluorescence analysis, sections were washed in TBS three times and then blocked and 
permeabilized for one hour at room temperature with 10% normal donkey serum (Jackson 
Immunoresearch) and 0.1% Triton-X in TBS. Sections were then incubated overnight at 4 ºC 
with primary antibodies in 2% normal donkey serum, 0.1% Triton-X in TBS. Primary antibodies 
included: Rabbit anti-DARPP32 (Cell Signaling), and Chicken anti Green Fluorescent Protein 
(Abcam). Secondary antibodies with the appropriate conjugated fluorphores were purchased 
from Invitrogen. The endogenous fluorescence of RFP was imaged. Sections were then washed 
in TBS and mounted. Images were obtained using a Leica SP5 confocal system with argon, 
DPSS He/Ne lasers. Images were obtained with a 63X oil immersion objective with a 2x digital 
zoom at 2048x2048 resolution (~120 nm resolution). All images were taken with the same laser 





Image analysis was conducted in ImageJ. Cell bodies were segmented using DARPP32 
staining. RFP+ puncta within each segment was counted manually. 10-20 cells were counted per 
section, 2-4 sections were counted per animal. Average number of puncta per cell was 
determined from n=3 animals per age. All images were collected and all analyses were 
conducted blind to condition.  
Statistics 
All analysis was conducted blind to condition. For statistical analysis between two 
groups, unpaired, two-tailed t tests were used. For analysis between 3 or more groups, one-way 
ANOVA was used. Normality was not formally tested. Sample size was not based on a formal 
power analysis but was based on past work from our groups and similar experiments from the 
literature. Statistical analysis was conducted in GraphPad Prism 7 (La Jolla, Ca). All bar graphs 





Chapter 6: Macroautophagy Controls Intrinsic Excitability via 
Degradation of Kir2 Channels.** 
6.1 Abstract 
The basal ganglia are a group of subcortical nuclei that contribute to action selection and 
reinforcement learning by evaluating sensorimotor and reward inputs and controlling 
thalamocortical activity and motor output. The principal neurons of the striatum, GABAergic 
spiny projection neurons of the direct (dSPN) and indirect (iSPN) pathways, maintain low 
intrinsic excitability and require convergent excitatory inputs to fire and, thereby, filter 
information before transmitting it to basal ganglia output nuclei. What cellular mechanisms 
ensure proper synaptic and intrinsic properties in SPNs? Recent findings indicate that 
macroautophagy regulates synaptic activity in excitatory neurons, the Drosophila neuromuscular 
junction, and nematode neurons. Here, I examined the effect of autophagy deletion on SPN 
physiology. Loss of autophagy in either SPN population led to changes in motor learning but 
distinct effects on cellular physiology. dSPNs, but not iSPNs, required autophagy for normal 
dendritic structure and synaptic input. In contrast, iSPNs, but not dSPNs, were intrinsically 
hyperexcitable. iSPN intrinsic hyperexcitability arose from reduced function of the inwardly 
rectifying potassium channel, Kir2. In the absence of autophagy, total and surface levels of Kir2 
protein were elevated but Kir2 activity was inhibited by acetylation. These findings define a 
novel mechanism by which autophagy regulates neuronal activity: control of intrinsic excitability 
via the regulation of potassium channel function. 
 
** Primary Atg7KO MEFs were generated by C Griffey and A Yamamoto. The western blot in Figure 6.10 was 






Although classically studied in the context of neurodegeneration, macroautophagy, 
hereafter referred to as autophagy, has recently been identified as a critical regulator of neuronal 
activity and function (Hernandez et al., 2012; Nikoletopoulou and Tavernarakis, 2018; Nixon, 
2013; Tang et al., 2014; Yamamoto and Yue, 2014). Autophagy is a process in which proteins or 
organelles are enclosed in a double membrane organelle, known as an autophagosome, which 
then traffics to the lysosome for degradation of its cargo (Klionsky, 2007). Autophagosomes also 
fuse with recycling endosome, to form amphisomes that act as key intermediates for the 
degradation of endosomal cargo including plasma membrane proteins (Eskelinen, 2005; 
Yamamoto and Yue, 2014).  
In the mammalian brain, autophagy has been best studied in cortical and hippocampal 
pyramidal neurons where it controls neurotransmission both pre- and postsynaptically. In early 
development, autophagic function is required presynaptically for axon pathfinding and circuit 
formation (Dragich et al., 2016; Stavoe et al., 2016) and, in mature neural circuits, the absence of 
presynaptic autophagy leads to deficits in neurotransmitter release and synaptic vesicle recycling 
due to the accumulation of damaged synaptic vesicles or mitochondria (Hernandez et al., 2012; 
Hoffmann et al., 2019; Vijayan and Verstreken, 2017). In the hippocampus and cortex, 
autophagy controls neurotransmission postsynaptically via the degradation of ionotropic 
glutamate and GABA receptors and synaptic scaffolding proteins such as PSD95 and Arc 
(Nikoletopoulou et al., 2017; Rowland et al., 2006; Shehata et al., 2012; Sumitomo et al., 2018; 
Tang et al., 2014; Yan et al., 2018). Developmental synaptic pruning in the cortex is dependent 
on both neuronal and microglial autophagy (Kim et al., 2017; Lieberman et al., 2018b; Tang et 





hippocampal synaptic plasticity (Glatigny et al., 2019; Nikoletopoulou et al., 2017). Thus, 
autophagy is a ubiquitous cellular process critical to proper synaptic function in the central 
nervous system.  
The brain is however composed of heterogenous populations of neurons with distinctive 
patterns of activity determined by the interplay of a complement of ion channels and synaptic 
inputs. Whether autophagy regulates neurotransmission via distinct processes in specific classes 
of neurons remains unknown. 
The striatum is the primary input nucleus of the basal ganglia, a collection of subcortical 
brain structures required for learning and executing goal-directed behaviors. In contrast to 
hippocampal and cortical pyramidal neurons where the contribution of autophagy to 
neurotransmission has been most studied, the striatum is composed of two intermixed and 
morphologically indistinguishable classes of GABAergic projection neurons: direct pathway 
(dSPN) and indirect pathway (iSPN) spiny projection neurons (Gerfen and Surmeier, 2011). 
SPNs receive convergent excitatory inputs from cortical and thalamic projection neurons, 
inhibitory input from local interneurons, and a variety of modulatory synaptic inputs (Doig et al., 
2010; Gerfen and Surmeier, 2011). SPN activity in response to these inputs is governed by their 
low intrinsic excitability and high latency to fire, necessitating the coordinated excitatory 
synaptic inputs on dendritic spines and shafts to elicit an action potential (Wilson and 
Kawaguchi, 1996). The disruption of normal SPN activity produces deficits in motor activity 
(Durieux et al., 2012; Kravitz et al., 2010); motivation (Carvalho Poyraz et al., 2016; Kellendonk 
et al., 2006); and responses to drugs of abuse (Dong et al., 2006). Striatal dysfunction has been 
linked to autism spectrum disorders (Fuccillo, 2016). which have been associated with reduced 





Tang et al., 2014; Yan et al., 2018). How autophagy contributes to striatal function and SPN 
physiology, however, remains unknown. 
Here, I generated conditional knockouts of Atg7, a protein required for autophagy 
(Komatsu et al., 2005), in dSPNs and iSPNs and find that loss of autophagy in either SPN 
subtype led to behavioral abnormalities in the absence of neurodegeneration. Loss of autophagy 
of dSPNs led to alterations in their dendritic arbor, dendritic spines and synaptic inputs, similar 
to that reported in pyramidal neurons. In contrast, dendritic arborization, spine density and 
synaptic inputs were not changed in iSPNs lacking autophagy. Instead, autophagy in iSPNs was 
required for the function of the inwardly rectifying Kir2 channel, which critically maintains the 
hyperpolarized resting membrane potential and low input resistance that are characteristic of 
SPNs. I found that ongoing autophagy contributes to the lysosomal delivery of endocytosed Kir2 
channels and in its absence, Kir2 channel abundance was elevated on the plasma membrane but 
had reduced activity. I further found that the excess channels are inactivated by acetylation, 
explaining the intrinsic hyperexcitability of autophagy-deificient iSPNs. These results introduce 
the regulation of neuronal intrinsic excitability by autophagy, how this occurs at a specific 
molecular target, and the role of this pathway in normal behaviors.  
3.3 Results 
3.3.1 Generation of Conditional Knockout Mice Lacking Autophagy in dSPNs or iSPNs. 
To address the role of autophagy in SPN physiology and striatal function, I generated 
separate lines of mice lacking Atg7 in dSPNs or iSPNs using Cre driver lines (CreDrd1aey262 
for dSPNs and CreAdora2aKG139 for iSPNs) (Figure 6.1A-B) (Gong et al., 2007; Komatsu et 
al., 2005, 2006). Mice lacking Atg7 in dSPNS or iSPNs (referred to as dSPNAtg7cKO and 





not shown). Littermate control mice harbored the floxed Atg7 allele without the Cre driver. I 
conducted a subset of electrophysiological and biochemical experiments in Cre+ Atg7wt mice 
but found no effect of Cre expression compared to Cre- Atg7Fl/Fl controls and have thus 
combined these data.  
To identify SPN subtype, I utilized BAC transgenic mice expressing the tdTomato 
fluorescent protein under the dopamine D1 receptor promoter (D1-tomato), which specifically 
labels dSPNs (Ade et al., 2011) and crossed this line into control, iSPNAtg7cKO and 
 
Figure 6.1. Specific loss of autophagy in dSPNs or iSPNs in the absence of neurodegeneration in dSPNAtg7cKO mice and 
iSPNAtg7cKO, respectively. (A) Schematic representation of the role of Atg3, 5, 7, 8 and Atg12 in a cascade leading to 
autophagosome formation. (B) Schematic of Atg7 locus in Atg7Fl/Fl mice and following Cre-mediated recombination. (Adapted 
from Komatsu et al 2006). (C) Immunofluorescent images of striatal sections from Atg7Fl/Fl (Control), D1-cre 
Atg7Fl/Fl (dSPNAtg7cKO) or A2Acre-Atg7Fl/Fl (iSPNAtg7cKO) mice. (D) p62+ cells per field in control, dSPNAtg7cKO or iSPNAtg7cKO 
mice. (E-F) Number of (E) D1-tomato+ or (F) D1-Tomato-, p62+ cells in iSPNAtg7cKO mice. (G-H) There were no difference sin 
NeuN+, D1-tomato+ cells per field. N=3 mice per genotype (at least 3 sections per mouse were counted). Data in (D, G, and H) 
were analyzed with one-way ANOVA followed by Holm-Sidak post-hoc test. Data in (E-F) were analyzed with a two-tailed, 





dSPNAtg7cKO mice. A Cre-dependent reporter at the Rosa26 locus could have been used to 
mark recombined cells but the Atg7 locus is close to the Rosa26 locus on chromosome 6 and I 
was therefore unable to generate recombinants (data not shown).  
As SPNs represent >95% of neurons in the striatum, D1-tomato negative cells are 
predominantly iSPNs (Shuen et al., 2008). In the absence of autophagy, cytosolic inclusions 
containing the autophagy cargo receptor, p62, form. p62 puncta were selectively observed in D1-
tomato-positive neurons (presumed dSPNs) in dSPNAtg7cKO mice and D1-tomato-negative 
(presumed iSPNs) in iSPNAtg7cKO mice (Figure 6.1C-F).  
Loss of neuronal autophagy can lead to neurodegeneration (Hara et al., 2006; Komatsu et 
al., 2006). I found no difference in the number of NeuN+ or D1-Tomato+ cells at 5 months of 
age in dSPNAtg7cKO or iSPNAtg7cKO mice compared to controls (Figure 6.1G-H). Together, 
these results demonstrate that these conditional knockouts permit the analysis of the 
consequences of the specific loss of dSPN or iSPN autophagy in the absence of 
neurodegeneration. 
6.3.2 Loss of Autophagy in SPNs Leads to Behavioral Deficits. 
I generated multiple cohorts of male and female dSPNAtg7cKO and iSPNAtg7cKO mice 
along with respective littermate controls. I combined data from the littermate control groups of 
each cross as I found no difference between littermate controls from these two crosses in any 
behavioral task I conducted. I also did not find an interaction between sex and genotype and have 





I identified multiple behavioral and phenotypic consequences of loss of autophagy in 
SPNs. Both male and female dSPNAtg7cKO mice weighed less than control mice from weaning 
until three months of age while iSPNAtg7cKO mice were indistinguishable from littermate 
controls (Figure 6.2A).  
I assessed motor learning, a task dependent on the striatum as well as other brain regions, 
using the accelerating rotarod (Durieux et al., 2012). On the first trial, dSPNAtg7cKO mice 
 
Figure 6.2. Autophagy in SPNs is required for motor performance and learning. (A) 9 week old male and female 
dSPNAtg7cKO mice, but not iSPNAtg7cKO mice, weigh less than controls. (B) Both dSPNAtg7cKO and iSPNAtg7cKO mice have a 
lower latency to fall off the accelerating rotarod. Control n = 35, dSPNAtg7cKO n = 23, iSPNAtg7cKO n = 13. (C) 
iSPNAtg7cKO mice, but not dSPNAtg7cKO, demonstrate locomotor hyperactivity in the open field arena. (D) Time course of 
locomotor activity in the open field. Control n = 32, dSPNAtg7cKO n = 15, iSPNAtg7cKO n = 14. (E) Automated scoring of 
stereotypies in the open field. (F) Manual scoring of grooming bouts over thirty minutes following habituation during a 






performed significantly worse than controls while iSPNAtg7cKO mice did not (Figure 6.2B). 
Both dSPNAtg7cKO and iSPNAtg7cKO mice had a significantly lower latency to fall off the 
rotarod than controls on trials two and three, indicating that autophagy in dSPNs and iSPNs was 
required for motor learning and performance (Figure 6.2B).  
Changes in striatal activity can also lead to alterations in locomotor behavior in a novel 
environment (Durieux et al., 2012). iSPNAtg7cKO mice displayed hyperactivity in the open-
field arena, which arose during the later habituation phase, compared to controls while 
dSPNAtg7cKO were not different (Figure 6.2C-D). Automated scoring of iSPNAtg7cKO 
mutants during the open field test revealed increased stereotypies (Figure 6.2E), which was 
confirmed by manually scored self-directed grooming bouts in a separate session (Figure 6.2F). 
These results demonstrate that loss of autophagy in dSPNs or iSPNs leads to behavioral deficits 
and disruptions in striatal function. 
6.3.3 Autophagy is Required for Proper Excitatory and Inhibitory Synapse Function on 
dSPNs but not iSPNs. 
Autophagy regulates dendritic spine density and both excitatory and inhibitory synaptic 
transmission in the cortex and hippocampus (Nikoletopoulou et al., 2017; Sumitomo et al., 2018; 
Tang et al., 2014; Yan et al., 2018). Due to the deficit in motor learning in dSPNAtg7cKO and 







Figure 6.3. Autophagy contributes to synaptic function and dendritic complexity in dSPNs but not iSPNs. (A) Sample 
dendritic trees of dSPNs from control of dSPNAtg7cKO mice. Reconstructions of neurobiotin filled neurons (left) and dendritic 
segment (right). (B) Sample dendritic trees from reconstructed iSPNs in control or iSPNAtg7cKO mice. Left: reconstructed 
dendritic tree. Right: dendritic segment. (C) Cumulative dendritic length is significantly reduced in dSPNs from dSPNAtg7cKO 
mice compared to control (left) but not in iSPNs from iSPNAtg7cKO mice compared to control (right). (D) Sholl analysis 
reveals a significant reduction in dendritic complexity in dSPNs from dSPNAtg7cKO mice compared to control (left) but not in 
iSPNs from iSPNAtg7cKO mice compared to control (right). (E) Dendritic spine density on dendritic segments 50-100 µm 
from the soma. (F) Representative traces of mEPSCs in dSPNs (top) and iSPNs (bottom). (G-H) A significant reduction in 
(G) mEPSC frequency and (H) mEPSC amplitude in dSPNs from dSPNAtg7cKO mice compared to control but no difference 
in iSPN mEPSC frequency or amplitude between genotypes. (I) Representative traces of mIPSCs in dSPNs (top) and iSPNs 
(bottom) (J-K) No difference in mIPSC frequency or amplitude after loss of autophagy in either dSPNs or iSPNs. See Table 






striatum, a striatal subregion required for motor learning (Durieux et al., 2012; Yin et al., 2009).  
Reconstruction of the dendritic tree from neurobiotin-filled dSPNs (D1-tomato positive 
cells) revealed reductions in the total dendritic length and the complexity of the dendritic tree in 
dSPNs from dSPNAtg7cKO mice compared to controls (Figure 6.3A-D). In contrast, loss of 
autophagy in iSPNs from iSPNAtg7cKO mice did not affect total dendritic length or dendritic 
complexity (Figure 6.3A-D). I also found a reduction in the dendritic spine density on dSPNs 
from dSPNAtg7cKO mice while the dendritic spine density on iSPNs from iSPNAtg7cKO mice 
were not different than controls (Figure 6.3E).  
Changes in dendritic spine density and dendritic architecture may lead to functional 
differences in excitatory or inhibitory inputs onto SPNs. I recorded miniature excitatory 
postsynaptic currents (mEPSC; VHold = -70 mV) and miniature inhibitory postsynaptic currents 
(mIPSC; VHold = 0 mV) in whole-cell patch clamp recordings in the presence of tetrodotoxin 
(TTX) to block action potentials.  The use of this internal solution permits measurement of both 
mEPSCs and mIPSCs in individual cells and the determination of the ratio of excitatory to 
inhibitory inputs. In a subset of cells, I confirmed that inward currents at VHold = -70 mV were 
glutamatergic in origin by bath applying the AMPAR antagonist, CNQX (5 µM) and outward 
currents at VHold = 0 mV were GABAergic by bath application of picrotoxin (25 µM; data not 
shown). I found a reduction in both mEPSC frequency and amplitude in dSPNs lacking 
autophagy without a change in mIPSC frequency of amplitude (Figure 6.3F-K).  
In iSPNs lacking autophagy, in contrast, neither mEPSC frequency and amplitude nor 
mIPSC frequency and amplitude were different than controls (Figure 6.3F-K), consistent with 
the absence of a change in dendritic length or spine density. These data demonstrate that, as in 





autophagy contributes to synaptic function in dSPNs but is dispensable for proper synaptic 
transmission onto iSPNs. 
6.3.4 Autophagy Controls iSPN Intrinsic Excitability. 
Despite the absence of synaptic deficits in iSPNs lacking autophagy, iSPNAtg7cKO mice 
demonstrated locomotor hyperactivity and deficits in motor learning (Figure 6.2). How is iSPN 
function affected by loss of autophagy? SPN activity is governed by the interplay of synaptic 
excitation and inhibition with a low intrinsic excitability (Kreitzer, 2009; Wilson and 
Kawaguchi, 1996). I, therefore, hypothesized that iSPNs lacking autophagy may be 
dysfunctional due to a change in their intrinsic excitability. In whole cell recordings, iSPNs from 
iSPNAtg7cKO mice exhibited a depolarized RMP, increased input resistance, and decreased 
rheobase, suggesting that autophagy is required for the normally low intrinsic excitability of 
iSPNs (Figure 6.4A-D). These effects occurred in the absence of a change in membrane 
capacitance (Figure 6.4E). The combination of increased input resistance, decreased rheobase 
and depolarized RMP led to a left-shifted current-response curve, suggesting that iSPNs were 
hyperresponsive to depolarizing inputs (Figure 6.4F). 
While neither the RMP nor the rheobase of dSPNs in dSPNAtg7cKO were different from 
controls, dSPNs lacking autophagy had an elevated input resistance and decreased membrane 
capacitance (Table 6.3). These results are consistent with change in the passive membrane 
properties of dSPNs caused by reduced dendritic length and complexity (Figure 6.3), in contrast 





The change in intrinsic excitability in iSPNs from iSPNAtg7cKO may arise  as a 
response to differences in the striatal network activity, in which case, dSPNs from 
iSPNAtg7cKO mice (which have autophagy) may also be affected, or they could be cell-
intrinsic, in which case dSPNs in these mice would not be affected.  I recorded from dSPNs in 
iSPNAtg7cKO mice and found no difference in the RMP, rheobase, input resistance or 
capacitance in dSPNs from iSPNAtg7cKO mice compared to control dSPNs, suggesting that 
autophagy regulates autophagy in iSPNs through a cell-intrinsic mechanism (Table 6.3).  
 
Figure 6.4. Loss of autophagy leads to intrinsic hyperexcitability due to reduced Kir2 currents in iSPNs. (A) 
Representative current clamp traces in iSPNs from control or iSPNAtg7cKO mice. (B-F) iSPNs lacking Atg7 display (B) 
depolarized resting membrane potential, (C) elevated input resistance, (D) decreased rheobase, (E) no change in capacitance 
and (F) a left-shifted current-response curve. iSPNCtrl: n=25(7), iSPNAtg7cKO: n=36(8). (G) Representative voltage clamp 
recordings of Kir2 currents. (H) iSPNs have lower Kir2 current density in iSPNAtg7cKO mice compared to iSPNs in iSPNCtrl 







These results demonstrate that autophagy directly regulates intrinsic excitability in iSPNs 
but not dSPNs and provide a new mechanism through which autophagy can control neuronal 
function. 
 
Figure 6.5. Autophagy is required for maximal Kir2 current but does not affect Kir2 voltage dependence. (A-B) 
Representative traces of voltage clamp recordings of iSPNs in (A) ACSF, (B) ACSF + BaCl2, and (C) BaCl2-sensitive (Kir2) 
currents. (D-F) Aggregate currents in conditions as in (A). (G) No difference in the voltage dependence or (H) voltage at 
half-maximal activation for Kir2 currents between genotypes. (I) Slope of Kir2 current is greater in iSPNControl than 
iSPNAtg7cKO cells. NS p>0.05,** p<0.05, *** p<0.001, † p<0.0001. Data in D-G were analyzed with a repeated measures 
two-way ANOVA followed by Bonferroni post-hoc tests. Data in H and I were analyzed with a two-tailed unpaired t test. ns 






6.3.5 Kir2 Currents are Decreased in the Absence of Autophagy. 
Although either reduced dendritic complexity (Gertler et al., 2008; Mainen and 
Sejnowski, 1996) or changes in specific ionic conductances can lead to intrinsic hyperexcitability 
following somatic current injection, I did not observe a change in dendritic arborization in iSPNs 
lacking autophagy (Figure 6.3), suggesting that a change in ion channel function underlies this 
phenotype. Inwardly rectifying potassium currents, mediated by Kir2.1 and Kir2.3 channels 
(referred to as Kir2 currents) (Cazorla et al., 2012; Karschin et al., 1996; Shen et al., 2007), are 
the predominant potassium conductance active around the resting membrane potential of SPNs 
and are the critical determinants of RMP, input and input resistance (Nisenbaum et al., 1994; 
Wilson and Kawaguchi, 1996). As iSPNs lacking autophagy exhibit a depolarized RMP and 
elevated input resistance, I hypothesized that autophagy may regulate Kir2 function.  
Kir2 currents are measured as an inwardly rectifying, barium sensitive current triggered 
by hyperpolarizing current steps (Figure 6.5A-F). I found a decrease in the whole cell Kir2 
current density in iSPNs from iSPNAtg7cKO mice compared to control iSPNs (Figure 6.4G-H). 
This was not associated with a change in the voltage dependence of the Kir2 current (Figure 
6.5G-I). Interestingly, there was no difference in Kir2 current density in dSPNs from 
dSPNAtg7cKO or iSPNAtg7cKO mice compared to controls (Table 6.3). These results suggest 
that autophagy is required for Kir2 currents in iSPNs but not dSPNs and further support the 
conclusion that autophagy controls neuronal function via cell-type specific pathways. 
6.3.6 Autophagy Controls Kir2 Degradation. 
Because autophagy has not been described to regulate neuronal intrinsic excitability or 







Figure 6.6. Autophagy is required for Kir2 degradation. (A-C) There was no difference in Kir2.1 or Kir2.3 mRNA 
expression in SPNs of iSPNAtg7cKO mice in an RNAscope assay (N=77-173 cells from 3 mice per group). Inset shows just 
RNAscope and DAPI. Scale bar 30 µm.  (D) Representative western blots of specified proteins from total striatal lysates 
from iSPNCtrl or iSPNAtg7cKO mice. Quantifications of (E) p62, (F) DARPP32, (G) Kir2.1, and (H) Kir2.3 relative to actin. 
(I-J) Kir2.1 is localized in LC3-GFP+ puncta in Atg5WT but not Atg5KO MEFs. BafilomycinA1 (BafA1; 100 nM 2 hours) 
treatment increases the number of LC3/Kir2.1-double labeled puncta in Atg5WT MEFs. Scale bar 20 µm. Inset scale bar 1 
µm. (K-L) A reduction of Lamp1+Kir2.1+ puncta in Atg5KO MEFs. Scale bar 20 µm, inset scale bar 1 µm. (M) Reduced 
degradation of SNAP-tag labelled Kir2.1 in Atg5KO MEFs. N: (WT,KO): T=0 min (35,30), T=30 min (30,27), T=60 min 
(25,38), T=180 min (33,67), T=360 min (40,20). (N) No significant difference in the internalization of antibody-labelled 
surface Kir2.1 channels in Atg5KO MEFs. N: (WT,KO): T=0 min (76,56), T=30 min (52,37), T=60 min (41,42), T=120 min 







To test if loss of autophagy leads to reduced Kir2 current via downregulation of Kir2.1 or Kir2.3 
mRNA levels, I coupled immunofluorescence and RNAScope analysis to measure the abundance 
of Kir2.1 and Kir2.3 mRNA on a single cell level in DARPP32 (to label all SPNs) and p62+ 
cells. Loss of autophagy did not affect the number of Kir2.1 or Kir2.3 RNAScope puncta per cell 
in iSPNAtg7cKO mice compared to controls (Figure 6.6A-C). These results suggest that 
decreased Kir2 current in the absence of autophagy does not result from a change in Kir2.1 or 
Kir2.3 mRNA expression.  
 
Figure 6.7. Loss of autophagy does not affect Kir2.1 expression in dSPNAtg7cKO mice. (A) Representative western blots 
from control or dSPNAtg7cKO mice. (B-G) Quantification of relative protein levels in control and dSPNAtg7cKO mice shows no 
significant difference between (B) Kir2.1, (C) Kir2.3, (D) Kv1.2, (E) PSD95, or (G) DARPP32, but a significant increase in 
(F) p62. (H) Representative western blots for Kv1.2 and PSD95 in control or iSPNAtg7cKO mice. (I-J) Quantification of 
Kv1.2 and PSD95 shows no difference between control and iSPNAtg7cKO mice. Data analyzed by two-tailed unpaired t test. 







Instead of regulating Kir2 channels at the transcriptional level, autophagy could affect 
Kir2 protein stability, which would explain reduced Kir2 current. I generated total striatal lysates 
from control, dSPNAtg7cKO, or iSPNAtg7cKO mice and confirmed that loss of autophagy led 
to an increase in p62 levels in both dSPNAtg7cKO and iSPNAtg7cKO mice compared to 
controls (Figure 6.6D-E and Figure 6.7).  
Furthermore, I validated my striatal dissections by blotting for DARPP32, an SPN 
marker, and found no difference across genotype (Figure 6.6D,F and Figure 6.7). Remarkably, 
however, total striatal levels of Kir2.1 and Kir2.3 were elevated in iSPNAtg7cKO mice 
compared to controls (Figure 6,6D,G-H), while levels of Kir2.1 and Kir2.3 in dSPNAtg7cKO 
were not different from controls (Figure 6.7A-C; note y-axis difference between Figure 6.6D,G-
H and 6.7A-C). These data suggest that autophagy oppositely regulates Kir2 channel abundance 
and Kir2 current specifically in iSPNs.  
Although autophagy has previously been shown to regulate integral plasma membrane 
proteins, either by controlling membrane protein trafficking, interaction with partners, or 
degradation (Gao et al., 2018; Rowland et al., 2006; Shehata et al., 2012; Sumitomo et al., 2018; 
Yan et al., 2018), the unexpected inverse relationship between total Kir2 protein and Kir2 current 
in iSPNs lacking autophagy warranted further validation. To confirm this relationship, I tested 
whether autophagy would modify the effect of Kir2.1 overexpression in vivo and whether the 
reduction in Kir2 currents in the absence of autophagy would be rescued by Kir2.1 
overexpression. To address this, I injected iSPNAtg7cKO, dSPNAtg7cKO and control (A2Acre+ 
Atg7WT or D1cre+Atg7WT) mice unilaterally with an adeno-associated virus (AAV) to yield 
Cre-dependent overexpression of either Kir2.1 and the fluorescent protein, ZsGreen (Rothwell et 





Figure 6.8. Atg7 reexpression but not Kir2.1 overexpression rescues changes in iSPN physiology. (A) 
Immunofluorescent images of striatal hemisections from mice injected with AAV1-DIO-mCherry or AAVDJ-DIO-Kir2.1-
t2A-zsGreen stained against mCherry (left) or GFP (right). Scale bar 500 µm. (B) Significant effect of Kir2.1 overexpression 
on Kir2 current density in dSPNs from control and dSPNs from dSPNAtg7cKO mice. (C) Significant effect of Kir2.1 
overexpression on Kir2 current density in iSPNs from control but not from iSPNAtg7cKO mice. N= iSPNCtrl (A2Acre Atg7wt/wt, 
mCh: n=5(2), Kir2.1: n=8(2)) or iSPNAtg7cKO (A2Acre Atg7Fl/Fl, mCh: n=11(3), Kir2.1: n=12(3)) expressing mCherry or 
Kir2.1 shows a significant interaction between virus and genotype (p<0.05). (D) Representative hemisections from 
iSPNAtg7cKO mice injected with AAV1-DIO-mCherry (left) or AAVDJ-Flex-Atg7-2A-ZsGreen (right) showing reduction in 
p62 puncta in cells expressing Atg7 (right) compared to mCherry (left). Scale Bar 500 µm. Inset, scale bar 20 µm. (E) 
Representative current clamp traces from mCherry expressing iSPN in a control (A2Acre) mouse, mCherry expressing iSPN 
in an iSPNAtg7cKO mouse or an Atg7-expressing iSPN from an iSPNAtg7cKO mouse. (F-J) Reexpression of Atg7 normalizes 
RMP, rheobase, Rin, and Kir2 current in iSPNs from iSPNAtg7cKO mice compared to mCherry control but only reduces Rin in 
controls. N=9-20 cells per group from at least 3 mice. Data in (B and F-J) were analyzed with a two-way ANOVA. ns 







After 3-4 weeks, acute brain slices were generated and Kir2 current density was measured using 
whole-cell voltage clamp recordings.  
Kir2 current density was higher in dSPNs overexpressing Kir2.1 compared to mCherry 
alone in D1cre+Atg7wt and dSPNAtg7cKO mice (Figure 6.8B). Similarly, Kir2.1 
overexpression increased Kir2 current density in iSPNs from A2Acre+Atg7wt mice (Figure 
6.8C). In contrast, Kir2.1 overexpression in SPNs from iSPNAtg7cKO mice did not increase 
Kir2 current density compared to mCherry expressing SPNs (Figure 6.8C), confirming that 
autophagy is required for overexpressed Kir2.1 channels to be functional. Furthermore, this 
experiment highlights the cell-type specificity of the requirement of autophagy for Kir2.1 
current.  
I confirmed that the effect of loss of autophagy on Kir2 current could be complemented 
in adulthood by constructing a virus to Cre-dependently express Atg7 in iSPNs (Figure 6.8D). 
Viral reexpression of Atg7, but not a fluorophore only control, reduced p62 accumulation in 
transduced cells (Figure 6.8D). Furthermore, reexpression of Atg7 corrected SPN 
hyperexcitability and increased Kir2 currents in iSPNAtg7cKO cells but had no effect in control 
iSPNs from iSPNctrl mice (Figure 6.8D-J). These results demonstrate that reduced Kir2 current 
in iSPNAtg7cKO mice could be complemented by Atg7 reexpression, but not Kir2.1 
overexpression, in adulthood.  
I next examined why Kir2 currents were decreased but Kir2 protein was increased in the 
absence of autophagy to elucidate the mechanism through which autophagy regulates neuronal 
intrinsic excitability. To do this, I expressed a Kir2.1 fusion with a C-terminal FLAG and SNAP-





(MEFs) lacking Atg5, a protein required for autophagosome biosynthesis, to address the role of 
autophagy in the handling of the Kir2 channel  (Figure 6.9A) (Kuma et al., 2004).  
 
Figure 6.9. Higher steady-state levels of Kir2.1 and reduced degradation of Kir2.1 in Atg5KO MEFs. (A) 
Schematic of Kir2.1-externalHA-Flag-SNAP (abb. Kir2.1 below) construct. (B) Representative western blots and (C) 
quantification for Flag, Kir2.1, LC3B and actin show elevated steady state levels of Kir2.1 in transiently transfected in 
Atg5KO MEFs compared to Atg5WT MEFs. N=3 per genotype. (D and E) Representative blots and aggregate data from 6 
independent replicates per timepoint treated with cycloheximide at t=0 min. Data were analyzed with a two-tailed 
unpaired t test in (C) and a two-way ANOVA followed by Bonferroni post-hoc test in (E). ns p>0.05, * p<0.05, ** 






I chose to use a well-validated transformed MEF cell line lacking Atg5 as opposed to 
primary striatal culture for two reasons: (1) the maturation of SPN intrinsic excitability occurs 
postnatally, suggesting that the intrinsic excitability of dissociated SPNs in culture may depend 
on distinct processes from what happens in vivo (Kuo and Liu, 2019; Lieberman et al., 2018a); 
(2) almost all SPNs in primary culture express markers of dSPNs, in which Kir2 channels are not 
regulated by autophagy in vivo (Falk et al., 2006).  
Transformed MEFs lacking Atg5 (Atg5KO MEFs) transiently transfected with 
Kir2.1FlagSNAP demonstrated a higher steady-state level of Kir2.1 expression but reduced 
LC3B-ii/LC3B-i, a measurement of autophagic activity (Figure 6.9B-C). Immunofluorescence 
analysis demonstrated colocalization of Kir2.1FlagSNAP with YFP-LC3 puncta, a marker of 
autophagosomes, in MEFs. The colocalization of Kir2.1FlagSNAP with YFP-LC3 increased 
following incubation with bafilomycin to collapse the lysosomal pH gradient and block 
autophagosome fusion with lysosomes (Yamamoto et al., 1998). I observed that the 
Kir2.1FlagSNAP colocalization with YFP-LC3 was dependent on Atg5 (Figure 6.6I-J). 
Furthermore, in the absence of Atg5, I found a reduced number of Kir2.1+Lamp1+ late 
endosomes/lysosomes (Figure 6.6K-L), supporting the conclusion that autophagy plays a role in 
the lysosomal degradation of Kir2.1.  
To address whether Kir2.1 degradation itself was dependent on autophagy, I pulse-
labeled transfected Atg5WT and Atg5KO MEFs with SNAPcell ligand and fixed cells following 
a chase interval (Figure 6.6M). I found that the half-life of labelled Kir2.1FlagSNAP was greatly 





Kir2.1FlagSNAP half-life was extended in Atg5KO MEFs using a cycloheximide pulse-chase 
assay (Figure 6.9D-E). This demonstrates that autophagy is required for Kir2.1 degradation.  
Primary Atg7KO MEFs were generated to confirm that Atg7, in addition to Atg5, was 
required for Kir2.1 degradation (Figure 6.10A). I pulse labelled primary Atg7WT and Atg7KO 
MEFs transfected with Kir2.1FlagSNAP and found an elevated level of SNAPcell-labeled 
Kir2.1FlagSNAP after a 120 min chase in Atg7KO MEFs compared to controls (Figure 6.10A-
C). 
 
Figure 6.10. Kir2.1 degradation is disrupted in Atg7KO MEFs. (A) Representative western blot showing the absence 
of Atg7 in Atg7KO primary MEFs. (B) Representative images of primary MEFs transfected with Kir2.1-Flag-SNAP and 
labelled with SNAPcell ligand. (C) Snap-labelled Kir2.1 is significantly reduced in Atg7WT cells but not Atg7KO cells. 
N: (0,120 min) WT: (7,6), KO: (7,6). (D) The distribution of Kir2.1 is not different between Atg7WT and Atg7KO cells. 
Data in (C) analyzed with a two-way ANOVA followed by Bonferroni post-hoc test. Data are combined from 2 






 These results show that autophagy is required for Kir2.1 degradation. Previous reports 
have suggested that Kir2.1 is endocytosed and trafficked to the lysosome for degradation in an 
ESCRT-dependent manner (Jansen et al., 2008; Kolb et al., 2014). Autophagy could contribute 
to lysosomal degradation of Kir2.1 by affecting internalization and endocytosis, or the transport 
of endocytosed Kir2.1 to the lysosome. To address this, I engineered a hemagglutinin (HA) tag 
(Kir2.1extHA-FlagSNAP) into an extracellular loop of Kir2.1, at a site which has previously 
been used to tag the extracellular face of Kir2.1 without affecting channel function (Chen et al., 
2002). I labelled live Atg5WT or Atg5KO MEFs transfected with Kir2.1extHA-FlagSNAP with 
anti-HA antibodies and measured the remaining surface resident-labelled channels after a chase 
period. I found no difference in the internalization of Kir2.1extHA-FlagSNAP in the absence of 
autophagy (Figure 6.6N), suggesting that autophagy is required for Kir2.1 degradation at a post-
endocytic step.  
I conclude that autophagy is required for the lysosomal delivery and degradation of 
endocytosed Kir2.1 channels. 
6.3.7 Lack of Autophagy Leads to Increased Surface Levels of Kir2 Channels Despite 
Reduced Channel Function. 
If autophagy is required for Kir2.1 degradation, but Kir2 channel abundance is elevated 
in the absence of autophagy, why are Kir2 currents decreased in cells lacking autophagy? One 
possibility is that Kir2 channels could be mislocalized in the absence of autophagy, and not be 
present on the plasma membrane.  
To address whether Kir2.1 function is regulated by autophagy in MEFs, I measured Kir2 





 detected a Ba2+-sensitive, inwardly-rectifying current that was absent from untransfected cells 
(Figure 6.11A). Despite the increase in total Kir2.1FlagSNAP levels in Atg5KO MEFs (Figure 
6.9B-C), the Kir2 current in Atg5KO MEFs was decreased relative to Atg5WT MEFs (Figure 
6.11B). This suggests that autophagy regulates Kir2 channel function and abundance in 
transformed MEFs and that the mechanism through which Kir2.1 is regulated by autophagy can 
be explored in this heterologous system. 
 
Figure 6.11. Autophagy is not required for Kir2 trafficking. (A) Sample traces from MEFs transfected with Kir2.1 
demonstrate an inwardly rectifying, barium sensitive current that is absent in untransfected cells. (B) Atg5KO MEFs have 
reduced Kir2.1 current compared to Atg5WT MEFs. WT: N=8, KO: N=12. (C) Representative micrographs of Atg5WT 
and Atg5KO MEFs. On right, the Kir2.1 channel in the WT image has been contrasted to compare staining pattern. Scale 
bar 20 µm. (D-F) Elevated levels of both surface and total levels of Kir2.1 in Atg5KO MEFs. Scale bar 20 µm, inset 
scale bar 1 µm.  (G-J) Subcellular fractionation reveals elevated levels of Kir2.1 and Kir2.3 in all fractions of 
iSPNAtg7cKO mice compared to controls but no change in the relative distribution of Kir2.1 or Kir2.3 between genotypes. 
(H) p62 is elevated in the total homogenate of iSPNAtg7KO mice. (I) No change in distribution or level of Kv1.2 between 
genotypes. iSPNCtrl: N=5. iSPNAtg7cKO: N=3. TH, total homogenate; PNS, post-nuclear supernatant; S2, 20,000xg 
supernatant; P2, 20,000xg pellet; P3, resuspended P2 spun at 100000xg; SPM, synaptic plasma membranes isolated 
from 1.0M and 1.2M sucrose interface. See Table S3 for detailed statistics. ns p>0.05, * p<0.05, ** p<0.01, *** 






Autophagy may be required for both the localization and the degradation of Kir2.1, 
which would explain why in the absence of autophagy, Kir2.1 levels are elevated but Kir2.1 
current is decreased. I found, however, that Kir2.1FlagSNAP was located on the surface and in 
intracellular vesicles in both control and Atg5KO MEFs (Figure 6.11C). In addition, similar 
patterns of Kir2.1 localization were observed in Atg7WT and Atg7KO primary MEFs (Figure 
6.10D).  
Next, I measured the steady-state amount of surface resident Kir2.1 by fixing MEFs 
transfected with Kir2.1extHA-FlagSNAP and staining for the HA tag without permeabilization. 
Subsequent permeabilization and staining for the FLAG tag permitted quantification of the total 
Kir2.1 protein expressed per cell. I found that both surface and total levels of Kir2.1 were 
elevated in Atg5KO cells relative to controls (Figure 6.11D-F), further emphasizing that the 
reduced Kir2 currents in the absence of autophagy do not arise from fewer surface-resident 
channels.  
I confirmed that Kir2.1 and Kir2.3 were also similarly localized in vivo in iSPNAtg7cKO 
striatum compared to control using subcellular fractionation. Kir2.1 and Kir2.3 are localized to 
the somatodendritic region and to dendritic spines in SPNs (Shen et al., 2007). I isolated striatal 
synaptosomes from iSPNCtrl or iSPNAtg7cKO mice using a sucrose gradient approach 
(Bermejo et al., 2014). To confirm that I had enriched for synaptic plasma membranes, I blotted 
for the cytosolic protein DARPP32 or the postsynaptic density scaffolding protein PSD95. I 
found that there was no difference in the total levels of PSD95 in total striatal lysates in 
iSPNAtg7cKO mice compared to controls (Figure 6.7H-J) and that we were able to enrich 
PSD95 and deplete DARPP32 in the synaptic plasma membrane (SPM) fractions in both 





supernatant (PNS), in both the S2 fraction, containing cytosol and light membranes, and SPM in 
both iSPNCtrl and iSPNAtg7cKO striatum (Figure 6.11G). Interestingly, although there was no 
relative difference in the distribution of Kir2.1 and Kir2.3, there were higher levels of both 
Kir2.1 and Kir2.3 in all fractions iSPNAtg7cKO compared to iSPNCtrl striatum (Figure 
6.11G,J).  
I examined whether the localization of another potassium channel expressed by dSPNs 
and iSPNs was affected by loss of autophagy. I found that there was no change in the localization 
or total level of Kv1.2, a voltage-gated potassium channel expressed by SPNs (Figure 6.11I-J 
and Figure 6.7H-I) (Shen et al., 2004), suggesting that autophagy selectively control Kir2.1 and 
Kir2.3 in iSPNs.  
These results were further confirmed by floating striatal membrane pellets in a 
discontinuous iodixanol gradient, which separates plasma membranes (light fraction) from other 
organelles (heavy fractions). Kir2 channels classically exhibit a bimodal distribution between 
heavy and light membrane fractions as a population of these channels exist in cholesterol-rich 
membrane domains (Tikku et al., 2007). No difference in the distribution of endogenous Kir2.1 
or KV1.2 was observed between iSPNCtrl and iSPNAtg7cKO striatum using this gradient 
approach (Figure 6.12A-D). I confirmed that Kir2 channels were not trapped in cholesterol-rich 
membranes, where they are inactive (Romanenko et al., 2004), by treating acute brain slices from 
iSPNAtg7cKO  mice with methyl-β-cyclodextrin (MβCD), to remove cholesterol, and found that 
Kir2 currents were not increased iSPNs relative to iSPNs from vehicle treated slices (Figure 
6.12E). These results demonstrate that Kir2 channels are localized to the plasma membrane but 







6.3.8 Kir2 Channels are Acetylated and Inactivated in the Absence of Autophagy. 
As Kir2 channels are localized to the plasma membrane in higher quantities in the 
absence of autophagy both in vivo and in MEFs (Figure 6.11D-J), it remained unclear why Kir2 
currents were decreased. I hypothesized that these channels may be inhibited by a post-
 
Figure 6.12. Plasma membrane floatation and MBCD treatment. (A) Schematic of iodixanol gradient. (B,D) 
representative blots of gradient fractions. (C) Aggregate data of Kir2.1 in each fraction normalized to the total amount of 
Kir2.1 across the gradient. No difference in Kv1.2 levels or distribution and no difference in Kir2.1 distribution was seen. 
N=3 mice per genotype. (E) Kir2 currents from iSPNs from slices pretreated with methyl-β-cyclodextrin (MBCD; 10 mM) 
were recorded. No effect of MBCD was seen at either genotype. iSPNCtrl: Veh N=8, MBCD N=6. iSPNAtg7cKO: Veh N=5, 
MBCD N=7 (Cells from 2 mice per condition). Data in (C and E) analyzed with a two-way ANOVA followed by Bonferroni 






translationally modification in the absence of autophagy. Several proteins that are selectively 
degraded by autophagy undergo lysine modification by ubiquitin or acetylation (Khaminets et 
al., 2016). Immunoprecipitation of Kir2.1extHA-FlagSNAP from Atg5WT or Atg5KO cells 
indicated that, in the absence of autophagy, the level of Kir2.1 acetylation was highly increased 
while its ubiqutination status was unaffected (Figure 6.13A).  
Both of these modifications can signal for proteins to enter the autophagy pathway for 
degradation and I therefore hypothesized that the acetylated lysine residue was also required for 
autophagic degradation of Kir2.1, as this would explain why a modified channel accumulates in 
the absence of autophagy: acetylated Kir2.1 may be targeted for degradation but, in the absence 
of autophagy, cannot be eliminated.  
To identify the acetylated lysine that may be responsible for inhibition of Kir2.1 and 
targeting it for autophagic degradation, I searched for lysines in Kir2.1 previously implicated in 
its degradation. Kir2.1 contains a motif in its C-terminus that regulates Kir2.1 surface residence 
and degradation (Ambrosini et al., 2014), is evolutionarily conserved and present in Kir2.3 
(Figure 6.13B). Three lysines are present within this sequence, two of which, K338 and K346, 
are known to be ubiquitinated (Figure 6.13B) (Ambrosini et al., 2014; Wagner et al., 2012). I 
mutated K334, K338 and K346 individually to arginines to prevent addition of ubiquitin or 
acetyl groups and screened these mutants in a degradation assay in Atg5WT cells.  Kir2.1 
K334R underwent significantly less degradation than Kir2.1 WT, K338R or K346R (Figure 
6.13C), suggesting that K334 is required for degradation of Kir2.1. 
I next examined whether the K334R mutant, which could not be modified, was also fully 
functional even in the absence of autophagy by transfecting Atg5WT and Atg5KO cells with 





but significantly increased channel function in Atg5KO cells compared to Kir2.1 WT (Figure 
6.13D-E), suggesting that modification of K334 was necessary for the inhibition of Kir2 function 
in the absence of autophagy.  
I next engineered a mutant Kir2.1 channel that harbors an acetylation-mimic glutamine 
instead of K334. Kir2.1 K334Q had reduced function in Atg5WT cells compared to Kir2.1 WT 
(Figure 6.13F-G), demonstrating that acetylation of Kir2.1 at K334 is both necessary and 
sufficient to control channel function. 
 
Figure 6.13. Hyperacetylation of Kir2.1 at K334 in the absence of autophagy inhibits channel activity. (A) 
Immunoprecipitation of Kir2.1 reveals elevated levels of acetylated lysines on Kir2.1 in Atg5KOMEFs without a change in 
ubiquitination. Representative blots shown from at least three independent replicates. (B) A conserved motif in the C-
terminal tail of Kir2.1 and Kir2.3 contains three modifiable lysines and has previously been implicated in Kir2 channel 
degradation. (C) A degradation screen in which K334, K338 and K346 were mutated to the unmodifiable residue, arginine, 
reveals that K334 is required for Kir2.1 degradation in Atg5WT MEFs. N: (T=0min, T=120 min) WT (52,79), K334R (27,51), 
K338R (40,41), K346R (23,11). (D-E) Kir2.1 K334R current is normalized in Atg5KO MEFs but does not affect Kir2.1 
current in Atg5WT MEFs. (F-G) Kir2.1 K334Q, with an acetylation-mimic at K334, has reduced current in Atg5WT MEFs. 
Voltage step protocol is the same as in (F). See Table 6.2 for detailed statistics. ns p>0.05, * p<0.05, ** p<0.01, *** p<0.001, 






These results suggest that, in the absence of autophagy, Kir2 channels are present on the 
plasma membrane but are inhibited by acetylation at K334.  I conclude that acetylation of K334 
acts to promote the autophagy-dependent degradation of Kir2.1.  
6.4 Discussion 
 Although originally studied in the central nervous system in the context of 
neurodegenerative disease, autophagy has recently been identified as a key regulator of 
neurotransmission. Furthermore, autophagic dysfunction occurs in neurodevelopmental disorders 
such as autism spectrum disorders, emphasizing the need to understand autophagic function at 
the synapse. Here, I investigated the role of autophagy in the function of both classes of 
GABAergic projection neurons in the striatum, a region implicated in the pathophysiology of 
several neurodevelopmental disorders. In dSPNs, autophagy is required for dendritic structure 
and spine density and the function of both excitatory and inhibitory inputs onto dSPNs. In iSPNs, 
I did not detect changes in dendritic arborization, spine density or excitatory and inhibitory 
inputs in the absence of autophagy. In contrast, however, autophagy was required for the 
degradation in acetylated Kir2 channels in iSPNs, leading to intrinsic hyperexcitability. Loss of 
autophagy in either dSPNs or iSPNs led to deficits in behavioral tasks considered to depend at 
least in part on the striatum (Durieux et al., 2012). These results demonstrate that autophagy 
contributes to striatal function via distinct molecular pathways in dSPNs and iSPNs. 
6.4.1 Control of Synaptic Function in dSPNs. 
 Autophagy is required for synaptic structure and function in C. elegans, the Drosophila 
neuromuscular junction, and excitatory neurons in the mouse cortex and hippocampus (Glatigny 
et al., 2019; Nikoletopoulou et al., 2017; Shehata et al., 2012; Shen and Ganetzky, 2009; Stavoe 





autophagy led to reduced complexity of the dendritic tree, lower dendritic spine density, and 
functional deficits in excitatory inputs. The mechanism through which autophagy may regulate 
dendritic structure and function in dSPNs remains unknown. Dendritic complexity and spine 
density can be controlled by neurotrophic factors (Horch et al., 1999; Li et al., 2012), 
mitochondrial function (Li et al., 2004), neuromodulatory signaling (Villalba and Smith, 2013), 
and synaptic inputs and neurotransmission (Alvarez and Sabatini, 2007; Lambot et al., 2016). 
Each of these cellular pathways is modulated by autophagy and therefore could lead to altered 
dSPN dendritic arborization and excitatory synaptic inputs (Kononenko et al., 2017; 
Nikoletopoulou et al., 2017; Youle and Narendra, 2011).  A key unanswered question is whether 
these synaptic pathologies arise during early dSPN development or as a degenerative process and 
could be addressed via a longitudinal analysis of these parameters in dSPNAtg7cKO mice. I 
hypothesize that, given the dynamic changes in autophagic flux that occur in SPNs during early 
postnatal development (P10-P18; Chapter 5), autophagy would play a role in dendritic growth 
and excitatory synaptogenesis on SPNs. 
Interestingly, in some neuronal populations, loss of autophagy leads to increase cell size 
and increased synaptic contacts (Shen and Ganetzky, 2009; Tang et al., 2014). Mechanistic 
studies aimed at defining how autophagy regulates synapse formation or maintenance would 
provide insight into how loss of the same cellular pathway can yield divergent synaptic 
phenotypes.  
 Perhaps most perplexing is the fact that iSPNs that lack autophagy do not show changes 
in dendritic complexity, spine density or excitatory inputs. One possible explanation would be a 
difference in the timing of Cre expression and Atg7 knockout between dSPNAtg7cKO and 





lines before postnatal day 7 (Kozorovitskiy et al., 2012, 2015), which is before excitatory 
synaptogenesis occurs in the striatum (Hattori and McGeer, 1973; Tepper et al., 1998). An 
additional confounding variable is Cre-mediated recombination that occurs in the cortex 
dSPNAtg7cKO mice, which could synergize with dSPN loss of autophagy to affect synaptic 
inputs (data not shown). iSPNAtg7cKO mice do not demonstrate Cre-mediated recombination 
outside of the striatum (data not shown). Alternatively, excitatory synaptogenesis onto iSPNs 
may occur in an autophagy-independent manner. For example, if mitochondrial function is 
required for dendritic growth and synapse formation in both SPN subtypes, additional 
mechanisms other than autophagy, such as differences in fission and fusion, may contribute to 
mitochondrial homeostasis in iSPNs. Once the mechanism through which autophagy regulates 
dendritic complexity and synaptogenesis in dSPNs, future studies could compare this process 
with iSPNs and define why loss of autophagy in iSPNs does not affect iSPN synaptogenesis.  
6.4.2 Autophagy Regulates iSPN Intrinsic Excitability via Kir2 Currents. 
In contrast to dSPNs, autophagy was not required for excitatory or inhibitory 
transmission onto iSPNs. Rather, whole cell recordings revealed an intrinsic hyperexcitability in 
iSPNs lacking autophagy that was characterized by a depolarized RMP, elevated input 
resistance, decreased rheobase and left-shifted current response curve.  
SPN intrinsic excitability is tightly regulated by a complement of potassium channels 
(Nisenbaum et al., 1994; Shen et al., 2004, 2005; Wilson and Kawaguchi, 1996). At 
hyperpolarized potentials, the RMP and input resistance of the cell is determined by Kir2 
currents, mediated by the Kir2.1 and Kir2.3 channels (Cazorla et al., 2012; Karschin et al., 1996; 
Shen et al., 2007). SPNs are thought to be depolarized from their resting potential of around -80 





current inactivates, and other potassium currents, such as IA, ID, and IM regulate the number of 
action potentials fired and the spike frequency (Kreitzer, 2009; Wilson and Kawaguchi, 1996). 
The depolarized RMP and increased input resistance around the RMP strongly support a primary 
role for reduced Kir2 currents in the hyperexcitable phenotype of iSPNs lacking autophagy.  
Autophagy has not been previously implicated in the regulation of potassium channels. 
To address the mechanism through which autophagy controls Kir2 channels and, in turn, 
neuronal activity, I conducted experiments in heterologous cells and in vivo in iSPNAtg7cKO 
mice with largely congruent results. I found that ectopically expressed Kir2.1 was localized in an 
LC3+ compartment in MEFs in an Atg5-dependent manner. Treatment with Bafilomycin A1, an 
inhibitor of the lysosomal proton pump which prevents fusion of autophagosomes with 
lysosomes and degradation of autophagic cargo (Yamamoto et al., 1998), increased the number 
of Kir2.1+ LC3+ puncta. This is consistent with previous studies that have shown that Kir2.1 
undergoes lysosomal degradation in mammalian cells (Jansen et al., 2008; Kolb et al., 2014). 
Finally, using the SNAPtag system and a cycloheximide pulse chase assay, I found that the half-
life of Kir2.1 was greatly extended in Atg5KO and Atg7KO MEFs. These data were supported 
by the finding that Kir2.1 and Kir2.3 protein had a higher steady abundance in the striatum of 
iSPNAtg7cKO mice without a change in mRNA expression.  
Autophagy associated genes, such as Atg5 and Atg7, have been proposed to play a role in 
other cellular processes such as LC3-associated phagocytosis, lysosomal exocytosis and 
endocytosis (Subramani and Malhotra, 2013).  Here, I argue that Kir2.1 is a direct substrate of 
autophagy for the following reasons. First, Kir2.1 degradation is deficient in both Atg5KO and 
Atg7KO MEFs. Additional studies in cells lacking other required autophagy proteins such as 





colocalization with LC3+ vesicles and the amount of Kir2.1 in LC3+ vesicles increases in 
response to blockade of autophagosome-lysosome fusion. Finally, Kir2.1 internalization, 
measured with antibody feeding assays, is not affected in Atg5KO MEFs, arguing against a role 
of Atg5 in endocytosis of Kir2.1. Collectively, these data argue that Kir2.1 must pass through an 
autophagy-dependent organelle, presumably an amphisome, before undergoing lysosomal 
degradation.  
 While autophagic degradation is classically initiated when cytosolic proteins are 
sequestered in newly formed autophagosomes or autophagic membranes surround membrane-
bound organelles (Klionsky, 2007), autophagy may be required for Kir2.1 degradation via a 
distinct mechanism. I found that autophagy is not required for Kir2.1 internalization, suggesting 
that autophagy acts at a post-endocytic step. Endosomes fuse with autophagosomes to form 
amphisomes, and this step is required for the degradation of some proteins and the overall 
function of the autophagy and endosomal system (Filimonenko et al., 2010; Hollenbeck, 1993; 
Liang et al., 2008; Rabinowitz et al., 1992; Sanchez-Wandelmer and Reggiori, 2013; Wang et 
al., 2016). I speculate that Kir2.1+ endosomes require fusion with an autophagic intermediate for 
lysosomal delivery. Alternatively, autophagic membranes may form de novo on the surface of 
Kir2.1+ endosomes, leading to the lysosomal degradation of endosomal contents. I cannot 
exclude the possibility that Kir2 channels are endocytosed in early autophagic structures that 
mature into autophagosomes in an Atg5/7-dependent manner for degradation(Ravikumar et al., 
2010; Wu et al., 2016). These potential mechanisms are consistent with data demonstrating a role 
for autophagy in the degradation of other membrane proteins including Notch1 (Wu et al., 2016), 





6.4.3 Selectivity and Cell-type Specificity of the Autophagic Degradation of Kir2 
Channels. 
 Recent work has highlighted a role for selective, as opposed to bulk, autophagy in the 
maintenance of cellular homeostasis. Here, I find that loss of autophagy does not lead to a global 
disruption of membrane or synaptic protein levels, but instead has relatively specific effects on 
Kir2.1 and Kir2.3 channels. For example, the protein level of the voltage-gated potassium 
channel, Kv1.2, which is expressed by both dSPNs and iSPNs (Shen et al., 2004) is not affected 
by loss of autophagy. Furthermore, components of the postsynaptic density, such as PSD95, 
which are degraded by autophagy in excitatory neurons (Nikoletopoulou et al., 2017; Tang et al., 
2014; Yan et al., 2018), are not affected by loss of autophagy in dSPNs or iSPNs. components. 
Finally, AMPA receptors, which can be degraded by autophagy in excitatory neurons (Shehata et 
al., 2012), do not seem to be affected in iSPNs as mEPSC amplitude is unchanged in 
iSPNAtg7cKO mice. An unbiased proteomics approach in iSPNAtg7cKO mice would provide 
additional evidence for the relatively selective degradation of Kir2 channels in iSPNs.  
How might this specificity be achieved? Other forms of selective autophagy depend on 
cargo adapter proteins, which interact with autophagosomal proteins, such as LC3, and specific 
cargo (Svenning and Johansen, 2013; Zaffagnini and Martens, 2016). In some cases, autophagy 
cargo adapters select substrates depending on substrate post-translational modifications, 
providing an additional mechanism that could regulate selectivity (Khaminets et al., 2016). 
Finally, substrates can directly interact with autophagosome proteins via intrinsic LC3-
interacting motifs (Birgisdottir et al., 2013). Future studies should address possible cargo 





Kir2 channels have intrinsic LC3-interacting motifs that could explain why Kir2 channels 
undergo autophagy-dependent degradation but other membrane proteins in iSPNs do not.  
In contrast to iSPNs, Kir2.1 and Kir2.3 abundance and Kir2 currents were unaffected by 
loss of autophagy in dSPNAtg7cKO mice. As Kir2 channels are expressed in both populations of 
SPNs and play equally important roles in dSPN and iSPN physiology (Cazorla et al., 2012; 
Gertler et al., 2008; Lieberman et al., 2018a; Shen et al., 2007), these data suggest that the 
degradation of Kir2 channels by autophagy occurs via cell type-specific mechanisms. This cell-
type specificity could arise from differential expression of cargo adapters, post-translational 
modification of Kir2 channels that target them for autophagic degradation, or increased activity 
of alternative endolysosomal protein degradation pathways that contribute to Kir2 degradation in 
cardiomyocytes (Ambrosini et al., 2014; Jansen et al., 2008; Kolb et al., 2014).  Future work will 
focus on the mechanism that confers cell-type specificity to the autophagic degradation of Kir2 
channels. 
6.4.4 Kir2 Channels are Acetylated and Have Reduced Activity in the Absence of 
Autophagy. 
In previous cases where autophagy regulates membrane proteins, substrate protein levels 
correlate with substrate protein activity (Gao et al., 2018; Shehata et al., 2012; Wu et al., 2016). 
Furthermore, most mutations or manipulations that inhibit lysosomal degradation of Kir2.1 lead 
to increased Kir2 currents (Ambrosini et al., 2014; Jansen et al., 2008; Kolb et al., 2014; 
Varkevisser et al., 2013). In iSPNs, however, loss of autophagy led to increased Kir2 abundance 





 One possible explanation for the inverse correlation between Kir2 protein abundance and 
Kir2 current in iSPNs and MEFs lacking autophagy could be via changes in its trafficking or 
surface residence. However, I found that surface levels of heterologously expressed Kir2.1 were 
elevated in the absence of autophagy, and loss of autophagy was not associated with intracellular 
Kir2.1 inclusions or increased ER localization in MEFs. This was consistent with my subcellular 
fractionation results in striatal tissue from control and iSPNAtg7cKO mice, which displayed no 
difference in the distribution of Kir2 channels but higher levels within each fraction. I thus 
conclude that autophagy is not required for Kir2 trafficking. 
 I, therefore, hypothesized that Kir2 channels were inhibited in the absence of autophagy 
via post-translational modification. I measured the relative levels of ubiquitination and 
acetylation, two PTMs that can target proteins for autophagic degradation (Khaminets et al., 
2016), of Kir2.1 in autophagy deficient cells. I found that acetylation but not ubiquitination of 
Kir2.1 increased in this condition. I found that K334, a conserved lysine that is in the same 
intracellular loop as two other lysines that can be ubiquitinated in Kir2.1 (Ambrosini et al., 2014; 
Ziv et al., 2011), was required for Kir2.1 degradation in wild-type cells. Mutation of K334 to 
arginine, which cannot be acetylated, rescued channel function in the absence of autophagy. 
Finally, changing K334 to an acetylation-mimic glutamine was sufficient to reduce channel 
function in wild-type cells. These results demonstrate that acetylation of Kir2.1 at K334 is 
required for proper channel degradation and function in the absence of autophagy. 
While it is likely not the only acetylated residue on Kir2.1, I found that K334 acetylation 
plays a critical role in channel function and half-life. Although I was unable to biochemically 
isolate acetylated Kir2.1 in wild-type cells, the genetic evidence suggests that Kir2.1 acetylation 





represent a short-lived intermediate and that the channel is deacetylated when it reaches an Atg5-
dependent organelle. Thus, in the absence of autophagy, acetylated Kir2.1 may never colocalize 
with its cognate deacetylase, explaining the elevated level of acetylated Kir2.1 in Atg5KO 
MEFs. Defining the specific acetyltransferase and deacetylase that control Kir2.1 acetylation 
would provide significant insight into how this process is regulated and whether this represents a 
response the physiological stimuli known to regulate Kir2.1 activity in the striatum (Cazorla et 
al., 2012; Lieberman et al., 2018a; Shen et al., 2007; Zhao et al., 2016). 
Although acetylation was initially described as a PTM for histones and other nuclear 
proteins, numerous examples suggest that acetylation may affect the function of non-nuclear 
proteins, including some proteins involved in autophagy (Narita et al., 2019). K334 is located 
within the Kir2 C-terminus, near regions that interact with obligate cofactors such as PIP2 and 
cholesterol, suggesting a possible mechanism for how acetylation at this residue could affect 
channel function. Finally, it is attractive to speculate that Kir2 acetylation at K334 could act as a 
dynamic regulator of Kir2 currents over both long and short timescales: acetylation at K334 
would not only reduce channel activity at the surface but also target Kir2 channels for autophagic 
degradation and affect long-term Kir2 activity.  
6.4.5 Implications for Neuropsychiatric Disorders with Dysfunctional Autophagy. 
I demonstrate, here, that the absence of autophagy in dSPNs or iSPNs results deficits in 
striatal-based behaviors. Our data are consistent with reports of hyperactivity in the open-field 
and reduction of motor learning in multiple animal models with disrupted SPN function (Durieux 
et al., 2012). A disruption of striatal-based learning, hyperactivity and increased stereotypies, as 
seen in dSPNAtg7cKO ¬and iSPNAtg7cKO mice, is also observed in neurodevelopmental 





autophagy-associated genes are risk factors for the development of ASDs and reduced 
autophagic function is observed in human post-mortem tissue from ASD cases and in mouse 
models of the disease, suggesting that changes in autophagic function in the striatum in addition 
to other brain regions may contribute to the pathophysiology of ASDs (Lieberman et al., 2018b; 
Poultney et al., 2013; Tang et al., 2014; Yan et al., 2018). Identifying the cell type-specific 
effects of loss of autophagy in distinct neuronal subtypes may permit targeted development of 
therapeutics that act downstream of the autophagy machinery to correct specific neural circuit 
deficits and avoid undesired effects of non-specific autophagic activation.   
6.5 Materials and Methods 
MATERIALS AND METHODS 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Rabbit anti-Red fluorescent protein polyclonal Rockland Cat # 600-401-379 
Rabbit anti-DARPP32 monoclonal Cell Signaling 
Technology 
Cat # 2306S 
Mouse anti-beta actin monoclonal Novus Biologicals Cat # NB600-501 
Mouse anti-Kir2.1 monoclonal Antibodies 
Incorporated 
Item # 73-210 
RRID:AB_110007
20 
Mouse anti-Kir2.3 monoclonal Antibodies 
Incorporated 
Item # 75-069 
RRID:AB_213074
2 
Mouse anti-Kv1.2 monoclonal Antibodies 
Incorporated 
Item # 75-008 
RRID:AB_229631
3 
Rabbit anti-PSD95 polyclonal Abcam Cat # Ab18258 
Guinea pig anti p62 polyclonal American Research 
Products 
Cat # 03-GP62-C 
Rabbit anti p62 polyclonal MBL Cat # PM045 
Rabbit anti LC3B polyclonal Novus Biologicals Cat # NB600-1384 
Chicken anti GFP polyclonal Abcam Cat # Ab13970 
Rat anti Lamp1 monoclonal Iowa Hybridoma 
Bank 
Cat # 1D4B 





Mouse anti ubiquitin antibody monoclonal VU-1 LifeSensors  Cat # VU101 
Mouse anti-acetyl-lysine monoclonal, clone 4G12 Millipore Cat # 05-515 
Mouse Anti-Flag M2 monoclonal Sigma Cat # F1804 
Rabbit anti-HA polyclonal Abcam Cat # ab9110 
Mouse anti-NeuN, monoclonal clone A60 Millipore Cat # MAB377 
Rabbit Anti-Atg7 (D12B11) monoclonal Cell Signaling 
Technology 
Cat # 8558 
Mouse anti-Tubulin (TU-01) Invitrogen Cat # 13-8000 
Pierce Protein A/G Magnetic Beads Thermo Cat # 88802 
Goat anti Guinea Pig IgG (H+L) Secondary 
antibody, Alexa 488 
Invitrogen Cat # A-11073 
Goat anti Guinea Pig IgG (H+L) Secondary 
antibody, Alexa 647 
Invitrogen Cat # A-24150 
Donkey anti-Rabbit IgG (H+L) Secondary 
Antibody, Alexa 488 
Invitrogen Cat # A-21206 
Donkey anti-Rabbit IgG (H+L) Secondary 
Antibody, Alexa 594 
Invitrogen Cat # A-21207 
Goat anti-Mouse IgG1 (H+L) Secondary Antibody, 
Alexa 488 
Invitrogen Cat # A-21121 
Donkey anti-Mouse IgG1 (H+L) Secondary 
Antibody, Alexa 594 
Invitrogen Cat # A-21125 
Goat anti-Chicken IgY (H+L) Secondary Antibody, 
Alexa 488 
Invitrogen Cat # A-11039 
Goat anti-Rat IgG1 (H+L) Secondary Antibody, 
Alexa 647 
Invitrogen Cat # A-21248 
Donkey anti-Rabbit IgG (H+L) Secondary IRDye 
680LT 
LI-COR P/N 925-68023 
Streptavidin, Alexa 488 conjugate Invitrogen S11223 








Chemicals, Peptides, and Recombinant Proteins   
Bafilomycin A1 Tocris Biosciences Cat # 1334 
Tetrodotoxin citrate Tocris Biosciences Cat # 1069/1 
Picrotoxin Tocris Biosciences Cat # 1128/1G 
SNAP-Cell 505-Star New England 
Biolabs 
Cat # S9103S 
SNAP-Cell TMR-Star New England 
Biolabs 
Cat # S9105S 
Neurobiotin tracer Vector Laboratories Cat # SP-1120 
XhoI New England 
Biolabs 
Cat # R0146S 
BamHI-HF New England 
Biolabs 





HindIII-HF New England 
Biolabs 
Cat # R3104S 
DpnI New England 
Biolabs 
Cat # R0176S 
Herculase II fusion DNA polymerase Agilent 
Technologies 
Cat # 600675 
dNTP mix ThermoFisher Cat # R0191 
Heat inactivated Fetal Bovine Serum ThermoFisher Cat # 10082147 
DMEM ThermoFisher Cat # 11966025 
Antibiotic-Antimycotic (100X) ThermoFisher Cat # 15240062 
TrypLE ThermoFisher Cat # 12604054 
Trichostatin A Tocris Biosciences Cat # 1406 
Nicotinamide Tocris Biosciences Cat # 4106 
N-ethylmaleimide Sigma Cat # E3876 
PR-619 Sigma Cat # SML0430 
Halt™ Protease Inhibitor Cocktail (100X) ThermoFisher Cat # 78430 
Bacterial and Virus Strains   
E. coli DH5a ThermoFisher Cat # 18265017 
AAVDJ-CMV-DIO-Kir2.1-t2A-ZsGreen Stanford Viral 
Vector Core 
AAV61 (Rothwell 
et al., 2014) 
AAV2-EF1a-DIO-mCherry (3.2 x 1012 viral 
genomes/mL) 
UNC Viral Vector 
Core 
 
AAVDJ-hSyn-FLEX-mmAtg7-t2A-ZsGreen (1.7 x 
1013 genome copies/mL) 
Vector BioLabs This study 
Critical Commercial Assays   
BCA protein assay kit ThermoFisher Cat # 23225 
RNAScope Multiplex Fluorescent Reagent Advanced Cell 
Diagnostics 
Cat # 320850 
RNAScope probe: Mm-Kcnj2 (Kir2.1) Advanced Cell 
Diagnostics 
Cat # 476261 
RNAScope probe: Mm-Kcnj4 (Kir2.3) Advanced Cell 
Diagnostics 
Cat # 525181-C3 
Immobilon Western Chemiluminescent HRP 
Substrate  
Millipore Can # 
WBKLS0500 
Experimental Models: Organisms/Strains   
Mouse: B6.Cg-Tg(Drd1a-tdTomato)6Calak/J Jackson Laboratories RRID: 
IMSR_JAX:01620
4 
Mouse: WT: C57BL/6J Jackson Laboratories RRID: 
IMSR_JAX:00066
4 
Mouse: Tg(Adora2a-cre)KG139Gsat MMMRC RRID:MMRRC_0
31168-UCD 






Mouse: Atg7tm1.1Tchi/Atg7tm1.1Tchi Gift of Masaaki 
Komatsu; (Komatsu 
et al., 2005) 
RRID:MGI:35901
36 
Mouse: 129S1/Sv-Hprttm1(CAG-cre)Mnn/J (Tang et al., 2002) RRID:IMSR_JAX:
004302 
Cell Line: Atg5-/- MEF cell line Gift of Ana Maria 
Cuervo; (Kuma et 
al., 2004) 
RRID:CVCL_0J75 
Cell Line: Atg5+/+ MEF cell line Gift of Ana Maria 
Cuervo; (Kuma et 
al., 2004) 
 
Software and Algorithms   
Igor Wavemetrics RRID:SCR_00032
5 
pClamp Molecular Devices RRID:SCR_01132
3 









METHODS AND MATERIALS 
Experimental Model and Subject Details 
Animals 
A2A-cre (KG139) and D1-cre (ey262) were obtained from the Mutant Mouse Resource and 
Research Center (MMRRC). Mice were backcrossed onto C57Bl6J mice from Jackson 
Laboratories (Bar Harbor, ME). Atg7Fl/Fl mice were a gift of Masaaki Komatsu (Komatsu et al., 
2005) and backcrossed with C57Bl6J background. D1-tomato mice (B6.Cg-Tg(Drd1a-
tdTomato)6Calak/J) were obtained from Jackson Laboratories. iSPNCtrl (Atg7Fl/Fl) and iSPNAtg7cKO 
experimental mice were obtained as followed. A2Acre hemizygous mice were crossed with 
Atg7Fl/Fl mice. A2Acre Atg7Fl/wt offspring were crossed with Atg7Fl/Fl mice, yielding experimental 





Atg7Fl/wt or Atg7Fl/Fl) harboring a single D1-tomato allele was used. The D1-tomato and the 
A2Acre alleles were always maintained in hemizygosity. The same strategy was used to generate 
dSPNCtrl (Atg7Fl/Fl) and dSPNAtg7cKO (D1cre Atg7Fl/Fl) mice. For viral injections, some crosses 
included A2Acre Atg7Fl/wt, D1cre Atg7Fl/wt with Atg7Fl/wt to generate A2Acre Atg7wt/wt (or D1cre 
Atg7wt/wt) and A2Acre Atg7Fl/Fl (or D1cre Atg7Fl/Fl) littermates. Mice were housed on a 12:12 hour 
light:dark cycle and provided with food and water ad libitum. Mice were genotyped using 
Transnetyx genotyping services (Memphis, TN). Pups were weaned on postnatal day 18-21 into 
same sex groups of 3-5 mice.  All subjects were randomly assigned to groups. All experiments 
were conducted according to NIH guidelines and approved by the Institutional Animal Care and 
Use Committees of Columbia University and the New York State Psychiatric Institute. 
Generation of primary Atg7WT and Atg7KO MEFs 
 
To generate Atg7 wildtype and knockout MEFs, male C57BL/6 mice homozygous for the 
conditional Atg7Fl allele (Komatsu et al., 2005), were crossed to female mice expressing Cre 
recombinase in the X-linked Hprt gene (Tang et al., 2002), permitting excision of the loxP-
flanked exon 14 of Atg7 at the zygote or early cleavage stage in progeny. Mice in the F1 
generation (Atg7+/-) were intercrossed to generate pregnant dams with F2 embryos for 
experimental isolation.  
At E14.5, embryos were collected from deeply anesthetized pregnant dams. Uterine horns 
were dissected and rinsed in ice-cold Hank’s buffered saline solution (HBSS), and embryos were 
individually separated into HBSS. The liver, heart, and head were removed from the embryos 
and collected for genomic DNA extraction. The remaining tissue was incubated in 0.25% trypsin 





pipettes and diluted in MEF media: DMEM (Thermo Fisher) with 10% FBS (Thermo Fisher), 
0.1mM beta-mercaptoethanol (Sigma), and 1x Antibiotic-Antimycotic (Thermo Fisher). Cells 
were filtered through a 100-micron sieve and plated in MEF media. After plating, genotypes 
were confirmed and cells were collected for Western blot analysis. 
Method Details 
Behavior 
Cohorts of iSPNCtrl and iSPNAtg7cKO or dSPNCtrl and dSPNAtg7cKO mice were assembled 
from 2-4 litters of the cross described above born within 3 weeks of each other. Behavioral 
experiments were conducted on these cohorts between 3-5 months of age. A similar number of 
male and female mice was used in behavioral experiments. Data were combined for Figure 1 as 
no interaction between sex and genotype was observed. See Table S1 for behavioral data split by 
sex. All behavioral results were combined from at least two independent cohorts of mice. Mice in 
these cohorts were handled weekly by the experimenter and weighed at these times. Two 
dSPNAtg7cKO mice were excluded from the behavioral analysis due to observed handling-induced 
seizures.  
Open field 
Each mouse is gently placed in the center of a clear Plexiglas arena (27.31 x 27.31 x 20.32 
cm, Med Associates ENV-510) lit with dim light (~10 lux), and is allowed to ambulate freely for 
50 minutes. Infrared (IR) beams embedded along the X, Y, Z axes of the arena automatically track 
distance moved, horizontal movement, vertical movement, stereotypies, and time spent in center 
zone. At the end of the test, the mouse is returned to the home cage and the arena is cleaned with 






The accelerating rotarod test is widely to evaluate the motor coordination and motor 
learning in rodents. Two to four experimental mice are placed on the still rotarod (Ugo Basile) in 
one lane of the rotating drum (3 cm in diameter, textured to avoid slips) for two minutes. The mice 
are returned to the homecage for thirty minutes. Mice are then returned to the rotarod, rotating at 
a constant speed for 5 rpm, for two minutes, followed by return to the homecage for thirty minutes. 
For the first experimental session (Trial 1), experimental mice are placed on the rotating drum. 
The rotating speed of the Rotarod (Ugo Basile) is set at 5 rpm. Once all mice are steady, the rotation 
speed is gradually increase from 5 to 40 rpm over a 5 minutes period. Latency to fall is recorded 
automatically when the animal lands on the sensing platform below each lane or when the mouse 
grabbed on to the drum and executed a full revolution without running. To avoid injury, a cut-off 
latency of 300s is applied to each trial. Animals were returned to the home cage for 30 minutes 
followed by two additional trials. The drum and the platform are wiped clean with paper towel 
moistened with 70% ethanol and let dry.  
Home cage repetitive behaviors 
Repetitive behaviors and stereotypies such as excessive self-grooming, circling, jumping, 
back flipping were evaluated in a simple test using clean mouse cages as described in a recent 
study (Yang et al., 2015). Each subject mouse is placed in a clean home cage, allowed to habituate 
for 30 minutes and monitored for an additional 30 min. The cage bottom was covered with a thin 
layer of clean bedding. The cage is with a metal wire bar lid as some repetitive back flipping 
involve the use of the metal lid. Occurrences of self-grooming were quantified for one minute 






D1cre Atg7wt/wt,  D1cre Atg7Fl/Fl,  A2Acre Atg7wt/wt or A2Acre Atg7Fl/Fl mice (2-3 months 
old littermates of both genders) were anesthestized with 5% isoflurane. Animals were transferred 
onto a Kopf Stereotax and maintained under isoflurane anesthesia (1-2%). Hair was removed, the 
scalp was sterilized using chlorhexidine solution and an incision was made. The coordinates of 
Bregma and Lambda were determined. Virus was injected at AP +0.8, ML, -1.6, and DV -2.8 from 
the dura. A small hole was drilled into the skull and 230 nL of virus (see above table for viral 
titers) was injected through a glass pipet using a Nanoject 2000 (Drummond Scientific; 50 pulses 
of 4.6 nL). The glass pipet was slowly withdrawn after 5 minutes. The skull was closed using 
vicryl sutures. Animals were housed for 3-4 weeks before being sacrificed for electrophysiology. 
Cloning/molecular biology 
The Kir2.1 coding sequence was PCR amplified from pAAV-mmKir2.1 (Gift from C. 
Kellendonk) into FUGW-VAMP2-Flag-SNAP (Sheehan et al., 2016) using the XhoI-BamHI sites 
(Tables 6.4-5). Kir2.1-ExtHA was synthesized by Genewiz with the HA tag inserted at amino acid 
114 (Chen et al., 2002) and subcloned into FUGW-mmKir2.1-FLAG-SNAP. For cell culture 
electrophysiology experiments, mmKir2.1 CDS was PCR amplified from FUGW-mmKir2.1-
FLAG-SNAP into the HindIII-BamHI sites of pcDNA2.1-eGFP (Addgene 13031).  
Site-directed mutagenesis of FUGW-mmKir2.1-FLAG-SNAP or FUGW-mmKir2.1-
ExtHA-FLAG-SNAP was conducted using Herculase II polymerase and primer pairs containing 
the desired mutation according to the manufacturer’s instructions (See Table 6.4). The PCR 





transformed into DH5α competent cells. Mutated sequences were confirmed by Sanger sequencing 
(Genewiz or Eton Biosciences).  
Plasmid preps for transfection were generated using Qiagen midi or maxiprep kits 
following manufacturer instructions.  
Cell culture 
Atg5WT and Atg5KO MEFs were obtained from Ana Maria Cuervo (Albert Einstein College 
of Medicine, New York). Cells were cultured using standard techniques in Dulbecco’s modified 
Eagle medium (DMEM; Gibco) supplemented with 10% fetal bovine serum (Gibco) and 
antibiotic-antimycotic mix (Gibco). Cells were not passaged more than ten times. Cells were 
incubated at 37 ºC in 5% CO2.  
Transfection 
For experiments, cells were plated and allowed to settle for 1-2 days. Cells were then 
transfected with Calfectin and plasmid DNA prepared with Qiagen Maxiprep or Midiprep kits 




Animals of either gender in Figure 6.3 and 6.4 were 4-6 weeks old at the time of 
experiment. Animals in Figure 6.7 were 3-4 months old. No interaction between sex and genotype 
was observed in electrophysiological or morphological analysis. Acute slices were generated as 





anesthesia. Brains were removed and submerged in ice-cold cutting solution (in mM): 10 NaCl, 
2.5 KCl, 25 NaHCO3, 0.5 CaCl2, 7 MgCl2, 1.25 NaH2PO4, 180 sucrose, 10 glucose bubbled with 
95% O2/5% CO2 to pH 7.4. The cerebellum was removed and the brain was mounted on the caudal 
surface on a vibratome. 250 µm coronal sections including the striatum were collected.  
Slices were allowed to recover at 34 ºC for 30 min in artificial cerebrospinal fluid (ACSF; 
in mM): 125 NaCl, 2.5 KCl, 25 NaHCO3, 2 CaCl2, 1 MgCl2, 1.25 NaH2PO4 and 10 glucose bubbled 
with 95% O2/5% CO2 to pH 7.4. Slices were then maintained at room temperature throughout the 
remainder of the experiment.  
Slices were transferred to a recording chamber under constant perfusion with carbogenated 
ACSF at 1.5-2 mL/min. Cells in the dorsal striatum were identified using a 40X water immersion 
objective and IR/DIC optics. D1-tomato, mCherry or GFP fluorescence was observed as indicated. 
Liquid junction potential was not corrected. Data were digitized at 10 kHz and filtered at 5 kHz. 
Signals were acquired on an Axon Instruments Axopatch 200B, digitized on a Digidata 1440A 
(Axon Instruments). All recordings were made within 6 hours of slice preparation.  
For synaptic recordings (in voltage clamp), whole cell recordings were established with 
glass pipettes (3-6 MΩ) filled with internal solution of (in mM): 120 CsMeSO3, 5 NaCl, 10 
HEPES, 1.1 EGTA, 4 MgATP, 0.3 NaGTP, 10 TEA, 1 mg/mL Qx314 Bromide, pH 7.25. Once 
the whole-cell configuration was established, the internal solution was allowed to diffuse into the 
cell for at least 10 minutes. Pipette capacitance was compensated. Series resistance was 
continuously monitored and cells were excluded if series resistance changed by more than 25% or 
pipette capacitance transients changed by more than 20%. TTX (1 µM) was perfused in the ACSF. 
mEPSCs were recorded at -70 mV for a 2-4 minute epoch. Cells were then held at 0 mV for a 2-4 





has previously been reported by our lab for amperometric quantal analysis (Mosharov and Sulzer, 
2005). Traces were imported to Igor and converted from .abf files. Traces were “smoothed” using 
the plugin. mEPSC traces were inverted (as the plugin detects positive-going peaks) and peaks 
were detected using a threshold of 4 standard deviations above the noise. Median interevent 
interval was used to calculate the event frequency and median peak amplitude is presented. For 
mIPSC traces, a threshold of 3 standard deviations was set. Settings were determined following 
manual inspection of a subset of records (from both control and cKO neurons) and then kept the 
same for final analysis of all traces. E/I ratio is the fraction of mEPSC frequency and mIPSC 
frequency.  
The input/output curve was determined in presence of 25 µM picrotoxin. A concentric 
bipolar tungsten electrode (Warner Instruments) was placed in the striatum greater than 100 µm 
from the cell. Cells were stimulated with single pulses (100 µs) at 50-450 µA intensity. The 
stimulating electrode was connected to an AMPI (Jerusalem, Israel) Isoflex and controlled with a 
Master 8 (AMPI). AMPA-mediated currents were recorded at a holding potential of -70 mV.  
For current clamp recordings, glass pipets were filled with (in mM): 115 potassium 
gluconate, 20 KCl, 20 HEPES, 1 MgCl2, 2 MgATP, 0.2 NaGTP adjusted to pH 7.25 with KOH, 
osmolarity 285 mOsm. ACSF contained 1.5 mM CaCl2 instead of 2 mM CaCl2 to reduce 
contribution of calcium currents to Kir2 current measurements (Lieberman et al., 2018a). 
Excitability parameters and Kir2 currents were measured as described in (Lieberman et al., 2018a). 
For current density measurements, the barium sensitive current (0.1 mM BaCl2) was normalized 







MEFs were cultured as described above. For electrophysiology experiments cells were 
cultured on 15 mm diameter glass coverslips placed in 35 mm diameter tissue culture dishes. Cells 
were transfected 36-48 hours before the experiment as described above. At the time of the 
experiment, coverslips were washed 3 times in recording saline (in mM): 135 NaCl, 4.8 KCl, 1.8 
CaCl2, 1 MgCl2, 10 Glucose, 5 HEPES, pH 7.4 (Ambrosini et al., 2014). Cells were identified 
using IR/DIC optics and fluorescence was confirmed. In recordings in Figure 6.11, cells were 
transfected with Kir2.1-Flag-SNAP and labelled 1 hour prior to recording with SNAPcell TMR 
Star as described below. Because of the low intensity of the TMR star fluorescence, we subcloned 
Kir2.1 into pcDNA-eGFP as described above to have native GFP fluorescence for recordings in 
Figure 6.13. No difference in maximal Kir2 amplitude between cells transfected with Kir2.1-Flag-
SNAP compared to Kir2.1-eGFP was found. Glass pipets (2-4 MΩ) were filled with (in mM): 115 
potassium gluconate, 20 KCl, 20 HEPES, 1 MgCl2, 2 MgATP, 0.2 NaGTP adjusted to pH 7.25 
with KOH, osmolarity 285 mOsm. After the whole cell configuration was established, cells were 
voltage clamped at -60 mV and currents were recorded using the same protocol as used for SPNs 
above (Lieberman et al., 2018a).   
Neuronal fills/spine counting 
Dendritic reconstructions were obtained and analyzed essentially as described in 
(Lieberman et al., 2018a). For dendritic reconstructions, neurobiotin (1mg/mL, Vector 
Laboratories) was added to the internal solution. Once the whole cell configuration was 
established, the neurobiotin was allowed to diffuse into the recorded cell for 15 minutes. The patch 
pipette was then carefully withdrawn. The slice was removed from the recording chamber and 
fixed overnight in 4% PFA in 0.1M phosphate buffer (PB), pH7.4. Only one cell was filled per 





conjugated streptavidin (1:200, ThemoFisher) in 0.6% TritonX-100 in TBS. Slices were then 
washed in TBS and mounted on slides. Slices were allowed to dry overnight in the dark before 
being coverslipped with Fluoromount-G containing DAPI. Slides were imaged on a Leica SP5 
confocal microscope in system optimized Z-stacks using a 20X objective. Segments of the 
dendritic tree approximately 50 microns from the soma were subsequently imaged with a 63/1.4x 
oil objective with system optimized z stacks to permit analysis of spine density.  
Dendritic trees were traced using the simple neurite tracer plugin in ImageJ. Traced 
neurites were collapsed into a max projection and analyzed using the Sholl analysis plugin. 
Dendritic spine density was manually determined from max projections of z-stacks obtained using 
the 63x objective. Dendritic protrusions defined by being 0.5-2 µm long with a shaft and head 
were counted from at least three dendritic segments of 20-50 µm per cell. The number of spines 
per micron were then averaged for each cell. At least 3 cells were analyzed per animal. Data were 
combined from 3 animals.  
In vivo biochemistry 
Whole striatal lysates were generated by acute cervical dislocation and decapitation. The 
brain was rapidly removed and the striatum was removed as described in (Lieberman et al., 2018a). 
Striata were sonicated in RIPA buffer containing 1X protease inhibitor cocktail (Pierce). Protein 
concentration was determined using the BCA kit and lysates were diluted in sample buffer. Lysates 
were stored at -80ºC until analysis. 
The synaptosome preparation technique was adapted from a recent study (Bermejo et al., 
2014). Two striata from a single mouse were removed as above and dounce homogenized in 1 mL 





Homogenized tissue (TH, total homogenate) was spun at 1000xg for 10 minutes. The supernatant 
was collected (PNS; post-nuclear supernatant) and spun at 10000xg for 15 minutes. The 
supernatant was collected and labeled S2. The pellet (Crude synaptosomal pellet; P2) then 
underwent hypotonic lysis by resuspending the pellet in 1 mL ddH2O followed by 4 strokes of 
dounce homogenization. Four µL of 1 M HEPES pH7.4 was added and the sample was rotated for 
30 minutes. Until this point, all centrifugation steps were completed on a tabletop ultracentrifuge. 
The sample was then spun at 25000 x g for 20 min in a fixed angle S140-AT rotor in a Sorvall 
ultracentrifuge. The supernatant (S3) was collected. The pellet was resuspended in 320 mM 
Sucrose, 4 mM HEPES pH7.4 and layered on top of a discontinuous sucrose gradient (0.8M, 1.0M, 
1.2M). The sample was then spun 150000xg for 2 hours. The 1.0M, 1.2M interface was collected 
and diluted to 320 mM sucrose, 4 mM HEPES pH7.4. The samples was then spun at 200000 x g 
for 30 minutes to collect the synaptic plasma membranes (SPM). Aliquots were collected from 
each fraction described during the procedure. Equivalent protein concentrations of each fraction 
were used for Western blot analysis.  
For the optiprep (iodixanol) gradient, samples were prepared using a procedure modified 
from Optiprep Application Sheet S62). Striata were dissected as for synaptosomal preparation and 
dounce homogenized in 250 mM Sucrose, 1 mM EDTA, 20 mM HEPES pH7.4. This homogenate 
was spun for 10 minutes at 1000xg. The supernatant was spun on an S80AT3 fixed-angle rotor at 
100000xg for 1 hour. The pellet was resuspended in 30% iodixanol, 250 mM Sucrose, 1 mM 
EDTA, 20 mM HEPES pH7.4. On top of the pellet, the following layers were loaded in equal 
volumes: 30%, 25%, 17%, 10%, 2.5% and spun at 165000xg for 3.5 hours. 100 µL fractions were 





Preparations were completed for the specified number of adult mice (3-4 months old, 
littermate and gender-matched iSPNCtrl and iSPNAtg7cKO) in parallel. For the total lysate 
experiment, samples were collected from 3 separate cohorts and combined for final analysis. 
Perfusion fixation 
Perfusion fixation was conducted as described (Lieberman et al., 2018a). Animals were 
deeply anesthesized with an intraperitoneal injection of euthasol. Following loss of the righting 
and toe-pinch reflex, animals were transcardially perfused with 10-20 mL 0.9% NaCl followed by 
50 mL of freshly prepared 4% paraformaldehyde in 0.1M PB, pH 7.4. Brains were removed and 
post-fixed in 4%PFA overnight at 4ºC. Brains were subsequently washed with PBS and sectioned 
in 30-50 µm sections on a Leica vibratome. Sections were stored at -20 ºC in cryoprotective 
solution (30% ethylene glycol, 30% glycerol, 0.1M PB, pH7.4) until staining.  
Immunohistochemistry 
Immunohistochemical analysis was performed as described (Lieberman et al., 2018a). 
Briefly, sections were removed from cryoprotectant solution and washed 3 times in TBS. Sections 
were then blocked in 10% normal donkey serum (NDS), 0.1% Triton-X 100, TBS for 1 hour at 
room temperature. Sections were then transferred to primary antibody solution in 2% NDS, 0.1% 
Triton-X 100, TBS overnight at 4 ºC. The next day, sections were washed 3 times in TBS and 
subsequently incubated in secondary antibodies in 2% NDS, 0.1% Triton-X 100, TBS at room 
temperature for 1 hour. Alexafluor conjugated secondary antibodies were used at a concentration 
of 1:500. Sections were then washed in TBS and mounted on slides, coversliped with 






Brain sections were removed from cryoprotectant and washed in TBS. Sections were then 
mounted on charged Superfrost slides and allowed to dry overnight. A border was made with a 
PAP pen around the sections. Sterile water was dropped onto the slide and allowed to sit twice for 
two minutes. Pretreat IV was dropped onto the slide and slides were incubated in a humidified 
oven at 40ºC for 30 minutes. Sections were rinsed twice for 2 minutes each in sterile water. 
Premixed probes were added to the slide and allowed to incubate for 2 hours at 40ºC. Each section 
received probes against either Kir2.1 or Kir2.3. A custom probe in the C3 channel was developed 
by Advanced Cell Diagnostics (Newark, CA) for Kir2.3. A commercially available probe in the 
C1 channel was used for Kir2.1. Signals were amplified using the RNAScope Fluorescence 
Multiplex Kit. Sections were then immunohistochemically labeled for DARPP32 and p62 as 
described above.  
Cell culture lysates 
Cells were grown in 10 cm diameter dishes. Dishes were rinsed twice with PBS. RIPA 
buffer containing 1X protease inhibitors, deubiquitinase inhibitors (5 mM N-ethylmaleimide, 50 
µM PR619) and deacetylase inhibitors (200 nM Trichostatin A and 5 mM Nicotinamide) was 
added to the plate. Dishes were rotated at 4ºC for 5 min. Cells were scraped off of the dish, 
sonicated and allowed to sit on ice for 1 hour. Lysates were then spun at 10000xg for 10 min. The 
supernatant was saved. Protein concertation was determined.  
Cycloheximide pulse chase 
Cells were plated and transfected in a 6-well plate. 36-48 hours after transfection with 
FUGW-Kir2.1-FLAG-SNAP, cells were treated with cycloheximide (0.1mg/mL) for the specified 






Cells were transfected with FUGW-Kir2.1-extHA-FLAG-SNAP or FUGW-Kir2.1-
K334R-FLAG-SNAP 36-48 hours before lysis. Cell lysates were generated as above. All steps 
were performed at 4ºC. For immunoprecipitation (IP), equal amounts of protein (0.5-1.0 mg) of 
lysate was precleared with Protein A/G magnetic beads (Thermo) for 1 hour. Beads were removed 
with a strong magnet. Four µg of rabbit anti-HA (Abcam) were added to the cleared supernatant 
and rotated overnight. The next day, 25 µL of Protein A/G magnetic beads were added and samples 
were rotated for one hour. Beads were collected, washed once in one volume of RIPA buffer, three 
times in one volume of RIPA buffer containing 500 mM NaCl (instead of 150 mM NaCl) and one 
final time in RIPA Buffer. Beads were then lysed in 1X sample buffer. The entire eluted volume 
of the IP was used for a gel.  
Western Blot analysis 
10% or 12% polyacrylamide homemade gels were prepared as described (Santini et al., 
2007). For some experiments, 4-12% gradient NuPage gels were used. Protein was transferred on 
PVDF membrane (pore size 0.2 µm; Immobilon-Fl). Membranes were blocked in 5% non-fat milk 
(Biorad) in TBS-T (TBS + 0.1% Tween-20) at room temperature for one hour. Membranes were 
incubated overnight at 4º in primary antibody in 5% bovine serum albumin in TBS-T. Antibody 
concentrations are specified in Table S4. Blots were then washed three times in TBS-T, followed 
by incubation in secondary antibody in 5% milk TBS-T for one hour at room temperature. Blots 
were washed three more times in TBS-T.  
Blots were developed as follows: Blots for PSD-95 and KV1.2 were imaged using a LICOR 





enhanced chemiluminescence solutions (Millipore) and imaged on an Azure Biosystems C600 
system.  
For some experiments, blots were stripped using 2% SDS, 62 mM Tris pH6.8, 0.8% β-
mercaptoethanol at 50-55ºC for 30 min. Blots were then rinsed in ddH2O and washed with TBS-T 
as described in (Kanner et al., 2017).  
Blots developed using the ECL technique were analyzed in ImageJ using standard routines. 
Blots developed using the LICOR Odyssey were analyzed in ImageStudio Lite. 
Snap labeling/immune/quantification 
For YFP-LC3 colocalization with Kir2.1, FUGW-Kir2.1-FLAG-SNAP and an expression 
vector expressing YFP-LC3 were co-transfected. Some cells were treated with Bafilomycin (100 
nM) or DMSO vehicle control (DMSO concentration 0.1%) for 2 hours.  
SNAPcell ligands were purchased from New England Biolabs, dissolved to 1 mM in 
DMSO and frozen in aliquots. Transfected cells (with FUGW-Kir2.1-FLAG-SNAP or specified 
mutants) on glass coverslips were placed in a 24 well plate in complete media. The media was 
replaced with complete media containing 1 µM SNAPcell ligand and incubated at 37 ºC in 5% 
CO2 for 30 minutes. Coverslips were then washed 3 times in PBS and returned to the incubator in 
fresh complete media (without SNAPcell ligand) for 30 minutes. Complete media was replaced 
again. This was considered time = 0 minutes. At the specified time, cells were removed from the 






Cells were fixed as described (Lieberman et al., 2017). Cells on glass coverslips were 
removed from the incubator and washed 3 times in PBS. Cells were then fixed in 4% 
paraformaldehyde (Electron Microscopy Sciences) diluted in 5% Sucrose and 1X PBS for 5 
minutes at room temperature. Coverslips were then washed in PBS and incubated in pre-chilled 
methanol and stored at -20 ºC until staining.  
Coverslips were removed and washed in PBS three times. Coverslips were then blocked in 
10% Normal Donkey serum in PBS with 0.1% triton x-100 for one hour at room temperature. 
Coverslips were then incubated for one hour at room temperature in primary antibody (See Table 
S4) in 2% NDS, PBS, 0.1% Triton X-100. Coverslips were then washed 3 times in PBS and 
incubated in secondary antibody diluted in 2% NDS, PBS, 0.1% Triton X-100 for one hour at room 
temperature. Coverslips were then washed in PBS and mounted on glass slides with Fluoromount-
G containing DAPI.   
For experiments that quantified colocalization of Kir2.1 signal with another organelle marker, 
images were acquired using a confocal microscope (Leica SP5 system) in a single mid-nuclear 
plane using a 63/1.4x oil objective.  
Surface labeling/internalization 
For determining the level of Kir2.1 on the cell surface in cell culture, cells were grown and 
transfected as described above with FUGW-Kir2.1-extHA-FLAG-SNAP. Cells were then fixed in 
4% PFA, 5% Sucrose, 1X PBS for 10 minutes at room temperature. Coverslips were washed in 
PBS and then blocked in 10% NDS, PBS (without triton) for one hour at room temperature. 
Coverslips were then incubated in Rabbit anti HA (Abcam) in 2% NDS, PBS (no triton) for one 





permeabilized with 10% NDS, PBS and 0.1% Triton X-100 for one hour at room temperature. 
They were then transferred to primary antibody solution containing Ms anti FLAG M2 (Sigma) 
2% NDS, PBS, 0.1% Triton X-100 for one hour at room temperature. Coverslips were then washed 
in PBS and transferred to secondary antibody in 2% NDS, PBS, 0.1% Triton X-100 for one hour 
followed by washes and mounting.  
For quantifying Kir2.1 internalization, live, transfected cells on glass coverslips were 
washed in ice cold Earl’s balanced salt solution (EBSS). Coverslips were then labeled with Rabbit 
anti HA antibody (10 µg/mL) in 5% BSA in EBSS for 15 minutes at 4 ºC. Cells were then washed 
2x in ice-cold 5% BSA/EBSS, 1x in PBS and into complete media. This was considered time = 0 
minutes. Coverslips were fixed at the specified time as described for surface labeling. Coverslips 
were blocked for thirty minutes in 10% NDS, PBS followed by incubation in AlexaFluor 
conjugated anti Rabbit secondary antibody. Cells were then blocked and permeabilized for staining 
against the FLAG tag as described above.  
Epifluorescence imaging 
For quantification of SNAPcell fluorescence, surface labeling and surface internalization, 
cells were imaged following staining on an Olympus IX81 inverted fluorescence microscope 
using a 63x/1.35 oil objective (Olympus) and the corresponding fluorescence fulter set. Images 
were captured using an Orca Flash 4 V3 camera (Hamamatsu) and MetaMorph software 
(Molecular Devices). For all experiments, specified fluorescence (ie SNAPcell ligand, surface 
signal) was normalized to FLAG fluorescence intensity (total Kir2.1 protein) for each cell to 
control for variations in the level of Kir2.1 expression following transient transfection. 
Exposures were set to ensure that no pixels were saturated. The exposure times were constant for 





20 cells from 3-4 fields were imaged. In all experiments, data was combined from at least three 
independent replicates, unless otherwise specified.  
Image analysis 
Brain slice 
NeuN, p62, or D1-tomato -positive cells were manually counted in single Z-planes of 500 
µm2 containing the dorsal striatum. Cells were counted from 4-8 images per animal. RNAScope 
puncta were manually counted in single Z-planes. The number of cells counted are listed in the 
Figure legend and arise from sections from at least three mice. All counting was conducted by an 
observer blind to genotype. 
Cell culture 
For analysis of colocalization of Kir2.1 puncta with organelle markers (YFP-LC3, 
Lamp1, or EEA1), a mask was created using a multiple threshold analysis plugin on ImageJ 
(Borgkvist et al., 2015) over YFP-LC3, Lamp1, or EEA1 puncta in single, mid-nuclear Z-planes. 
Results were similar when data were combined from multiple Z-sections per cell. Puncta with 
Kir2.1 intensity greater than two standard deviations above the background were considered 
Kir2.1+.  
Kir2.1-FLAG-SNAP degradation was analyzed using epifluorescent images (as described 
above) and ImageJ. ROIs were set over cells in the FLAG channel (total Kir2.1) and the mean 
intensity of this ROI was collected from the FLAG channel and the SNAPcell labelled channel 
(pulse-labelled Kir2.1). The ratio of SNAPcell intensity of FLAG intensity was determined for 





was collected form the specified number of cells and combined from 3 individual coverslips 
(separate transfections and labeling) per time point. 
A similar approach was taken to analyze surface staining of Kir2.1-extHA-FLAG-SNAP 
or Kir2.1 internalization. An ROI was drawn over cells in the FLAG channel (total Kir2.1) and 
the mean intensity of the FLAG channel and the HA channel was collected. The intensity of the 
HA channel was normalized against the FLAG intensity for each cell/ROI. This ratio was 
collected form the specified number of cells and combined from 3 individual coverslips (separate 
transfections and labeling) per time point. 
All image analysis was conducted blind to condition. 
Data analysis 
All data analysis was conducted blinded to genotype and treatment. Electrophysiology data 
was analyzed offline using Clampfit Software (Molecular Devices, Sunnyvale, California). 
Statistical analysis was conducted in GraphPad Prism 7 (La Jolla, CA). No explicit power analysis 
was used but group sizes were determined based on past work (Lieberman et al., 2018a; Tang et 
al., 2014). Comparisons between two groups were made with a two-tailed, unpaired t-test. 
Comparisons between 2 or more groups were made with a one-way ANOVA followed by a 
Bonferroni post-hoc test. Comparisons with two variables were made with a two-way ANOVA 
followed by Bonferroni post-hoc tests unless otherwise specified. For electrophysiology N is the 
number of cells recorded from and the number of mice is listed in parentheses. Data were not 
formally tested for being parametric. Some datasets were formally tests for outliers with the 
Grubbs’ test with a cutoff of P<0.05. RNAScope data (puncta per cell) were analyzed with the 





Table 6.1. Statistics split by sex for behavioral experiments in Figure 6.2. 
Sex Genotype (N) Mean (SEM) Statistics 
Rotarod – learning rate (rpm/trial; trial 3- trial 1) 
Male Control (28) 57.29 (10.17) P = 0.0088 
dSPNAtg7cKO (20) 15.85 (8.333) 
iSPNAtg7cKO (11) 22.45 (13.17) 
Female Control (22) 57.18 (12.89) P = 0.0029 
dSPNAtg7cKO (14) 38.43 (12.69) 
iSPNAtg7cKO (12) -11.92 (12.33) 
Combined Control (50-) 57.24 (7.954) P = 0.0001 
dSPNAtg7cKO (34) 25.15 (7.306) 
iSPNAtg7cKO (23) 4.522 (9.526) 
Sex x Genotype F(2,101) = 2.218 p = 0.1141 
Open Field – Distance traveled (cm) 
Male Control (17) 6777 (397.9)  P = 0.0159 
dSPNAtg7cKO (7) 8073 (883.5)  
iSPNAtg7cKO (6) 9318 (573.1) 
Female Control (15) 9307 (369.4) P = 0.0257 
dSPNAtg7cKO (7) 7967 (773.3) 
iSPNAtg7cKO (8) 10433 (584.5) 
Combined Control (32) 7963 (351.7) P = 0.0048 
dSPNAtg7cKO (15) 7762 (585.4) 
iSPNAtg7cKO (15) 9955 (427.4) 
Sex x Genotype F(2,54) = 3.045 p = 0.0558 
Open Field – Last 10 minutes 
Male Control (17) 916.8 (67) P < 0.0001 
dSPNAtg7cKO (7) 1242 (153.7) 
iSPNAtg7cKO (6) 1482 (210.3) 
Female Control (15) 1695 (120.3) P = 0.0260 
dSPNAtg7cKO (7) 1280 (202.2) 
iSPNAtg7cKO (8) 1954 (117.2) 
Combined Control (32) 1259 (91.43) P = 0.0002 
dSPNAtg7cKO (15) 1203 (127.8) 
iSPNAtg7cKO (15) 1912 (108.1) 
Sex x Genotype F(2,54) = 5.598 P = 0.0062 
Open Field – Stereotypies (data normalized) 
Male iSPNCtrl (7) 1.00 (0.030) P = 0.0293 
iSPNcKO (6) 1.136 (0.047) 
Female iSPNCtrl (8) 1.00 (0.038) P = 0.0819 
iSPNcKO (8) 1.094 (0.032) 
Combined iSPNCtrl (15) 1.00 (0.024) P = 0.0043 
iSPNcKO (14) 1.112 (0.027) 






Male iSPNCtrl (7) 2 (1.05) P = 0.20 
iSPNcKO (8) 3.875 (0.915) 
Female iSPNCtrl (8) 2.75 (0.25) P = 0.0266 
iSPNcKO (8) 5.25 (0.98) 
Combined iSPNCtrl (15) 2.4 (0.50) P = 0.0157 
iSPNcKO (16) 4.6 (0.67) 








Table 6.2. Detailed statistical table. 
 
Figure Groups (n;N)*: Mean (sem) Test$ Results p-value 
6.3C 
(left) 
dSPNCtrl (23;5): 26.05 
(77.83) 








iSPNCtrl (12;3): 2640 (128.4) 
















































dSPNCtrl (15;5): 1.428 
(0.062) 








iSPNCtrl (8;3): 1.062 
(0.07246) 


















iSPNCtrl (22;5): 3.192 
(0.2325) 








dSPNCtrl (19;5): -11.03 
(0.5341) 








iSPNCtrl (23;5): -9.669 
(0.4282) 












dSPNCtrl (17;5): 3.351 
(0.2287) 








iSPNCtrl (20;5): 3.480 
(0.2026) 








dSPNCtrl (17;5): 9.972 
(0.3499) 








iSPNCtrl (21;5): 9.950 
(0.3571) 






6.4B iSPNCtrl (34;7): -77.54 
(0.5402) 






6.4C iSPNCtrl (32;7): 162 (7.628) 






6.4D iSPNCtrl (26;7): 165.4 (7.917) 






6.4E iSPNCtrl (32;7): 72.75 (3.425) 










Current: F(13,772) = 
62.06 
Genotype: F(1,772) = 
23.37 













Current: F(10,400) = 
421.5 
Genotype: F(1,40) = 
6.586 











D = 0.08428 0.5688 









6.6E iSPNCtrl (5): 1.142 (0.3889) 






6.6F iSPNCtrl (14): 1 (0.05291) 






6.6G iSPNCtrl (7): 1 (0.4578) 






6.6H iSPNCtrl (7): 1 (0.4917) 






6.6J Veh (15): 12.6 (1.650) 
BafA1 (8): 43.25 (7.490) 
Atg5KO (6): 0.6667 (0.3333) 
One-way 
ANOVA 
F2,26 = 25.64 <0.0001 
6.6L Atg5WT: 19.92 (2.690) 




T23 = 3.083 0.0053 
6.6M Atg5WT: 
0 min (35) 
30 min (30) 
60 min (25) 
180 min (33) 
360 min (40) 
Atg5KO: 
0 min (30) 
30 min (27) 
60 min (38) 
180 min (67) 
360 min (20) 
Two-way 
ANOVA 
Time: F4,335 = 6.071 
Genotype: F1,335 = 
40.49 








0 min (76) 
30 min (52) 
60 min (41) 
120 min (28) 
Atg5KO: 
0 min (56) 
30 min (37) 
60 min (42) 
120 min (38) 
Two-way 
ANOVA 
Time: F3,362 = 25.88 
Genotype: F1,362 = 
25.88 













Current: F(14,252) = 
150.5 
Genotype: F(1,18) = 
2.962 











6.11E Atg5WT (55): 1.00 (0.089) 





6.11F Atg5WT (49): 0.9360 (0.1028) 










Fraction: F2,12 = 
43.47 
Genotype: F1,6 = 
0.1245 
Intx: F2,12 = 0.1053 
 
DARPP32: 
Fraction: F2,12 = 
33.30 
Genotype: F1,6 = 
0.1975 
Intx: F2,12 = 2.040 
 
Kir2.1: 
Fraction: F2,12 = 
99.16 
Genotype: F1,6 = 
9.373 
Intx: F2,12 = 2.217 
 
Kir2.3: 
Fraction: F2,12 = 
101.2 
Genotype: F1,6 = 
6.615 
Intx: F2,12 = 3.649 
 
Kv1.2: 
Fraction: F2,12 = 
10.43 
Genotype: F1,6 = 
2.236 






























































Time: F(1,390) = 32.56 
Kir Genotype: F(3,390) 
= 3.211 

















Cell genotype: F(1,42) 
= 6.584 
Kir Genotype: F(1,42) 
= 3.800 









6.13G WT (12): 1.000(0.03576) 





* In figures 6.3-6.4, n is the number of cells, N is the number of mice. In figure 6.6A-H and 
6.11J, n = number of mice. In Figure 6.6J-N, 6.11E-F, and 6.13C-G, n is the number of cells 
(combined from at least three independent biological replicates).  
$ Post hoc analysis: for two way ANOVA, I used Bonferroni post-hoc test. For one way 





Table 6.3. Intrinsic excitability in dSPNs. 












































Table 6.4. Primers used in this study. 
Primer Sequence Notes 
MF3 AAAAAACTCGAGATGGGCAGTGTGAGAACCAAC 5' Kir cloning 
XhoI 
MF4 AAAAAAGGATCCGTTATCTCCGATTCTCGCCTTA  3' Kir cloning 
BamHI 
MF12 fwd ccagtgctctttgaagagaGacactactataaagta K334R fwd 
SDM 
MF12 rev tactttatagtagtgtCtctcttcaaagagcactgg K334R rev 
SDM 
MF13 Fwd gagaaacactactataGagtagactattcaagattc K338R fwd 
SDM 
MF13 Rev gaatcttgaatagtctactCtatagtagtgtttctc K338R rev 
SDM 
MF14 Fwd agactattcaagattccataGgacttatgaagtacctaa K346R fwd 
SDM 
MF14 Rev ttaggtacttcataagtcCtatggaatcttgaatagtct K346R rev 
SDM 
MF23 AAAAAAAAGCTTatgggcagtgtgagaaccaac 5' Kir2.1 --> 
pcDNA 
HINDIII 
MF41 Rev tactttatagtagtgttGctcttcaaagagcactgg K334Q rev 
SDM 












Table 6.5. Plasmids used in this study. 
Plasmid Notes Source 
FUGW-VAMP2-FLAG-
SNAP 
 (Sheehan et al., 2016) 
pAAV-mmKir2.1  Gift of C. Kellendonk 
FUGW-mmKir2.1-FLAG-
SNAP 
PCR-subcloning of mmKir2.1 from 
pAAV-mmKir2.1 to FUGW-





HA tag (YPYDVPDYA) inserted at 
amino acid 114 of Kir2.1 




Site-directed mutagenesis of 




Site-directed mutagenesis of 




Site-directed mutagenesis of 




Site-directed mutagenesis of 




Site-directed mutagenesis of 




Site-directed mutagenesis of 
mmKir2.1 à K346R 
This study 
pcDNA3-EGFP  Addgene 13031 
pcDNA3-mmKir2.1-EGFP PCR-subcloning of mmKir2.1 from 
FUGW-mmKir2.1-FLAG-SNAP to 





PCR-subcloning of mmKir2.1 from 
FUGW-mmKir2.1-ExtHA-FLAG-
SNAP to pcDNA3-EGFP using 
































pcDNA3-EGFP using HindIII 
BamHI sites 
This study 






Table 6.6. Antibodies used in this study.  








































































































































































































































Chapter 7: General Discussion and Future Directions 
 Here, I have explored the role of molecular and circuit factors in the postnatal maturation 
of the striatum.  
Taking advantage of a spontaneous mutant mouse identified at Jackson Laboratories and 
first reported in 1968 that lacks the nigrostriatal dopaminergic projection, I demonstrated in 
Chapter 3 that DA signaling is required for the maturation of dSPN intrinsic excitability. 
Electrophysiological and biochemical experiments revealed that DA induces a reduction in dSPN 
intrinsic excitability via the lipid PIP2 and Kir2 channels. Importantly, DA replacement could 
rescue dSPN hyperexcitability when given from P0-P28 or P18-28 but not when initiated in 
adulthood. These results provide evidence for a non-cell autonomous mechanism that contributes 
to striatal maturation. 
In Chapter 4, I present what is, to my knowledge, the first characterization of ChI 
electrophysiology during postnatal development. I show that ChI spontaneous firing frequency 
increases from P10 through adulthood. Using whole cell recordings, I found that an initial 
increase in ChI activity between P14 and P18 results from a decrease in the 
afterhyperpolarization and subsequent increases in ChI firing frequency most likely arise from 
increased Ih. The functional consequence of immature ChI activity was enhanced frequency-
dependence of DA release. These results could explain changes locomotion and motivation 
during the juvenile period in rodents (Altman and Sudarshan, 1975; Hall et al., 1977; Westerga 
and Gramsbergen, 1990).  
In Chapters 5 and 6, I explored the role of autophagy in the striatum. Originally studied in 





circuit development and neurotransmission. However, nothing is known about the function of 
autophagy in striatal physiology. This is a particularly interesting question given that previous 
studies on autophagy in nervous system function have focused on excitatory projection neurons 
while SPNs are GABAergic and autophagy has been implicated in the pathophysiology of 
developmental disorders such as ASD which can involve striatal pathology.  
I began in Chapter 5 by discovering that autophagic flux is elevated early in the juvenile 
period and steadily declines before reaching adult levels around P28. I then used pharmacology 
to demonstrate that this developmental suppression of autophagy occurs because mTOR activity 
increases between P10 and adulthood. These results suggest that autophagy is tightly regulated 
during postnatal development of the striatum but left unanswered what function autophagy may 
have in striatal physiology.  
To address this, I generated conditional knockouts of a required autophagy gene, atg7, in 
dSPNs or iSPNs and describe their phenotype in Chapter 6. Using patch-clamp 
electrophysiology, I found that autophagy regulated synaptic inputs onto dSPNs but not onto 
iSPNs. In contrast, autophagy loss in iSPNs led to intrinsic hyperexcitability, which arose 
because autophagy was required for the degradation of modified, and inactive, Kir2 channels. 
These results suggest a cell-type specific mechanism for the control of neural activity by 
autophagy.  
In this chapter, I will discuss several themes that connect these four chapters, future 






7.1 Common themes 
7.1.1 Convergence on the Regulation of Intrinsic Excitability 
 Although sometimes neglected relative to changes in synaptic transmission or plasticity, 
altered intrinsic excitability can disrupt neural circuits with equal devastation. Here, I have 
examined the effect of two insults with some connection to neurodevelopmental diseases, 
developmental loss of DA (Volkow et al., 2007, 2009) and reduced autophagy (Lieberman et al., 
2018b; Poultney et al., 2013; Tang et al., 2014; Yan et al., 2018), on striatal physiology. I took an 
unbiased approach, patch-clamp electrophysiology, to define changes in SPN physiology in 
transgenic mice lacking striatal DA or autophagy.  
 The fact that both of these manipulations converge on the regulation of a potassium 
channel in SPNs suggests that SPN intrinsic excitability is tightly regulated and emphasizes how 
important it is for striatal physiology and function. SPNs were originally described in blind 
recordings as a population of striatal neurons with low tonic firing rates (Crutcher and DeLong, 
1984a, 1984b; Kimura et al., 1984; Liles, 1985). Intracellular recordings by Wilson and others 
demonstrated that SPN intrinsic conductances hold the cell near the potassium reversal potential 
in the absence of synaptic inputs and strongly oppose depolarizing synaptic inputs (Wilson, 
1993; Wilson and Groves, 1981; Wilson and Kawaguchi, 1996). During postnatal development, 
SPN activity reaches maturity around P28, almost one week after the completion of excitatory 
synaptogenesis but around the time that full inward rectification and mature intrinsic excitability 
is present (Hattori and McGeer, 1973; Lieberman et al., 2018a; Peixoto et al., 2016; Tepper et 
al., 1998). Finally, in mouse models of schizophrenia and drug addiction, SPN intrinsic 
excitability is elevated (Cazorla et al., 2012; Dong et al., 2006). These data led to speculation 





filtering extraneous synaptic inputs; however, little is known about the molecular mechanisms 
that control the development of adult-like SPN intrinsic excitability or maintain SPN intrinsic 
excitability in adulthood.  
 Most reports describing changes in SPN intrinsic excitability in transgenic animals or 
following neurotoxic lesions find that they arise as homeostatic responses to synaptic deficits or 
atrophy of the dendritic tree. For example, work from Surmeier and others have demonstrated 
dSPN hyperexcitability in parkinsonian mice and rats (Azdad et al., 2009; Fieblinger et al., 2014, 
2018; Suárez et al., 2014; Warre et al., 2011). However, these have been ascribed to homeostatic 
responses to (1) loss of DA signaling or (2) loss of dendritic spines and excitatory inputs 
following DA denervation. The converse has also been reported; Kellendonk and Cazorla virally 
overexpressed Kir2.1 in SPNs and found a reduction in SPN dendritic length and arbor 
complexity (Cazorla et al., 2012). These reports suggest that SPNs carefully modulate their 
intrinsic excitability in response to changes in the strength of synaptic inputs.  
Remarkably, loss of DA signaling led to dSPN hyperexcitability and loss of autophagy 
led to iSPN hyperexcitability without changes in dendritic arborization or detectable changes in 
synaptic inputs. One possible explanation for this is that loss of autophagy and DA signaling had 
primary effects on excitability that would have led to homeostatic changes in synaptic inputs or 
dendritic arborization at later time points. In fact, a recent report demonstrated dendritic atrophy 
and synaptic changes in 6-month old Pitx3KO mice (Suarez et al., 2018). However, the time 
course of homeostatic changes is significantly faster following adult DA depletion, happening 
within 3-4 weeks of the lesion (Azdad et al., 2009; Fieblinger et al., 2014, 2018; Suárez et al., 
2014; Warre et al., 2011), while I did not observe a change in dendritic arborization at P28 in 





SPNs may be developmentally regulated and not fully present during the first postnatal month. 
Age-dependent homeostatic plasticity would be distinct for the striatum compared to cortical 
areas, which show homeostatic plasticity as early as the first postnatal week in response to 
changes in sensory experience (Tien and Kerschensteiner, 2018; Turrigiano and Nelson, 2004). 
Future work should aim to understand the molecular mechanisms that control homeostatic 
plasticity in the adult SPN and address whether these are developmentally regulated.  
In conclusion, this work highlights the importance of understanding the regulation of 
intrinsic excitability in SPNs and the crosstalk between synaptic strength and intrinsic 
excitability.  
7.1.2 Developmental Regulation of Molecular Signaling 
 An additional theme in this work is that molecular signaling pathways, mostly studied in 
adults, are developmentally regulated.  
In Chapter 3, I demonstrate a non-canonical coupling between D1R signaling on dSPNs 
with PIP2 levels. This is non-classical for a number of reasons, including the fact that D1R signal 
primarily through PKA via Ga,s and Ga,olf (Corvol et al., 2001; Hervé et al., 1993) whereas 
GPCR-control of PIP2 levels primarily occurs via Gq coupled receptors (Hilgemann et al., 2001). 
Although I did not fully elucidate the signaling pathway that mediates this effect, I do find that 
that D1R stimulation no longer couples to PIP2 in adult animals that have been DA-depleted 
from birth (adult Pitx3KO mice). These data suggest that crosstalk between signaling pathways 
may be distinct in early postnatal development but require receptor stimulation, in this case by 
DA, to mature to the adult-state. Considering the existing literature that D1R coupling to 





suggests both that neuromodulators that affect striatal development and drugs of abuse may have 
distinct effects on striatal circuits during the juvenile period.  
In Chapter 5, I also touch on this theme by showing that basal activity of mTOR 
signaling increases during the third postnatal week. In this work, I relate this to control of 
autophagy; however, mTOR signaling has numerous downstream effectors including protein 
synthesis (Bockaert and Marin, 2015). This wave of mTOR activity may, therefore, remodel the 
SPN proteome via changes in protein degradation and synthesis. Why does mTOR activity 
change at this age? During the third postnatal week, excitatory synaptogenesis (Hattori and 
McGeer, 1973; Tepper et al., 1998), increased DA release (Chapter 3) and maturation of ChIs 
(Chapter 4) occurs which may affect receptor activity upstream of mTOR. Alternatively, the 
effect could occur secondary to changes in the efficacy of receptor coupling to downstream 
kinases such as mTOR or decreases in opposing signaling cascades mediated by AMPK (Kim et 
al., 2011). Regardless, these possibilities warrant further exploration into the biochemistry of 
molecular signaling during different developmental stages.  
How could the maturation of molecular signaling affect striatal physiology? The work of 
Lovinger and others has clearly shown that protocols that induce synaptic plasticity in the adult 
lead to different alterations in synaptic strength in rodents younger than P21 (Ade and Lovinger, 
2007; Choi and Lovinger, 1997; Partridge et al., 2000; Tang et al., 2001). Directly connecting 
these alterations with changes in molecular signaling pathways within the SPN would be an 
attractive future direction. In addition, my work in Chapter 3 suggests that, without appropriate 
receptor stimulation (ie DA signaling through D1R) at the appropriate time (~P18-P28), 





Thus, this work highlights a developmental plasticity in molecular signaling pathways 
within the SPN that may lead to differential transduction of external signals to adaptations in 
neural activity.  
7.1.3 Cell-type Specific Mechanisms in the Control of Striatal Physiology. 
  A final key theme in this dissertation is the cell-type specific biology between SPN 
subtypes. In Chapter 3, I demonstrate that DA is required for the maturation of dSPN intrinsic 
excitability but not for the maturation of iSPN intrinsic excitability. In Chapter 6, I show that 
autophagy regulates distinct aspects of SPN physiology between subtypes: synaptic inputs and 
dendritic arborization in dSPNs and intrinsic excitability in iSPNs.  
 The cell-type specific effects that I report here are puzzling for several reasons. First, the 
two populations of SPNs are intermingled and morphologically indistinguishable in the striatum  
(Kreitzer, 2009). They also diverge late during embryonic development, suggesting further that 
they may share common cell biology (Tinterri et al., 2018). Finally, relatively few genes are 
differentially expressed between dSPNs and iSPNs in adults (Heiman et al., 2008; Saunders et 
al., 2018). This suggests that there remains an unexplored area of SPN biology that may underlie 
cell-type specific differences reported here.  
 The fact that DA affects dSPN maturation but iSPN maturation could be easily explained 
by differential expression of D1R. However, iSPN intrinsic excitability matures with the same 
time course as dSPNs (See Chapter 3, Figure 3.1), suggesting that an alternative factor must be 
present to initiate iSPN maturation but is not sufficient for dSPN maturation. Possible candidates 





 In contrast, the differential effect of loss of autophagy is more difficult to explain. This 
point has already been discussed above in the discussion of Chapter 6. However, it is important 
to point out here that no obvious candidates, such as cargo adapters, emerge from transcriptomic 
data that would explain differences in the specificity of autophagic degradation between SPN 
subtypes. An alternative possibility is differences in overall vesicle trafficking and lipid 
dynamics between SPN subtypes. This could potentially explain the cell-type specificity of 
dSPN maturation observed in Chapter 3 and the effect of loss of autophagy in Chapter 6 as 
phosphotidylinositol lipids contribute to vesicular identity (Cremona and De Camilli, 2001; 
Odorizzi et al., 2000) and to Kir2 channel activity (Hibino et al., 2010). Furthermore, one could 
imagine that these differences would not be detected in published transcriptomic approaches 
(Heiman et al., 2008; Saunders et al., 2018). Future studies could address these cell biological 
questions in the acute brain slice using cell-type specific tagging of different regulatory proteins 
involved in these processes. Additionally, cell-type specific, or even compartment-specific 
proteomics could provide an unbiased survey of the molecular constituents of SPN subtypes. 
 To conclude, these open questions suggest that generalizing the role of specific biological 
pathways in cellular function within the nervous system, which is made up of innumerable cell 
types, has significant limitations. In contrast, a comparative approach, between cell types within 
a single brain nucleus (dSPN vs iSPN) or between nuclei (SPNs vs cortical pyramidal neurons) 
can yield important insights into neuronal cell biology.  
7.2 Implications for neurodevelopmental disease 
 I will limit extrapolation of the data I presented here to human disease except for two 
salient points. First, the increasing therapeutic and recreational use of stimulants (Raman et al., 





vaping (Miech et al., 2019) in adolescents, highlight the importance of studies aimed at 
understanding the effects of these drugs on normal brain development.  Some of the effects of 
these drugs have been proposed to be mediated by the striatum (Volkow et al., 2001, 2009; Zhou 
et al., 2001). Future efforts to elucidate the effect of these drugs on striatal circuitry can build off 
the framework of striatal development that I report here.  
Second, these results highlight the importance of longitudinal studies of animal models in 
the study of neurodevelopmental diseases. Identifying the first deficit in neurophysiology, and 
designing therapeutics to target this step, in animal models of neurodevelopmental disorders 
could enhance the opportunity to have disease-modifying effects. Current efforts to develop treat 
neurodevelopmental disorders with drugs that correct circuit deficits in adults may not correct 
the pathological change but instead target homeostatic, and perhaps still maladaptive, 
mechanisms that arise as a result of the primary defect. Finally, better diagnostics and 
biomarkers are necessary preliminary steps in the pursuit of such disease-modifying agents, as 
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